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Abstract 
 
 
Adipose tissue development is regulated by a complex interaction between 
the local actions of insulin, glucocorticoids and insulin like growth factors 
(IGFs). A series of experiments was undertaken in which the normal 
development of individual adipose tissue depots and their development 
following periconceptional under- and overnutrition, formula feeding and 
juvenile obesity was investigated in sheep. Expression and abundance of 
glucocorticoid receptor (GR), 11ȕ-K\GUR[\VWHURLG GHK\GURJHQDVHV ȕ-
HSDs), insulin receptor, p85 subunit of phosphatidylinositol 3-kinase (p85), 
glucose transporter 4 (Glut4), insulin like growth factor (IGF) 1 and 2 and 
their receptors (IGF-R) were measured as markers of sensitivity to 
glucocorticoids, insulin and IGFs in individual adipose tissue depots. 
 
It was found that during early postnatal life omental adipose tissue grows 
faster than other depots. In all investigated groups there were marked 
differences in the expression of all investigated genes between adipose 
tissue depots.  
No effect was found of periconceptional nutrition on expression of the 
investigated genes. Weight of the mother prior to conception was negatively 
associated with omental GR and 11ȕ-HSD1. Free fatty acid levels at 4 
PRQWKV RI DJH ZHUH UHODWHG WR RPHQWDO DQG VXEFXWDQHRXV ȕ-HSD1 
expression. Perirenal expression of IGF1R at 4 months was negatively 
Abstract XIV 
   
correlated with perirenal and subcutaneous adipose tissue mass. IGF1R 
expression correlated with IR and GR expression.  
Formula feeding resulted in reduced expression of Glut4 and increased ȕ-
HSD1 expression.  
A combination of formula feeding and juvenile obesity resulted in a 
redistribution of adipose tissue in favour of the perirenal depot. Obesity per 
se resulted in a reduction of the expression of all genes and proteins 
examined.   
 
We have shown significant differences in markers of tissue sensitivity to the 
actions of insulin, glucocorticoids and insulin like growth factors between 
different adipose tissue depots in the body, highlighting the importance of 
examining those depots individually in future studies. 
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1. Literature Review 
 
1.1 Obesity in our present society 
 
In our present day society obesity is a massive health problem. Obesity is 
defined as a body mass index (BMI) of 30 kg/m2 or higher and overweight is 
defined as a body mass index of 25 kg/m2 or higher. The WHO estimated 
that globally 1.6 billion adults were classified as overweight, while 400 million 
were classified as obese in 2005 (WHO, 2006), furthermore the WHO 
predicts that by 2015 these numbers will have risen to 2.3 billion adults being 
classified as overweight and 700 million being classified as obese (WHO, 
2006). 
In England 43% of men and 33% of women are considered overweight, while 
22% of men and 24% of women are classified obese (BHF, 2006). The 
number of obese adults has increased by more than 50% during the last 
decade (BHF, 2006).  
According to the World Health Organization, 8-15% of all disease burden in 
developed countries is caused by overweight and obesity and 21% of all 
cases of coronary heart disease (CHD) are caused by overweight (Murray & 
Lopez, 2002).  
Of particular worry is the prevalence of obesity amongst children. In the 
United States 16% of children aged 2-19 years were considered obese in 
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2001-2002 (Hedley et al., 2004), while in the same period in Australia 5% of 
primary school children were obese. It has been shown that approximately 
25-50% of obese children will remain obese in adulthood (Hedley et al., 
2004).  
Obesity is an important risk factor for the metabolic syndrome, which is a co-
occurrence of four metabolic risk factors and diseases; insulin resistance, 
type 2 diabetes mellitus (T2DM), dyslipidaemia and hypertension (Reaven, 
1993). The metabolic syndrome is, like obesity, an important risk factor for 
the development of cardiovascular disease (CVD). CVD and T2DM are the 
major health problems in westernised countries accounting for 40% of all 
deaths in the United Kingdom (UK) in 2003 (BHF, 2005). Coronary heart 
disease and stroke are the two major clinical outcomes of CVD. Coronary 
heart disease on its own is estimated to cost the UK economy about £7900 
million a year  (BHF, 2005).  
The metabolic risk factors associated with obesity are dependent on the 
regional organisation (distribution) of adipose tissue: increased central i.e. 
around the viscera, as opposed to peripheral e.g. subcutaneous adipose 
tissue is associated with higher cardiovascular risk (Krotkiewski et al., 1983; 
Fujioka et al., 1987; Despres et al., 1989; Pouliot et al., 1992; Wajchenberg, 
2000; Busetto, 2001; Miyazaki et al., 2002; Misra et al., 2004; Despres & 
Lemieux, 2006).  According to the INTERHEART case-control study 
approximately 63% of all heart attacks in Western Europe are secondary to 
abdominal obesity (Yusuf et al., 2004). The risk of a heart attack doubles in 
people with an increased waist-hip ratio (WHR) compared to people with a 
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normal WHR (Yusuf et al., 2004). The surgical removal of visceral adipose 
tissue leads to an improvement in metabolic status both in rodents and in 
humans (Gabriely et al., 2002; Thorne et al., 2002; Gabriely & Barzilai, 
2003). A study by Butler and colleagues indicated that in adults of 20 years 
and older truncal skinfold thickness could independently predict the 
development of type 2 diabetes (Butler et al., 1982). The prevalence of 
FHQWUDO REHVLW\ GHILQHG DV D :+5   LQ PHQ DQG :+5   LQ
women) in England was 33% in men and 30% in women in 2003 (BHF, 
2006). 
Because of the enormous impact that visceral obesity has on our society, 
particularly on our health and economy, it is important to understand the 
underlying aetiology of the development of visceral obesity. 
 
1.2 Programming of adipose tissue depots in early life 
 
A large number of studies have investigated factors in early life that can 
program the onset of obesity and cardiovascular diseases in childhood and 
adulthood. In 1986 Barker and hLVFROOHDJXHVGHVFULEHGWKH³HDUO\´RULJLQVRI
DGXOW GLVHDVH K\SRWKHVLV ZKLFK VWDWHG WKDW µenvironmental factors, 
particularly nutrition, act in early life to program the risks for the early onset of 
cardiovascular and metabolic disease in adult life¶ (Barker & Osmond, 1986). 
They based this hypothesis on the observation that the geographical 
distribution of mortality rates of ischaemic heart disease in England and 
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Wales during 1968 - 1978 was strongly related to the geographical 
distribution of neonatal mortality rates during 1921 - 1925 (Barker & 
Osmond, 1986).  
Studies that investigated the effects of the Dutch hunger winter of 1944 ± 
1945 have further confirmed this hypothesis. Women that were pregnant 
during the Dutch hunger winter of 1944 - 1945 produced offspring that were 
more likely to become obese and suffer from other metabolic diseases such 
as diabetes and hypertension in later life (Ravelli et al., 2000; Roseboom et 
al., 2001, 2003).  
 
Numerous other studies have further investigated the early origins of adult 
health and disease hypothesis and a strong relationship between birth weight 
and the development of obesity in later life has been demonstrated (McMillen 
& Robinson, 2005; Taylor & Poston, 2007; Vickers et al., 2007; Yajnik & 
Deshmukh, 2008).  
Some of the studies that confirmed this relationship were large studies that 
followed the 1958 British birth cohort. Studies based on the British birth 
cohort demonstrated that a combination of low birth weight and a high 
postnatal growth rate amplified the risk of developing obesity (Ravelli et al., 
1976; Parsons et al., 2001). Another study examined the relationship 
between early growth patterns and the development of obesity in adulthood 
in a French cohort of 21-27 year olds with intra-uterine growth restriction or 
normal intra-uterine growth. It found that early growth patterns were not 
associated with body weight or BMI, but that a pattern of rapid growth in 
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early life was associated with an increase in the percentage body fat mass 
(Jaquet et al., 2000). 
Several other studies confirmed that small for gestational age (SGA) infants 
are more likely to have accelerated growth in early postnatal life, so-called 
µFDWFK-XS JURZWK¶ (Fitzhardinge & Steven, 1972; Albertsson-Wikland et al., 
1993)  and that SGA infants have a higher relative body fat mass from 2-12 
months of age (Hediger et al., 1998; Ong et al., 2000; Brown et al., 2002; 
Gray et al., 2002; Cole, 2004). These relationships between birth weight and 
catch up growth and adipose tissue mass in later life are also found in other 
large mammals such as sheep and pigs (Greenwood et al., 1998; Poore & 
Fowden, 2004; Louey et al., 2005; De Blasio et al., 2007). 
 
A large body of evidence has indicated that birth weight is not only related to 
the development of obesity in later life, but also to a distribution of adipose 
tissue which favours the central areas. The 1979 Amsterdam Growth and 
Health Longitudinal Study found associations between low birth weight 
(LBW) and a high waist circumference (in females) or a high waist-hip ratio 
(in males) in adult life (Te Velde et al., 2003). Another study which looked at 
7 to 12 year old American school children found that LBW was associated 
with relatively more central subcutaneous adipose tissue and an increase in 
truncal fat (Malina et al., 1996). It estimated that 2-8% of the variation in 
relative subcutaneous adipose tissue distribution at school age is explained 
by variation in birth weight (Malina et al., 1996). While Barker and colleagues 
estimated that for every kilogram decrease in birth weight resulted in a 7% 
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increase of subscapular skinfold thickness (Barker et al., 1997). Loos and 
colleagues compared male twins at the age of 18-34 years. They found that 
the twin who was lighter at birth was also shorter and lighter as an adult, had 
a higher waist-hip ratio and less lean body mass compared to his heavier 
sibling (Loos et al., 2001).  Comparisons between Indian and Caucasian 
babies also indicated that poor intra-uterine growth was a predictor of a 
higher central adipose tissue mass at the age of 8 years (Bavdekar et al., 
1999; Yajnik, 2000). 
Other studies found that growth restricted infants with catch up growth had 
an increased body mass index during the first year of life (Jaquet et al., 
1999) and a higher body mass index, higher adipose tissue mass and an 
increase in truncal fat distribution during childhood (Ong et al., 2000) and in 
adult life (Law et al., 1992; Leger et al., 1997; Jaquet et al., 2001; Parsons et 
al., 2001). 
Numerous experimental animal models have been developed that mimicked 
the relationship between intra-uterine growth restriction, catch up growth and 
central adiposity in later life. Maternal nutrient restriction in sheep and other 
animals did not lead to offspring with low birth weight, but did lead to 
offspring with increased postnatal growth rate, increased prevalence of 
obesity during childhood and an increase in visceral adipose tissue 
distribution (Heasman et al., 1999; Poore & Fowden, 2004; Ford et al., 2007; 
Symonds et al., 2009). Vickers and colleagues showed that rat pups that 
were low birth weight as a result of maternal nutrient restriction, had an 
increased feed intake from weaning to adulthood, which was associated with 
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a greater retroperitoneal and gonadal adipose tissue mass. They also 
showed that these pups had higher levels of circulating leptin and insulin, but 
not glucose (Vickers et al., 2000; Vickers et al., 2001).  
Other models that are often used to study the effects of a poor early 
nutritional environment on the development of adipose tissue are the models 
of placental restriction (PR). PR can be experimentally induced by uterine 
carunclectomy, maternal hyperthermia, single umbilical artery ligation, 
bilateral uterine artery ligation, placental embolisation and overfeeding of the 
adolescent ewe (Simmons et al., 2001; Morrison, 2008). Placental restriction 
in sheep has been shown to result in asymmetrical foetal growth restriction 
with a higher reduction in body weight compared to crown-rump length or 
girth (Owens et al., 1994; Robinson et al., 1994; Kind et al., 1995). Offspring 
of rats with placental insufficiency have increased postnatal growth rates and 
increased perirenal, gonadal and omental adipose tissue masses (Simmons 
et al., 2001). Lambs that have been placentally restricted in utero have an 
increased postnatal growth rate, an increase in relative perirenal fat mass 
and an increase in whole body insulin sensitivity compared to controls at 6 
and 8 weeks of age, as indicated by the capacity of insulin to suppress 
circulating FFA levels (Louey et al., 2005; De Blasio et al., 2007). 
7KH µWKULIW\ SKHQRW\SH K\SRWKHVLV¶ SURYLGHV D PHFKDQLVP WKDW H[SODLns the 
relation between low birth weight or a sub-optimal intra-uterine environment 
and the development of obesity in later life. The hypothesis states that poor 
nutrition in early life leads to permanent programmed changes in glucose-
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insulin metabolism in the offspring leading to an increase in insulin 
resistance in later life (Hales & Barker, 2001). 
 
It is clear that a restriction in nutrient supply during pregnancy can have 
detrimental effects on the later health of offspring, but it appears that these 
effects can even find their origin earlier in life during the periconceptional 
period. Exposure of the oocyte and/or embryo to maternal undernutrition 
(periconceptional undernutrition; PCUN) resulted in a decrease in foetal 
weight and an increase in relative perirenal adipose tissue in twin 
pregnancies in sheep (Edwards et al., 2005). Furthermore, a relationship 
was seen in twin pregnancies between weight loss of the ewe and placenta 
and offspring size, such that an increase in weight loss resulted in relatively 
heavier placentae and larger foetuses at 55 days of gestation (MacLaughlin 
et al., 2005). Furthermore, it has been shown that PCUN in sheep results in 
an increase in arterial blood pressure in the foetus and an increased and 
precocious activation of the HPA axis during late gestation (Edwards & 
McMillen, 2002a, b; Edwards et al., 2005). 
When maternal undernutrition extends from the periconceptional period into 
early pregnancy (i.e. from 60 days prior to conception and up to 30 days of 
pregnancy) a reduced foetal growth rate occurs with hyperactivation of the 
HPA axis and an increase in premature deliveries in sheep (Bloomfield et al., 
2003; Oliver et al., 2005) 
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As opposed to challenges that restrict the nutritional supply to the foetus an 
increasing number of researchers are investigating the effects of an 
increased supply of nutrients to the foetus on the development of obesity. 
Rats that were fed a diet that consisted of 24% fat produced offspring with 
an increased body weight and and increased visceral adipose tissue mass 
(Khan et al., 2003; Khan et al., 2004; Taylor et al., 2005). 
Similar observations are seen in women who are obese during pregnancy. 
Obese women are more likely to develop gestational diabetes or reduced 
insulin sensitivity (Sebire et al., 2001; LaCoursiere et al., 2005). The 
increased nutrient supply, associated with the reduction in insulin sensitivity, 
can result in increased growth of the foetus and macrosomia (Sebire et al., 
2001; Yajnik et al., 2002; Bergmann et al., 2003; Catalano et al., 2003; 
Gillman et al., 2003; Jensen et al., 2003; Ehrenberg et al., 2004). Catalano 
and colleagues showed that the strongest predictor of foetal fat accretion 
was pregravid maternal insulin sensitivity. They hypothesised that obese 
women, having lower insulin sensitivities, are therefore more at risk of having 
a large baby (Catalano et al., 1995). The Hyperglycaemia and Adverse 
Pregnancy Outcome Study Cooperative Research Group found that even in 
normal maternal glucose ranges there is an association between maternal 
glucose levels and birth weight of the offspring (Metzger et al., 2008), while 
Jensen and colleagues showed that even in women with a normal glucose 
tolerance, obesity or being overweight was still associated with an increased 
risk of macrosomia (Jensen et al., 2003). 
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In addition, babies that are born with a high birth weight are more likely to 
stay heavy throughout childhood and adulthood and thus have an increased 
risk of obesity in adulthood (Curhan et al., 1996a; Curhan et al., 1996b; 
Sorensen et al., 1997; Rasmussen & Johansson, 1998; Parsons et al., 2001; 
Pietilainen et al., 2001; Gillman et al., 2003; Oken & Gillman, 2003). Whether 
obesity during the periconceptional period and during pregnancy affects the 
distribution of adipose tissue in the offspring has yet to be established. 
A possible mechanism that explains the relation between high birth weight 
and obesity in later life could be a genetic predisposition. Furthermore an 
increase in adipose tissue at birth, as is likely to be present in the high birth 
weight infant, leads to an increase of FFA exposure to the liver which 
ultimately leads to reduced skeletal muscle insulin sensitivity and therefore 
increased lipogenesis which leads to further adipose tissue growth and a 
perputeous cycle. This cycle and the underlying mechanism of this cycle are 
described in more detail in section 1.3.4.2. 
 
Another nutritional challenge that could affect adipose tissue development 
and nutrition occurs during a critical period in early postnatal life, lactation. 
The effect of breastfeeding on the incidence of obesity and cardiovascular 
risk factors in adulthood has been a subject of debate in many studies over 
the last decades. Numerous studies in developed and developing countries 
have shown that breastfeeding leads to a reduced prevalence of obesity or 
overweight at school age and later on in life and that this effect is still present 
when confounding factors such as social class are taken into account (Pettitt 
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et al., 1997; von Kries et al., 1999; Toschke et al., 2002). Some studies also 
showed a dose response relation between the duration of breastfeeding and 
the risks of developing obesity or overweight later in life (von Kries et al., 
1999; Gillman et al., 2001). Interestingly, a study of the Dutch famine cohort 
showed no difference in BMI, waist-circumference and waist-hip ratio 
between breast and formula fed individuals (Ravelli et al., 2000). Several 
large meta-analyses have been performed in order to elucidate the real 
relationship between breastfeeding and obesity. The general conclusion was 
a small but significant protective effect of breastfeeding on the incidence of 
obesity later in life (Dietz, 2001; Dewey, 2003; Arenz et al., 2004; Harder et 
al., 2005; Owen et al., 2005). Both Harder and colleagues and Owen and 
colleagues managed to confirm a dose response relationship in their meta-
analyses (Harder et al., 2005; Owen et al., 2005); whilst Dewey and 
colleagues concluded that the protective effect of breast feeding was more 
prominent in adolescence compared to childhood, suggesting a programmed 
effect (Dewey, 2003).  
 
It seems to be clear that challenges of over- or undernutrition during the 
periconceptional, gestational and immediate postnatal period can have long 
lasting effects on health in later life, including significant changes in the 
prevalence of obesity and in particular visceral adipose tissue. The 
mechanisms that are responsible for these programmed effects, and 
particularly for the effect of increased visceral adipose tissue, are not 
completely elucidated yet and are subject of this study. 
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Cross ref show s a summary of animal models used to investigate 
challenges in early life on obesity (Error! Reference source not found.). 
 
 
 
Table 1.1; Summary of animal models used to investigate challenges in early life on 
obesity 
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1.3 Adipose tissue growth and development 
Adipose tissue is an abundant tissue in the adult human body. Average body 
composition of an adult man is 9-18% adipose tissue and of an adult woman 
is 14-28% adipose tissue (DiGirolamo & Fine, 2000). Adipose tissue 
distinguishes itself from other tissues by its almost unlimited ability to expand 
in size. In obese people total fat mass may comprise 60 to 70% of body 
weight (Hausman et al., 2001). 
 
1.3.1 ADIPOSE TISSUE DEVELOPMENT IN EARLY LIFE 
Human foetuses begin to store adipose tissue, in the form of multilocular or 
brown adipose tissue, from the 20th week of gestation onwards (Merklin, 
1974; Himms-Hagen & Ricquier, 1998; Cannon & Nedergaard, 2004). In 
sheep, adipose tissue, in the form of multilocular or brown adipocytes, can 
be detected from as early as 70 days gestation. From about 70 ± 110 days 
gestation brown adipose tissue undergoes a relatively accelerated growth as 
opposed to total body mass (Alexander, 1978). During late gestation adipose 
tissue grows in proportion to whole body mass in sheep (Alexander, 1978). 
The tissue starts to develop as individual clusters of lipid droplets which later 
confluence to form adipose tissue depots. The size of the clusters increases 
while the number of clusters remains relatively constant during growth 
(Ailhaud et al., 1992).  Just like in humans, in pig and sheep, brown adipose 
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tissue depots are detectable before birth (Merklin, 1974; Alexander, 1978; 
Hausman & Richardson, 1982).  However the total contribution of adipose 
tissue to body mass is only 1.5% in newborn sheep, whilst in the human, 
adipose tissue contributes approximately 16% of body mass (Fowden, 1995). 
 
During the first 7-30 days of postnatal life in a sheep adipose tissue 
undergoes rapid growth. Perirenal adipose tissue mass remains stable for 
the first two days of life but proliferates rapidly thereafter (Clarke et al., 
1997b). During early postnatal life white or unilocular adipose tissue in the 
perirenal depot grows relatively faster than the liver, lung, heart, kidneys and 
adrenal glands (Clarke et al., 1997b). In foetal life most adipocytes contain 
multiple lipid locules. Tissue with predominantly multilocular adipocytes is 
called brown adipose tissue. During the first 2-3 weeks of postnatal life most 
of those multilocular adipocytes undergo a transformation and become 
unilocular cells. Tissue with predominantly unilocular adipocytes is called 
white adipose tissue (Gemmell et al., 1972). These cells have one large lipid 
droplet, which can contribute to 80-95% of adipocyte cell volume. The 
nucleus and cytoplasm of the cells are eccentrically located and form a rim at 
the side of the cell. In sheep, as well as in humans, nearly all multilocular 
adipocytes have transformed and display the morphometric and molecular 
characteristics of mature unilocular adipocytes by 30 days postnatal age 
(Gemmell et al., 1972; Clarke et al., 1997b; Mostyn et al., 2003).  
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1.3.2 ADIPOSE TISSUE GROWTH 
In a state of positive energy balance then adipose tissue growth occurs. This 
growth can be either due to an increase in cell size (hypertrophy) or an 
increase in adipocyte number (hyperplastic growth). Many authors nowadays 
believe that adipocytes are unable to expand beyond a given maximum 
volume. After these cells have reached their maximum volume it is believed 
that the increased stretch will trigger local preadipocytes to differentiate into 
mature adipocytes. Thus according to this theory the adipocytes induce 
hyperplastic growth when hypertrophy is no longer possible (Bjorntorp, 1974; 
Faust et al., 1978; Bjorntorp, 1991; Cinti, 2005). Other authors believe that 
maximum cell number is determined during early life, which limits the ability 
of hyperplastic growth (Spalding et al., 2008).  
1.3.2.1  Lipogenesis 
After a meal the plasma free fatty acid (FFA) concentration rises. FFAs enter 
adipocytes where they are transformed into and stored as triglycerides. An 
essential factor in this process of lipogenesis is lipoprotein lipase (LPL).  
LPL is an enzyme that is present on the luminal endothelial surface of 
tissues such as adipose tissue and skeletal muscle. It is essential in the 
hydrolysis of triacylglycerol from circulating chylomicrons and very low 
density lipoprotein (vLDL) into fatty acids that can enter the cell (Braun & 
Severson, 1992).  LPL is produced mainly in adipocytes, myocytes and 
cardiomyocytes (Semenkovich et al., 1989a). LPL mRNA levels in 
adipocytes are increased by the effects of insulin. Insulin however, does not 
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alter the rate of LPL gene transcription which suggests that insulin increases 
LPL mRNA stability (Semenkovich et al., 1989b). 
 
LPL mRNA expression in adipose tissue is influenced by peroxisome 
proliferator-activated receptor-J (33$5Ȗ 33$5Ȗ, when combined with 
retinoid-x-receptor-DOSKD 5;5ĮELQGV WRSHUR[LVRPHSUROLIHUDWRU UHVSRQVH
elements on the DNA and acts as a general transcription factor. It stimulates 
LPL mRNA expression but also influences genes involved in adipocyte 
proliferation (Schoonjans et al., 1996; Gregoire et al., 1998; Auwerx, 1999; 
Kersten et al., 2000; Combs et al., 2002; Picard & Auwerx, 2002). 
Once free fatty acids have entered the cell they bind to acetyl coenzyme A 
(acetyl CoA). Once bound to acetyl CoA, three FFA molecules can bind with 
one glycerol molecule to form a triglyceride. More details about this process 
can be found in Figure 1.1. 
Glucocorticoids are also likely to have a lipogenic effect by stimulation of 
33$5Ȗ DQG E\ VWLPXODWLRQ RI VWHURO UHJXODWLQJ HOHPHQW ELQGLQJ SURWHLQ &
(SREBP1C), which also functions as a transcriptor factor in the regulation of 
LPL (Samra et al., 1998). The possible role of glucocorticoids in lipogenesis 
will be discussed in more detail in paragraph 1.5.   
Another factor that influences lipogenesis is growth hormone (GH). GH 
interferes with insulin signalling at the post-receptor level and therefore 
reduces insulin sensitivity and ultimately adipogenesis (Yin et al., 1998). 
An overview of the processes involved in lipogenesis can be found in Error! 
Reference source not found.. 
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1.3.2.2  Lipolysis 
In periods of negative energy balance triglycerides in adipocytes are broken 
down into free fatty acids and released into the blood stream. This process of 
lipolysis is catalysed by the enzyme hormone sensitive lipase (HSL) and 
initiated in response to increased glucagon levels (Braun & Severson, 1992).  
The regulation of lipolysis is a very complicated process and involves 
numerous factors. Glucocorticoids have been shown to increase HSL in in 
vitro studies and therefore stimulate lipolysis (Slavin et al., 1994). Insulin, on 
the other hand, has a direct inhibitory effect on lipolysis. The effects of 
insulin and glucocorticoids on adipose tissue growth will be discussed in 
more detail in paragraph 1.4 and 1.5 respectively. 
 
Other factors that influence lipolysis include catecholamines, growth 
hormone  and leptin. Adipose tissue is innervated by sympathetic nerve 
fibres with noradrenaline as the neurotransmitter. The nerve endings 
innervate the vessels up to the smallest capillaries and the adipose cells 
itself via neuro-DGLSRF\WLFMXQFWLRQVZKLFKFRQWDLQĮ2ȕ1, ȕ2 DQGȕ3 receptors. 
Activation of beta-receptors leads to increased levels of cyclic AMP in the 
cell, which leads to an increase in the activation of protein kinase A, resulting 
in activation of hormone sensitive lipase and therefore stimulating lipolysis. 
Circulating adrenaline can also stimulate lipolysis through this pathway 
(Belfrage et al., 1981; Bjorgell et al., 1981; Stralfors & Belfrage, 1983; Frayn, 
2003; Cinti, 2005).  
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Growth hormone has been shown to stimulate lipolysis by inhibiting the 
effects of insulin (Beck et al., 1957; Zierler & Rabinowitz, 1963). Several 
studies have indicated that circulating FFA levels rise following continuous or 
pulsatile GH administration (Moller et al., 1990a; Moller et al., 1990b; Moller 
et al., 1992). 
Leptin is a 16kDA protein that is mainly produced by adipose tissue (Zhang 
et al., 1994). The expression of leptin is directly related to lipid content and 
size of adipocytes (Lonnqvist et al., 1997; Chilliard et al., 2001; Muhlhausler 
et al., 2002). Leptin is an important factor in energy homeostasis; it 
decreases appetite and increases energy expenditure. Leptin has been 
shown to stimulate fatty acid oxidation and release in adipocytes and skeletal 
muscle of rats both in vitro and in vivo (Shimabukuro et al., 1997; William et 
al., 2002). 
An overview of the processes involved in lipolysis can be found in Error! 
Reference source not found.. 
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Figure 1.1; Overview of lipogenesis and lipolysis. 
AC, adenylate cyclise; ACS, acyl-coenzyme A synthetise; Į-AR, Į-adrenoreceptor; ATP, 
adenosine triphosphate; ȕ-AR, ȕ-adrenoreceptor; CO2, carbon dioxide; FATP, fatty acid 
transporter protein; FFA, free fatty acid; Glut4, insulin-sensitive glucose transporter 4; 
Glycerol-3, glycerol 3-phosphate; IR, insulin receptor; HSL, hormone sensitive lipase; LPL, 
lipoprotein lipase; PKA, protein kinase C. Modified from Avram and colleagues (Avram et al., 
2005) 
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1.3.2.3  Adipogenesis 
The balance between increasing fat mass (lipogenesis, preadipocyte 
reproduction and differentiation) and decreasing fat mass (lipolysis, 
apoptosis, necrosis and dedifferentiation) depends on the balance between 
energy intake (i.e. as food) and energy expenditure (i.e. as physical activity).  
Adipocytes develop from preadipocyte precursor cells. This process of 
adipogenesis is triggered by peroxisome proliferator-DFWLYDWHG UHFHSWRU Ȗ
33$5Ȗ (Spiegelman & Flier, 1996). Numerous other factors influence the 
proliferation and differentiation of adipocytes and preadipocytes, including 
insulin, insulin like growth factors (IGFs), glucocorticoids and FFAs. It is now 
believed that preadipocytes can differentiate into new adipocytes at any 
period in life (Ailhaud et al., 1990; Ailhaud et al., 1991). 
33$5ȖZKHQERXQGWRUHWLQRLG-x-receptor-alpha acts as a transcription factor 
and has a key role in the induction of early growth arrest of adipocytes and in 
their terminal differentiation (Gregoire et al., 1998; Auwerx, 1999; Kersten et 
al., 2000; Combs et al., 2002; Picard & Auwerx, 2002). Insulin has an 
important role in adipogenesis by promoting the clonal expansion of 
adipocytes (Gregoire et al., 1998). 
IGF1 is another important and essential factor in adipose tissue growth. It 
promotes clonal expansion of growth arrested preadipocytes in vivo and in 
vitro in rats (Smith et al., 1988; Ramsay et al., 1989b; Wright & Hausman, 
1995; Gregoire et al., 1998; Rajkumar et al., 1999; Holzenberger et al., 2001; 
Avram et al., 2007). In cell lines, IGFs have stimulatory effects on DNA 
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synthesis and cell replication in embryo cultures and cell lines (Zapf et al., 
1978; Soret et al., 1999). The effects of IGF1 on adipose tissue proliferation 
appear to be due to autocrine / paracrine mechanisms as opposed to 
endocrine mechanisms (Faust et al., 1978; Lau et al., 1990; Peter et al., 
1993; Considine et al., 1996; Marques et al., 1998; Marques et al., 2000; 
Butler et al., 2002).  
*OXFRFRUWLFRLGV KDYH D UROH LQ DGLSRJHQHVLV E\ VWLPXODWLRQ RI 33$5Ȗ DQG
stimulation of C/EBPa, factors that stimulate adipocyte differentiation. 
Cortisol has been shown to be essential for adipocyte differentiation (Hauner 
et al., 1987; Samra et al., 1998). 
Besides the discussed external factors that promote adipogenesis, it appears 
that an increase in fatty acid levels also plays an important role in the 
induction of adipocyte differentiation (Ailhaud et al., 1995; Sampath & 
Ntambi, 2004; Madsen et al., 2005). This relationship is reflected in a 
correlation between plasma non-esterified fatty acids (NEFAs) during the first 
24 hours after birth and relative perirenal adipose tissue mass (Duffield, 
2007). 
 
1.3.3  EXCESSIVE ADIPOSE TISSUE GROWTH 
By definition, in most overweight and obese people adipose tissue growth 
has been excessive. As discussed previously, this process can be due to 
both hypertrophy and/or hyperplasia of adipose tissue; currently prevailing 
wisdom favours predominatly hypertrophic growth up to a µmaximum cell 
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size¶ followed by hyperplastic growth thereafter. (Bjorntorp, 1974; Faust et 
al., 1978; Bjorntorp, 1991; Cinti, 2005).  
The maximum size an adipocyte can reach is genetically variable and 
dependent on the particular adipose tissue depot. This volume is called the 
µFULWLFDOFHOOVL]H¶ (Bjorntorp, 1974; Faust et al., 1978; Bjorntorp, 1991; Cinti, 
2005). The critical cell size can is also dependent on the source of energy in 
the diet (Schoonmaker et al., 2004). In mild obesity, cell size normally 
remains within its critical size and therefore mild obesity is described as 
being hypertrophic with regard to cell size and numbers. Whilst in severe 
obesity the critical cell size is exceeded and hyperplasia is induced 
(Spiegelman & Flier, 1996). Obesity with an onset in early life is also 
believed to be hyperplastic (Lemonnier, 1972; Spiegelman & Flier, 1996). 
Spalding and colleagues showed that in most people who would become 
obese the adipocyte number is already increased by the age of 10 years 
(Spalding et al., 2008). 
In obesity, the rise of the free fatty acid concentration in the blood will lead to 
a reduction in insulin stimulated glucose uptake in skeletal muscle. The 
pancreas will partially compensate this effect by secreting more insulin. 
However, the extra secreted insulin together with decreased clearance leads 
to peripheral hyperinsulinemia (Wajchenberg, 2000). The process of the 
development of insulin resistance secondary to obesity will be described in 
more detail in paragraph 1.3.4.2.  
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1.3.4 REGIONAL DIFFERENCES IN ADIPOSE DEPOTS  
Obesity is a very important health problem in our present day society. The 
metabolic risk factors associated with obesity are dependent on the 
distribution of adipose tissue. Increased central as opposed to peripheral 
adipose tissue is associated with higher cardiovascular risks (Krotkiewski et 
al., 1983; Fujioka et al., 1987; Despres et al., 1989; Pouliot et al., 1992; 
Wajchenberg, 2000; Busetto, 2001; Miyazaki et al., 2002; Misra et al., 2004; 
Despres & Lemieux, 2006).  According to the INTERHEART case-control 
study approximately 63% of all heart attacks in Western Europe are 
secondary to abdominal obesity (Yusuf et al., 2004). The risk of a heart 
attack doubles in people with an increased waist-hip ratio (WHR) compared 
to people with a normal WHR (Yusuf et al., 2004). The surgical removal of 
visceral adipose tissue leads to an improvement in metabolic status both in 
rodents and in humans (Gabriely et al., 2002; Thorne et al., 2002; Gabriely & 
Barzilai, 2003).  
1.3.4.1 Adipose tissue depots in the body 
Adipose tissue can be divided anatomically into subcutaneous fat, which has 
a superficial and a deep layer, and visceral fat. About 80 percent of total fat 
mass is located subcutaneously and about 20 percent intra-abdominal 
(Marin et al., 1992a). Visceral adipose tissue is an amalgamation of adipose 
tissue that can be divided in intraperitoneal and retroperitoneal fat. 
Intraperitoneal fat can be found in the omentum and in the mesenterium, this 
depot is often called omental fat. Retroperitoneal fat is mainly found around 
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the kidneys and is called perirenal adipose tissue. Visceral adipose tissue 
can also be found pericardial and around the genitalia (Himms-Hagen & 
Ricquier, 1998; Fukuchi et al., 2003). A study by Marin and colleagues 
investigated the relations between different adipose tissue depots and 
metabolic variables such as plasma insulin, blood glucose levels and glucose 
disposal rate during a euglycemic glucose clamp. Fasting insulin and fasting 
glucose were positively related to visceral and retroperitoneal adipose tissue 
mass. Glucose disposal rate was negatively related with total body fat, 
abdominal, visceral and retroperitoneal adipose tissue mass. They found that 
all relations were strongest for intra-peritoneal adipose tissue mass. 
Furthermore they found that adipose tissue lipid uptake was higher in 
omental than subcutaneous adipose tissue and that adipocytes in the 
omental adipose tissue depot were less sensitive to the antilipolytic effects of 
insulin. They suggested that the omental adipose tissue depot has a higher 
turnover rate of lipids compared to the other depots (Marin et al., 1992a). 
Special interest has been given to deep subcutaneous abdominal adipose 
tissue. Some authors believe that this adipose tissue depot should be 
FRQVLGHUHGD µFHQWUDO¶ DGLSRVH WLVVXHGHSRWZLWK LQFUHDVHGPHWDEROLF ULVNV
others believe this depot is part of the subcutaneous or peripheral adipose 
tissue depot. Miyazakie and colleagues found that in adults with type 2 
diabetes between the ages of 30-60 years, the amount of deep 
subcutaneous fat at L4-L5 level as determined by MRI was associated with 
both peripheral and hepatic insulin resistance (Miyazaki et al., 2002). While 
both Abate and Goodpaster and colleagues found that an increase in 
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abdominal subcutaneous adipose tissue led to a similar or even greater 
increase in the risk of insulin insensitivity compared to an increase in visceral 
adipose tissue (Abate et al., 1995; Goodpaster et al., 1997) suggesting that 
the abdominal subcutaneous depot should be considered, at least with 
regards to risks of insulin resistance, as a visceral adipose tissue depot. 
There is a wide variation of the distribution of fat within humans. Females 
tend to deposit more subcutaneous compared to visceral adipose tissue 
(Kotani et al., 1994; Dua et al., 1996; Legato, 1997). Men have for every 
given amount of total body fat on average twice as much abdominal fat as 
premenopausal women with the same amount of total body fat (Han et al., 
1997), which could be part of the explanation why men are more susceptible 
to developing cardiovascular diseases. 
 
Different adipose tissue depots develop at different stages in life. Previous 
studies have shown that in large mammals, like sheep, at birth the most 
important visceral adipose tissue depot is the perirenal adipose tissue depot, 
while the subcutaneous depot is also present at birth (Clarke et al., 1997b; 
Symonds & Stephenson, 1999). After birth during early postnatal life, the 
omental and the subcutaneous adipose tissue become more abundant. Little 
is known about the growth rate of those different depots and the factors that 
influence the distribution of adipose tissue between visceral fat depots. 
Furthermore it is not know whether the development of a specific depot at a 
certain stage in life of the individual is related to risks associated with that 
particular depot in later life. 
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1.3.4.2 Molecular difference between adipose tissue depots and 
mechanisms that could explain increased risks associated with 
visceral obesity 
Several mechanisms have been put forward to explain the difference in risk 
patterns associated with a primarily centripedal distribution of adipose tissue. 
The most important of those mechanisms is the production of cytokines by 
visceral adipose tissue and the direct release of free fatty acids from the 
visceral depot to the liver via the hepatic portal vein. Visceral adipose tissue 
in comparison to subcutaneous adipose tissue is more sensitive to lipolytic 
stimulation by, for example, the sympathetic nervous system. On the other 
hand, it is less sensitive to antilipolytic stimuli by, for example insulin 
(Rebuffe-Scrive et al., 1989; Arner et al., 1990; Marin et al., 1992a; Vikman 
et al., 1996). Therefore visceral adipose tissue seems to have more lipolytic 
activity resulting in an increased flow of non esterified fatty acids (NEFA) into 
the portal vein (Svedberg et al., 1990; Boden et al., 1998; Smith & 
Zachwieja, 1999). These NEFAs are directly transported to the liver where 
they have several effects associated with an increased metabolic risk 
pattern. For example, an increase in NEFAs in the liver will lead to a 
decrease in hepatic insulin clearance and an increase in insulin secretion. 
Both factors lead to a decrease in glucose tolerance and an increase in 
insulin resistance. Increased NEFAs in the portal vein circulation also lead to 
an increase in the production of very low density lipoproteins by the liver, 
leading to dyslipideamia (Svedberg et al., 1990; Boden et al., 1998). 
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Therefore an increased lipolytic activity in the portal vein drainage area, 
caused by an increase of visceral adipose tissue, contributes to all symptoms 
of the metabolic syndrome. Figure 1.2 summarises the effects of visceral 
adiposity on the development of the metabolic syndrome (Figure 1.2). 
 
 
 
 
Figure 1.2; Effects of visceral adiposity on the development of the metabolic 
syndrome 
Adapted from Wajchenberg and colleagues (Wajchenberg, 2000). 
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Numerous studies have further confirmed the differences in fatty acid 
turnover between visceral and subcutaneous adipose tissue. For example 
the uptake of triglycerides has been shown to be higher in omental 
compared to subcutaneous adipose tissue, but this was not correlated with 
LPL activity (Marin et al., 1992a). Martin and Jensen found that triglyceride 
turnover higher was in abdominal versus gluteo-femoral adipose tissue in 
men in vivo (Martin & Jensen, 1991; Jensen, 1997). Differences in LPL 
activity between men and women have also been proposed as an 
explanation in the observed gender differences in fat distribution. LPL activity 
in women is higher in subcutaneous fat cells compared to omental fat cells 
and consequently adipocyte size is greater in subcutaneous tissue than in 
omental tissue, while the opposite was found of men (Arner et al., 1991; 
Bouchard et al., 1993).  
Van Harmelen and colleagues investigated the proliferation and 
differentiation capacity of human adipocyte precursor cells from the omental 
and subcutaneous adipose tissue of obese subjects. They found that stromal 
cells from the subcutaneous region proliferated significantly faster than those 
from the omental region (Van Harmelen et al., 2004). In a similar study 
Tchkonia and colleagues confirmed these findings (Tchkonia et al., 2005). 
The increased proliferative capacity of the subcutaneous depot could be 
UHODWHGWRDGLIIHUHQFHLQ33$5ȖP51$H[SUHVVLRQEHWZHHQGHSRWV33$5Ȗ
mRNA expression levels were significantly lower in visceral adipose tissue 
compared with subcutaneous fat tissue, although this was not found in obese 
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people (Lefebvre et al., 1998). Furthermore, subcutaneous adipose tissue 
was also found to be PRUH VHQVLWLYH WR WKH 33$5Ȗ DJRQLVW WURJOLWD]RQH
compared to visceral adipose tissue (Adams et al., 1997).  
 
Besides differences in fatty acid turnover another theory attempts to explain 
differences in risk profile of different adipose tissue depots by differences in 
their production of cytokines. Cytokines such as Interleukin 6 (IL-6) increase 
hepatic triglyceride secretion (Nonogaki et al., 1995). IL-6 production in 
omental tissue of obese subjects was higher than in subcutaneous 
abdominal adipose tissue of the same subject (Fried et al., 1998; 
Wajchenberg et al., 2002). Therefore visceral obesity could induce 
hypertriglyceridemia through elevated IL-6 levels which cause extra 
triglyceride synthesis in the liver. IL-6 stimulates corticotropin releasing 
hormone (CRH), adrenocorticotropic hormone (ACTH) and cortisol secretion 
while cortisol suppresses adipose IL-6 production (Path et al., 1997). 
 
Other molecular differences that have been found between adipose tissue 
depots include differences in androgen receptor levels and leptin mRNA 
expression. Finally, some genetic polymorphisms have been associated with 
adipose tissue distribution. Androgen receptor levels have been found to be 
higher in visceral fat than in subcutaneous fat. This difference has been used 
in an attempt to explain gender differences in adipose tissue distribution. 
Exposure to testosterone increases the number of androgen receptors while 
estrogen exposure decreases the number of androgen receptors which could 
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potentially be a mechanism that protects females from central adiposity 
(Haarbo et al., 1991; Polderman et al., 1994). 
Leptin mRNA levels have been found to be greater in subcutaneous than in 
omental fat tissue. Leptin levels are also positively correlated to adipocyte 
size and adipose tissue triglyceride storage (Hamilton et al., 1995; Montague 
et al., 1997; Tritos & Mantzoros, 1997; Van Harmelen et al., 1998; 
Wajchenberg et al., 2002). Halleux and colleagues found that leptin 
secretion was stimulated by glucocorticoids in visceral adipose tissue. They 
therefore proposed that the regional distribution of GR and leptin might be 
linked (Halleux et al., 1998). 
 
Several polymorphisms are associated with fat distribution. Trp64Arg, a 
PXWDWLRQ RI WKH ȕ-adrenergic receptor gene, is associated with visceral 
obesity and insulin resistance (Widen et al., 1995; Kim-Motoyama et al., 
1997). Other polymorphisms that possibly influence regional fat distribution 
are the LPL HindIII polymorphism, the apo-B-100 gene EcoR-1 
polymorphism, polymorphisms in the Mob-1 region of human chromosome 
16p12-p11.2 and a polymorphic marker (LIPE) in the hormone-sensitive 
lipase gene on chromosome 19q13.1-13.2 (Pouliot et al., 1994; Vohl et al., 
1995; Klannemark et al., 1998). Also, the Bc/I restriction enzyme at the GR 
gene is associated with a more visceral fat distribution (Buemann et al., 
1997). 
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There is little doubt that an abundance of visceral adipose tissue increases 
metabolic risk. This paragraph has demonstrated that numerous molecular 
differences can be responsible for differences in adipose tissue distribution 
or differences in risks associated with different adipose tissue depots. It is 
however not known whether a differential sensitivity to the actions of 
regulators of adipose tissue growth during early life can explain adipose 
tissue distribution later in life. This thesis will focus on the differential 
sensitivity of adipose tissue depots in early life to the actions of such 
regulators and in particular the sensitivity of adipose tissue depots to the 
actions of insulin, glucocorticoids and insulin like growth factors. In the next 
section of this thesis we will explain the action of those regulators of adipose 
tissue growth in more detail. 
 
1.4 The effects of insulin on adipose tissue 
 
Insulin is a very important factor in adipocyte growth and development. 
Insulin is responsible for glucose uptake into the cell but also exhibits an 
inhibitory effect on lipolysis and a stimulatory effect on adipogenesis by 
promoting the clonal expansion of adipocytes and proliferation and 
differentiation of preadipocytes (Belfrage et al., 1981; Gregoire et al., 1998; 
Soret et al., 1999). The effects of insulin on cells are dependent on a 
complex cascade of insulin signalling in the cell. If errors occur in this 
signalling cascade the cells can become resistant to the effects of insulin. 
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Insulin resistance is an important risk factor in the development of diabetes 
and cardiovascular disease. Insulin resistance is also one of the 
characteristics of the metabolic syndrome. 
A study in sheep from our research group showed that plasma insulin during 
the first 24 hours of life is directly related to perirenal adipose tissue mass 
and the size of perirenal adipocytes at three weeks of age (Duffield, 2007). 
Landin and colleagues showed that the anti-lipolytic effect of insulin was 
lower in obese compared to lean individuals and this was related to insulin 
resistance (Landin et al., 1990). These data suggest that increased exposure 
of adipose tissue to insulin, as is the case in these obese, insulin resistant 
individuals, results in a reduced sensitivity of adipose tissue to the effects of 
insulin. 
 
1.4.1 INSULIN SIGNALLING IN THE CELL 
Adipose tissue deposition is influenced by several factors amongst which 
insulin is one of the most important ones. Insulin inhibits lipolysis and 
therefore promotes adipose tissue growth. The local tissue-specific effects of 
insulin are dependent on the level of circulating insulin, the density of 
membrane bound insulin receptors and the intracellular efficiency of insulin-
stimulated second messenger signalling. The intracellular insulin signalling 
cascade involves binding of insulin WR WKHĮ-subunit of insulin receptor (IR) 
which is a tyrosine-kinase transmembrane receptor (Cheatham & Kahn, 
1995). $FWLYDWLRQ RI WKH Į-subunit leads to auto-SKRVSKRU\ODWLRQ RI WKH ȕ-
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VXEXQLW RI WKH UHFHSWRU 3KRVSKRU\ODWLRQ RI WKH ȕ-subunit of the receptor 
leads to tyrosine phosphorylation of insulin receptor substrate (IRS) 1 and 2 
which leads to activation of phophatidylinositol 3 kinase (PI3-Kinase) which 
in turn activates Akt (also known as protein kinase B) (Alessi et al., 1997; 
Peterson & Schreiber, 1999). Activation of Akt leads to a translocation of 
glucose transporter 4 (Glut4) from the plasma to the cell membrane, leading 
to a passive influx of glucose into the cell (Rea & James, 1997) (Figure 1.3). 
Akt also leads to phosphorylation of glycogen synthase kinase-3, which 
results in modulation of glucose metabolism, cell growth / survival and 
differentiation (Whiteman et al., 2002).  
Other effects of insulin in the cell include the modulation of gene expression 
RI 65(%3F DQG 33$5Ȗ65(%3& UHJXODWHV OLSLG V\QWKHWLFHQ]\PHV OLNH
pyruvate dehydrogenase, fatty acid synthase and acetyl CoA carboxylase in 
adipocytes, which results in modification of adipocyte growth and 
differentiation (Kim & Spiegelman, 1996; Vidal-Puig et al., 1997; Foretz et al., 
1999; Shimomura et al., 1999; Le Lay et al., 2002). Insulin inhibits lipolysis 
by decreasing cAMP levels through phosphorylation and subsequent 
activation of cAMP specific phosphodiestenase-3 (Belfrage et al., 1981; 
Smith & Manganiello, 1989; Degerman et al., 1990).  
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Figure 1.3; The intra-cellular insulin signalling cascade 
Insulin binds to the insulin receptor (IR) which is present on the plasma membrane, this 
results in a phosphorylation of insulin receptor substrate, which leads to activation of PI3-
kinase, which leads to activation of Akt, which leads to translocation of Glut4 to the cell 
membrane and influx of glucose into the cell. 
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1.4.2 MECHANISMS FOR RESISTANCE TO THE ACTIONS OF INSULIN AT THE TISSUE 
LEVEL 
If errors occur in the insulin signalling cascade, cells become resistant to the 
effects of insulin. Different explanations for this phenomenon have been 
described in the literature.   
It has been shown that PI3-kinase is essential for insulin stimulated glucose 
transport (Cheatham et al., 1994). The most prominent subunit of PI3-kinase 
is the p85 subunit which catalyses the phosphorylation of several other 
phophatidylinositols. Blocking of PI3-kinase, using dominant-negative 
mutants or pharmacological agents, abolishes most metabolic effects of 
insulin on insulin sensitive cells inclucing Glut4 translocation, glucose uptake, 
anti-lipolysis and activation of fatty acid and DNA synthesis (Cheatham et al., 
1994; Hara et al., 1994; Okada et al., 1994; Alessi & Downes, 1998). If IRS 
undergoes a phosphorylation of serine instead of a tyrosine phosphorylation 
the p85 subunit of PI3-kinase disassociates and the insulin signal gets 
blunted (Le Marchand-Brustel et al., 2003; Tanti et al., 2004). 
The inhibition of Akt either by adenoviral expression of a dominant-negative 
Akt or by the introduction of synthetic interfering RNA against Akt resulted in 
a reduction of insulin-stimulated Glut4 translocation and glucose uptake 
(Katome et al., 2003). 
Studies that investigated the effect of drugs as colchicines, vinblastine and 
nocodazole have highlighted the importance of the cytoskeleton in regulating 
Glut4 translocation. These drugs disrupt the microtubule structure, which has 
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been shown to block Glut4 vesicle trafficking (Guilherme et al., 2000; Olson 
et al., 2001). 
1.4.3 INSULIN SIGNALLING IN DIFFERENT ADIPOSE TISSUE DEPOTS 
Insulin seems to have different strengths of effect in different adipose tissue 
depots. The antilipolytic effects of insulin were observed to be weaker in 
visceral adipocytes compared to subcutaneous adipocytes in humans, 
indicating a relative insulin resistance of the visceral adipose tissue depot 
(Zierath et al., 1998). In vitro studies of human adipocytes have found that 
the IR binding capacity is lower in visceral compared to subcutaneous 
adipocytes, which results in a  reduction of the activation of IR signalling 
including a reduction in tyrosine phosphorylation of IR and IRS and a 
reduction in PI3-kinase activation (Zierath et al., 1998). However, an in vivo 
study found the insulin stimulated glucose uptake per surface area to be 
higher in visceral compared to subcutaneous adipose tissue (Virtanen et al., 
2003). This difference in insulin-stimulated glucose uptake was also found in 
an in vitro study by Lundgren and colleagues. They found that the insulin-
stimulated glucose uptake was twice as high in human omental compared to 
subcutaneous adipocytes. They also found an increase in Glut4 expression 
in omental compared to subcutaneous adipose tissue, whilst IRS-1 and PI3-
kinase levels were similar between depots (Lundgren et al., 2004). 
Furthermore they found that dexamethasone treatment resulted in a 
decrease in the cellular content of IRS-1 and Akt in omental adipose tissue, 
but resulted in no change in IRS-1 and Akt content in subcutaneous adipose 
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tissue, suggesting that omental adipose tissue is more sensitive to 
glucocorticoids compared to subcutaneous adipose tissue (Lundgren et al., 
2004).  
The relatively increased glucose uptake in omental adipose tissue compared 
to subcutaneous adipose tissue could be partly explained by differences in 
protein abundance of molecules in the insulin signalling cascade. Protein 
levels of IR, IRS-2, p85, GSK-Į DQG *6.-ȕ ZHUH DOO KLJKHU LQ RPHQWDO
compared to abdominal subcutaneous adipose tissue. Furthermore, the 
tyrosine phosphorylation of IRS was also higher in the omental compared to 
abdominal subcutaneous adipose tissue, which would result in a greater 
phosphorylation of Akt (Giorgino et al., 2005; Laviola et al., 2006).  
Although the above mentioned studies clearly indicate a relatively increased 
glucose uptake in the omental depot compared to the subcutaneous adipose 
tissue depot, some controversy remains regarding the exact depot specific 
differences in insulin action, as is indicated by a decreased anti-lipolytic 
effect of insulin in the omental depot.  
 
1.4.4 EVIDENCE FOR THE DEVELOPMENTAL PROGRAMMING OF GENES INVOLVED IN 
INSULIN SIGNALLING 
Numerous studies show the plasticity of the insulin signalling cascade and 
the subsequent development of whole body insulin sensitivity or resistance 
during its development in early life. Birth weight has been shown to influence 
glucose metabolism in early postnatal life and in adulthood in humans, rats, 
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guinea-pigs, pigs and sheep (Clarke et al., 2000; Poore & Fowden, 2002; 
Kind et al., 2003; Wolf, 2003; De Blasio et al., 2007). Strong associations 
have been found between a low birth weight (LBW) and the development of 
insulin resistance and type 2 diabetes mellitus in adult life (Bavdekar et al., 
1999; Veening et al., 2002). Bazaes and colleagues have shown that small 
for gestational age (SGA) infants have a modified glucose metabolism from 
as early as 48 hours in postnatal life. They had higher levels of plasma FFA, 
lower levels of plasma leptin and were more insulin sensitive compared to 
average for gestational age (AGA) infants (Bazaes et al., 2003). In lambs of 
45 days of age an inverse relationship was found between birth weight and 
insulin sensitivity (De Blasio et al., 2007). Another study by Clarke and 
colleagues indicated that both at one and at three months of age lighter 
lambs had higher LHTXDQWLWDWLYHO\ µEHWWHU¶glucose tolerance compared to 
their heavier twin siblings (Clarke et al., 2000). In guinea pigs of 90 days old 
(young adulthood) it was found that low birth weight was associated with 
hyperinsulinaemia and an increased insulin-glucose ratio (Kind et al., 2003). 
In pigs of 1 year of age a decreased glucose tolerance was found in the pigs 
that had a LBW (Poore & Fowden, 2002). Taken together these studies 
suggest that low birth weight is associated with increased insulin sensitivity in 
early postnatal life and decreased insulin sensitivity in adulthood. The effects 
of low birth weight on reduced insulin sensitivity in adulthood are amplified 
when the individual becomes obese (Hales et al., 1991; Valdez et al., 1994; 
Lithell et al., 1996; Jaquet et al., 2000). In children with a high BMI an 
increased insulin resistance is already found from the age of 8 years in 
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children who were LBW compared to normal birth weight children with the 
same high BMI (Bavdekar et al., 1999). Curhan and colleagues estimated 
that the adjusted odds ratio for whole body insulin resistance and T2DM was 
1.75 in men with a LBW compared to men with an average or high birth 
weight (Curhan et al., 1996b).  
The effects of low birth weight are often mimicked in experimental studies 
that use maternal nutrient restriction or placental restriction to produce 
offspring with a low birth weight. Restriction of nutrients during pregnancy 
has been shown to decrease plasma levels of insulin and IGF1 in sheep 
(Osgerby et al., 2002). The offspring of nutrient restricted rats had decreased 
levels of plasma insulin and increased levels of plasma glucose at both 3 
and 11 weeks of postnatal life (Holemans et al., 1996).  
Rats that were protein restricted during pregnancy produced offspring that 
were insulin resistant and had a reduction in insulin stimulated glucose 
uptake in the muscle at 15 months of age, indicating the lasting effect (i.e. 
well into adulthood) of nutritional challenges that occurred during early life. 
The reduced insulin stimulated glucose uptake in the muscle was not 
attributed to changes in IR or Glut4 mRNA expression (Ozanne et al., 2003). 
Offspring of protein restricted rats at the age of 3 months however, showed 
an increased basal glucose uptake in muscle cells, which was not associated 
with a change in plasma insulin. Increased levels of IR and Glut4 protein in 
muscle were found which may have contributed to the increased basal 
glucose intake in the muscle cells. The insulin stimulated glucose uptake in 
muscle however, was unchanged compared to control rats (Ozanne et al., 
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1996). These different patterns of insulin stimulated glucose uptake at 
different stages in life suggests maternal protein restriction leads to an initial 
increase in insulin sensitivity in skeletal muscle in these offspring followed by 
a downregulation of insulin receptor levels and the development on insulin 
resistance in mature adulthood. In adipose tissue of offspring of protein 
restricted rats a similar observation is seen at 6 weeks of postnatal age. 
These rats show a decrease in IR number in the adipocyte, which may 
indicate a reduction in insulin sensitivity during adult life (Shepherd et al., 
1997). Numerous authors have also indicated that the development of 
obesity in later life in offspring that were growth restricted in foetal life in 
usually associated with the development of insulin resistance in adipose 
tissue (Jaquet et al., 1998; Jaquet et al., 1999; Phillips et al., 1999; Jaquet et 
al., 2000).  
As opposed to a reduction in maternal nutrient intake some studies have 
investigated the effect of a nutritional challenge that consisted of an 
increased nutrient intake during pregnancy on insulin sensitivity in the 
offspring. An increase of maternal nutrient intake to 155% of maintenance 
energy intake during late gestation resulted in increased levels of foetal 
circulating glucose and insulin. This challenge however had no effect on 
foetal weight, foetal adipose tissue mass or plasma leptin (Muhlhausler et al., 
2002).  
Other studies have investigated nutritional challenges in the periconceptional 
period, and have shown that insulin sensitivity can be programmed as early 
as the periconceptional period. Periconceptional undernutrition in sheep 
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resulted in a reduction in foetal sheep plasma glucose, insulin and IGF1, but 
not IGF2 during late gestation (Bauer et al., 1995; Lee et al., 1997; Gallaher 
et al., 1998).  
The programming effects of growth and nutrition during early life are certainly 
not limited to the ante-natal stage of life as is shown by the tremendous 
amount of studies that have investigated the effect of different growth 
patterns in early life on the development of metabolic diseases in childhood 
and adulthood (Barker et al., 1993; Lithell et al., 1996; Bavdekar et al., 1999; 
McMillen & Robinson, 2005). An accelerated rate of growth during early 
postnatal life appears to be associated with early increased insulin sensitivity 
and a subsequent emergence of insulin resistance (Whincup et al., 1997; 
Bavdekar et al., 1999; Eriksson et al., 2001). Numerous studies have also 
shown a particular increase in adipose tissue insulin resistance in adulthood 
in individuals that had an accelerated postnatal growth rate (Jaquet et al., 
1998; Jaquet et al., 1999; Phillips et al., 1999; Jaquet et al., 2000). The 
increased risk of the development of insulin resistance in individuals that 
undergo an accelerated post-natal growth is further amplified if those 
individuals become obese during childhood or adulthood (Curhan et al., 
1996b; Whincup et al., 1997; Bavdekar et al., 1999; Eriksson et al., 2001; 
Veening et al., 2002).  
The detrimental effects of low birth weight and an accelerated postnatal 
growth are often combined in individuals that undergo the so-FDOOHGµFDWFK-up 
JURZWK¶,WKDVEHHQVKRZQWKDWLQGLYLGXDOVZLWKWKHORZHVWELUWKZeight often 
are the ones with the highest weight gain velocity in the first two months of 
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life and the highest insulin sensitivity during this early period of life (Gray et 
al., 2002). Similarly piglets that were born low birth weight exhibited catch-up 
growth during early life compared to their higher birth weight siblings. These 
low birth weight piglets had a decreased glucose tolerance at 1 year of age 
(Poore & Fowden, 2002). In rats it has been observed that LBW pups (as a 
result of maternal nutrient restriction) had an increased feed intake from 
weaning to adulthood, leading to greater retroperitoneal and gonadal 
adipose tissue mass, and an accelerated growth rate when exposed to a 
hypercaloric post-weaning diet even though the weight in adulthood was not 
different between the low and average birth weight rats (Vickers et al., 2000; 
Vickers et al., 2001).  
These studies strongly indicate that a combination of growth patterns during 
prenatal, early postnatal life and childhood leads to particular differences in 
whole body and tissue specific insulin sensitivity in later life. It is unknown to 
date whether changes in the early growth patterns can result in adipose 
tissue depot specific differences in the sensitivity of the particular depot to 
the actions of insulin. 
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1.5  The effects of glucocorticoids on adipose tissue 
Glucocorticoids have an important influence in the pathogenesis of obesity. 
Patients with chronic elevated cortisol levels, like patients with Cushings 
Syndrome have a significant redistribution of adipose tissue towards the 
central depots (Lamberts & Birkenhager, 1976; Wajchenberg et al., 1995).  
 
1.5.1 GLUCOCORTICOID SIGNALLING IN THE CELL 
Glucocorticoids exert their effects on cells through the glucocorticoid receptor 
(GR), which is a member of the steroid receptor family. GR is located in the 
cell nucleus and, after passive diffusion of glucocorticoids into the cell, binds 
to the free glucocorticoid. Binding of glucocorticoids to GR induces a 
conformational change in GR which leads to the dissociation of heat shock 
proteins that are attached to GR. Dissociation of heat shock proteins leads to 
formation of homodimers and exposure of the DNA and protein binding sites 
of GR. GR-homodimers then bind to hormone response elements in the DNA 
where they initiate or inhibit transcription (Lan et al., 1984; Yamamoto, 1985; 
Scheidereit et al., 1986; Strahle et al., 1987) (Figure 1.4). GR can also 
function as a co-activator and bind to other proteins involved in transcription, 
such as glucocorticoid receptor interacting protein 1 or cAMP response 
element binding protein (Kwok et al., 1994; Hong et al., 1996). 
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It is believed that all the actions of glucocorticoids are initiated through 
inhibition or initiation of transcription by the glucocorticoid ± GR complex 
(Duval et al., 1983; Lan et al., 1984; Fulton et al., 1985).  
 
 
Figure 1.4; Mechanism of glucocorticoid action in the cell 
Glucocorticoids (GC) enter the cell nucleus by passive diffusion where they bind to the 
glucocorticoid receptor (GR); this causes a conformational change of GR and leads to 
dissociation of the heat shock proteins (HSP). GR then forms homodimers and binds to 
hormone response elements (HRE) on the DNA where they initiate or inhibit transcription. 
Chapter 1 45 
Literature Review 
 
1.5.2 ACTIONS OF GLUCOCORTICOIDS IN ADIPOSE TISSUE 
The effects of glucocorticoids on adipose tissue seem to be complex and 
diverse. In vitro studies in rats, have shown that glucocorticoids stimulate 
lipolysis by increasing the activity of hormone sensitive lipase (Fain et al., 
1963; Slavin et al., 1994). These observations have been confirmed by 
human in vivo studies that showed an increase in fatty acid turnover with 
hypercortisolaemia (Divertie et al., 1991; Dinneen et al., 1995). A study by 
Samra and colleagues investigated the effects of a hydrocortisone infusion 
on plasma NEFA levels in human, and they found that plasma NEFA levels 
in the whole body increased, but that NEFA efflux from subcutaneous 
adipose tissue was reduced. This indicated a reduction in HSL in the 
subcutaneous depot as a response to glucocorticoids. The increased whole 
body lipolysis was considered to be most likely secondary to an increase in 
visceral lipolysis (Samra et al., 1998). Furthermore, studies by Ottosson and 
colleagues in human, and Ramsay and colleagues in pigs, indicated that 
glucocorticoids can also stimulate lipoprotein lipase, at least in vitro, and 
therefore have stimulatory effects on lipogenesis (Ramsay et al., 1989a; 
Ottosson et al., 1994). Fried and colleagues investigated the effects of 
insulin and dexamethasone on LPL mRNA and activity in omental and 
abdominal subcutaneous adipose tissue in human. They found that insulin 
could increase LPL mRNA and activity only in abdominal subcutaneous 
adipose tissue, while dexamethasone increased LPL mRNA and activity in 
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both tissue, but the effects were more marked in the omental adipose tissue 
depot. When both insulin and dexamethasone were added together, a 
synergistic increase in LPL activity was seen (Fried et al., 1993). 
Besides effects on lipogenesis and lipolysis, glucocorticoids also have 
effects on adipogenesis. Glucocorticoids promote the differentiation of 
adipocyte precursor cells in vitro in human, sheep and pig (Hauner et al., 
1987; Ramsay et al., 1989a; Casteilla et al., 1991; Soret et al., 1999). 
Glucocorticoids also augment IGF1 action in vitro in human and mice, 
(Conover et al., 1985; Tronche et al., 2004) and stimulate IGF1R expression 
in rats (Bennett et al., 1984). In human and sheep, glucocorticoids are also 
known to stimulate PPAR-Ȗ Dnother important adipogenic transcription 
factors (Wu et al., 1996; Vidal-Puig et al., 1997; Soret et al., 1999). 
Furthermore glucocorticoids have been shown to have an inhibiting effect on 
glucose uptake in the human and rat adipocyte, while at the same time 
stimulating plasma insulin levels (Rizza et al., 1982; Lenzen & Bailey, 1984; 
Carter-Su & Okamoto, 1985). Lundgren and colleagues found that the 
dexamethasone induced reduction in glucose uptake in the human adipocyte 
was only present in the omental and not in the subcutaneous adipose tissue 
depot (Lundgren et al., 2004). Furthermore they found that dexamethasone 
treatment resulted in a decreased expression of insulin receptor substrate 1 
in omental adipose tissue only (Lundgren et al., 2004). 
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1.5.3 LOCAL AVAILABILITY OF GLUCOCORTICOIDS 
People with elevated glucocorticoids, like patientVZLWK&XVKLQJ¶V6yndrome, 
display all characteristics of the metabolic syndrome; increased glucose 
intolerance, central obesity and hypertension. Most people with the metabolic 
syndrome however have normal plasma glucocorticoid levels. Nevertheless, 
the actual plasma glucocorticoid concentrations may not necessarily mirror 
circulating levels. This is because many tissues express the enzyme 11 beta 
hydroxysteroid dehydrRJHQDVH ȕ-HSD), which was first discovered in 
1953 (Amelung et al., 1953). Nowadays at least two, only distinctly related, 
LVRIRUPVDUHNQRZQȕ-+6'DQGȕ-HSD2.  
ȕ-+6'DQGȕ-HSD2 have an important role in regulating glucocorticoid 
OHYHOVLQORFDOWLVVXHVȕ-HSD1 is a bidirectional enzyme which can convert 
inactive cortisone into active cortisol and vice versa. In vivo ȕ-HSD1 is 
WKRXJKWWRZRUNPDLQO\DVDUHGXFWDVHWRDFWLYDWHFRUWLVRQHLQWRFRUWLVROȕ-
HSD2 works as a dehydrogenase and inactivates cortisol by converting it into 
cortisone (Figure 1.5). 
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Figure 1.5; Conversion of cortisone into cortisol and vice versa 
Function of 11-beta hydroxysteroid dehydrogenase enzymes type 1 and 2 in the conversion 
of cortisone into cortisol and vice versa. 
 
 
In humans and large mammals cortisol is the main biologically active form of 
glucocorticoids. The equivalent of cortisol in rodents is corticosterone. 
95% of the cortisol circulating in human blood is bound to proteins, mainly 
corticosteroid binding globulin (Dunn et al., 1981), so the amount of freely 
available cortisol is low. At the diurnal peak cortisol levels are 400 ± 600 
nmol/l while nadir levels only reach 0.5 ± 1 nmol/l (Dunn et al., 1981). 
Cortisone shows no diurnal rhythm, is hardly bound to globulins and 
circulates at levels of 50 - 100 nmol/l (Walker et al., 1992). On a local level 
ȕ-HSD1 is capable of converting this cortisone into cortisol to ensure 
adequate cortisol availability as its affinity for substrate is much higher than 
ȕ-HSD2.  
ȕ-HSD1 is found abundantly in most mammalian tissues (Agarwal et al., 
1989; Moisan et al., 1990; Ricketts et al., 1998). 11ȕ-HSD1 is NADP(H) 
dependent. It works in vivo mainly as a reductase to convert cortisone into its 
biological active form cortisol in humans and large mammals and it converts 
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11-dehydrocorticosterone into corticosterone in rodents (Low et al., 1994; 
Hundertmark et al., 1995; Jamieson et al., 1995; Rajan et al., 1996).  
,Q KXPDQV DQG ODUJH PDPPDOV ȕ-HSD2 converts the active form of 
cortisol into its inactive variant cortisone (Albiston et al., 1994). In rodents 
ȕ-HSD2 has a similar activity on corticosterone. The dehydrogenase 
conversion is nicotinamide adenine dinucleotide (NAD) dependent. The 
enzyme is mainly expressed in aldosterone target tissues such as the 
kidneys, colon, sweat and salivary glands, hippocampus, and the 
cardiovascular system (Smith et al., 1996; Hirasawa et al., 1997). 
Glucocorticoids have a higher affinity for the mineralocorticoid receptor (MR) 
than mineralocorticoids have. To ensure the availability of MR for 
DOGRVWHURQH LQRUGHU WRUHJXODWHVDOWEDODQFHȕ-HSD2 deactivates cortisol 
in aldosterone target tissues (Arriza et al., 1987; Edwards et al., 1988; 
Funder et al., 1988; Andrews & Walker, 1999). 
 
1.5.4 GLUCOCORTICOIDS, THE METABOLIC SYNDROME AND OBESITY 
Insulin resistance and glucose intolerance are, like most other components 
of the metabolic syndrome, associated with slightly higher cortisol levels 
(Phillips et al., 1998; Reynolds et al., 2001). High blood pressure is also 
associated with higher cortisol levels (Watt et al., 1992; Filipovsky et al., 
1996). The tissue sensitivity for glucocorticoids is dependent on the density 
of glucocorticoid receptors. In hypertension and diabetes mellitus type 2 the 
expression of GR is increased (Walker et al., 1996; Walker et al., 1998; 
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Andrew et al., 2002). In human skeletal muscle GR expression is related to 
insulin sensitivity and blood pressure (Reynolds et al., 2002; Whorwood et 
al., 2002). Panarelli showed that the metabolic syndrome is associated with a 
polymorphism of the GR gene (Panarelli et al., 1998). 
The C57B1/6 strand of mice is known for having the metabolic syndrome. 
7KHVH PLFH KDYH KLJKHU OHYHOV RI ȕ-HSD1 in adipose tissue and less 
GRZQUHJXODWLRQRIȕ-HSD1 after a high fat diet (Morton et al., 2004). 
 
Obesity also shows several associations with glucocorticoid action. Visceral 
obesity is associated with lower morning peak cortisol levels (Ljung et al., 
1996; Phillips et al., 1998; Rosmond et al., 1998), but higher cortisol levels in 
the evening nadir (Ljung et al., 1996; Rosmond et al., 1998) and higher 
urinary cortisol excretions (Strain et al., 1980; Marin et al., 1992b; Pasquali et 
al., 1993). Total cortisol production in obesity is increased (Andrew et al., 
1998; Fraser et al., 1999; Stewart et al., 1999). Hypothalamic-pituitary-
adrenal (HPA) axis activity after stress is also increased with obesity (Marin 
et al., 1992b; Hautanen & Adlercreutz, 1993; Pasquali et al., 1999) and the 
negative feedback of glucocorticoid levels on HPA axis activity is decreased 
in obesity (Ljung et al., 1996; Jessop et al., 2001).  
The effects of glucocorticoids on central and peripheral fat are different. 
Glucocorticoids appear to increase lipolysis and down regulate lipoprotein 
lipase in peripheral fat but stimulate preadipocyte differentiation and 
triglyceride synthesis in central fat (Samra et al., 1998). In obesity in humans, 
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no upregulation of subcutaneous adipose tissue GR mRNA was found 
(Lindsay et al., 2003; Wake et al., 2003). 
A study on leptin resistant Zucker rats showed that obesity is correlated with 
KLJKHU ȕ-+6' DFWLYLW\ LQ RPHQWDO WLVVXH DQG ORZHUȕ-HSD1 activity in 
liver (Livingstone et al., 2000)7KHUHDVRQIRUWKHORZHUȕ-HSD1 activity in 
the liver might be a compensation for the higher cortisol levels in the portal 
YHLQZKLFKDUHGXHWRWKHKLJKȕ-HSD1 activity in omental tissue.  
,Q KXPDQV WKH DFWLYLW\ RI ȕ-HSD1 in omental fat is higher than in 
VXEFXWDQHRXV IDW VXJJHVWLQJ D UROH IRU ȕ-HSD1 in the development of 
visceral obesity (Bujalska et al., 1999). The results from this activity assay 
however may be biased by the amount of GR, which has been shown to be 
higher in visceral than in peripheral fat (Masuzaki et al., 2001).  
6HYHUDOVWXGLHVIRXQGWKDWWKHDFWLYLW\DQGP51$H[SUHVVLRQRIȕ-HSD1 in 
abdominal subcutaneous adipose tissue is increased in obese humans 
(Rask et al., 2001; Rask et al., 2002; Lindsay et al., 2003; Wake et al., 
2003).   
1.5.4.1 ȕ-HSD1 overexpression 
0LFHRYHUH[SUHVVLQJȕ-HSD1 are obese and have more visceral fat than 
control mice (Masuzaki et al., 2001). This relative increase in visceral fat may 
EHH[SODLQHGE\WKHOHYHOVRI*5ĮZKLFKDUHPXFKKLJKHULQYLVFHUDOWKDQLQ
peripheral fat in mice (Masuzaki et al., 2001)1RGRZQUHJXODWLRQRI*5ĮLV
found in these animals. The obesity in these mice is caused by hypertrophy 
and not hyperplasia of adipose tissue (Masuzaki et al., 2001).  
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7KH ȕ-HSD1 overexpressing mice have more insulin resistance and 
glucose intolerance, especially after a high fat diet, and the levels of 
triglycerides and free fatty acids are higher in these mice (Masuzaki et al., 
2001). Corticosterone levels are higher in the portal veins of those mice but 
normal in the systemic circulation (Masuzaki et al., 2001). This can be 
explained by a higher corticosterone production in omental tissue which 
leads to an overflow of corticosterone into the portal vein. The mice have 
increased plasma levels of angiotensinogen, angiotensin II, and aldosterone, 
suggesting activation of the circulating renin-angiotensin system (RAS). The 
mice are more likely to have salt-sensitive hypertension. Furthermore 
administration of a selective angiotensin II receptor AT-1 antagonist at a low 
dose abolishes the effect on blood pressure (Masuzaki et al., 2003). The 
mice also show dyslipidemia (Masuzaki et al., 2001). The ȕ-HSD1 
overexpressing mice all have symptoms of the metabolic syndrome 
VXJJHVWLQJ D UROH IRU ȕ-HSD1 in the pathogenesis of the metabolic 
syndrome. 7KH ȕ-HSD1 overexpressing mice also have elevated leptin 
levels and appear to be leptin resistant and exhibit hyperphagia (Masuzaki et 
al., 2001). 
1.5.4.2 ȕ-HSD1 knock-out or deficiency 
ȕ-HSD1 knock out mice show no developmental defects, they are fertile 
and fully viable (Kotelevtsev et al., 1997). In these mice lower activities of 
gluconeogenic enzymes have been found after fasting and lower glucose 
levels after stress or after a fatty meal (Kotelevtsev et al., 1997; Morton et al., 
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2004; Kerstens et al., 2005). These mice also proved to be diabetes resistant 
and normotensive. As expected, they have lowered intra-adipose 
glucocorticoid levels but mildly elevated plasma glucocorticoid levels (Morton 
et al., 2001). The mice also tend to distribute their adipose tissue more 
towards peripheral regions, indicating a role for ȕ-HSD1 in the regulation 
of fat distribution. These mice have reduced triglyceride levels, raised high 
density lipoprotein levels, lowered hepatic fibrinogen synthesis and increased 
lipid beta oxidation (Morton et al., 2001). The mice have reduced resistin, 
reduced TNFĮUHGXFHGOHSWLQDQGLQFUHDVHGDGLSRQHFWLQOHYHOVLQIDWWLVVXH
(Morton et al., 2004) 33$5Ȗ UHFHSWRU OHYHOV Dre higher in adipose tissue 
(Morton et al., 2001). Altogether they seem to have a cardioprotective 
phenotype; with better glucose tolerance and increased insulin sensitivity, 
DJDLQVXJJHVWLQJDUROHIRUȕ-HSD1 in the pathogenesis of the metabolic 
syndrome (Harris et al., 2001).  
The plasma corticosterone levels are modestly elevated, but the adipose 
tissue corticosterone levels are lowered. The HPA axis response to stress is 
appropriate in these mice (Harris et al., 2001). These mice gain less weight 
after feeding a high fat diet, although they have hyperphagia. It is possible 
that these mice have an enhanced metabolic rate. In summary it seems that 
ORZHU ȕ-HSD1 levels lead to lower levels of glucocorticoid action and 
increased insulin sensitivity (Walker et al., 1995; Andrews et al., 2002; 
Andrews et al., 2003).  
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ȕ-HSD1 deficiency has also been described in humans. These people 
have features of adrenal androgen excess. They have enhanced metabolic 
clearance of cortisol and compensatory hypothalamic-pituitary-adrenal gland 
D[LVDFWLYDWLRQ1RFRGLQJPXWDWLRQVKDYHEHHQIRXQGRIWKHȕ-HSD1 gene 
in this syndrome. The syndrome is called apparent cortisone reductase 
deficiency (Phillipov et al., 1996; Draper et al., 2003). Patients with this 
syndrome had mutations in the gene for hexose-6-phosphate besides the 
PXWDWLRQLQWKHȕ-HSD1 gene (Draper et al., 2003). Hexose-6-phosphate is 
important for the production of the cofactor NADPH and therefore hexose-6-
phospate may have an important role in the regional deposition of adipose 
tissue (Draper et al., 2003; Bujalska et al., 2005). 
&DUERQR[RORQH LQKLELWV ȕ-+6' DFWLYLW\ DQG ȕ-HSD2 activity in the 
kidney. Treatment with carbonoxolone enhances insulin sensitivity (Walker et 
al., 1995) and  inhibits hepatic glucose production in patients with diabetes 
mellitus type 2 (Andrews et al., 2003). 
 
1.5.4.3 ȕ-HSD1 polymorphisms 
Besides the non-coding mutation which has a role in the aetiology of the 
syndrome of apparent cortisone reductase deficiency an intronic 
SRO\PRUSKLVPLQWKHȕ-HSD1 gene has been found. This polymorphism is 
associated with an increased body mass index, altered body composition 
and insulin resistance (Gelernter-Yaniv et al., 2003). Caramelli et al 
investigated the relationship between obesity and common mutations in the 
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ȕ-HSD1 gene. They found no significant association, but their study was 
performed on only 8 obese patients (Caramelli et al., 2001). In a larger study 
Draper et al looked at the association between genomic differences in the 
ȕ-HSD1 gene and obesity. They also found only weak correlations (Draper 
et al., 2002). 
 
1.5.4.4 ȕ-HSD2 knock out mice or mutations 
Patients with the syndrome of apparent mineralocorticoid excess (AME) have 
been VKRZQ WR KDYH PRUH PXWDWLRQV LQ WKH ȕ-HSD2 gene than normal 
controls (Mune et al., 1995; Dave-Sharma et al., 1998). In this syndrome 
glucocorticoids occupy mineralocorticoid receptors causing sodium retention, 
hypertension and hypokalemia. Carbonoxolone, which is found in liquorice, 
IXQFWLRQV DV DQ LQKLELWRU RI ȕ-HSDs and excessive amounts of liquorice 
can cause symptoms similar to AME (Stewart et al., 1987)ȕ-HSD2 knock 
out mice have been produced and they also suffer from AME (Kotelevtsev et 
al., 1999) ,W FRXOGEHSRVVLEOH WKDWGXH WRD ODFNRIȕ-HSD2 activity, an 
excess amount of cortisol is available. This excess amount of cortisol would 
then compete with mineralocorticoids for binding to the MR given the equal 
affinity each has for the MR receptor. 
,W LV SRVVLEOH WKDW ȕ-HSD2 plays an important role in fat deposition by 
reducing the amount of available cortisol. It could therefore be protective for 
obesity and the metabolic syndrome. This role has not been investigated yet 
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and the differenFHVRIȕ-HSD2 levels between regional depots are still to 
be investigated.  
1.5.5 GLUCOCORTICOID SENSITIVITY IN DIFFERENT ADIPOSE TISSUE DEPOTS 
The effects of glucocorticoids on central and peripheral fat are different. 
Glucocorticoids appear to increase lipolysis and down regulate lipoprotein 
lipase in peripheral fat but stimulate preadipocyte differentiation and 
triglyceride synthesis in central fat in humans (Fried et al., 1993; Samra et 
al., 1998).  
The influence of glucocorticoids on the regional fat depots is dependent on 
the concentration of glucocorticoid receptors (GR). GR concentrations in 
visceral adipose tissue were found to be higher than in subcutaneous 
adipose tissue (Rebuffe-Scrive et al., 1985). In obesity in humans, no 
upregulation of GR mRNA was found (Lindsay et al., 2003; Wake et al., 
2003). 
$QRWKHU HVVHQWLDO FRPSRQHQW IRU ORFDO JOXFRFRUWLFRLG DFWLRQ LV ȕ-HSD1 
which converts inactive cortisone into active cortisol. In humans the activity 
RIȕ-HSD1 in omental fat is higher than in subcutaneous fat, suggesting a 
UROH IRU ȕ-HSD1 in the development of visceral obesity (Bujalska et al., 
1999; Walker, 2004). The results from this activity assay however may be 
biased by the amount of GR, which has been shown to be higher in visceral 
than in peripheral fat (Masuzaki et al., 2001).  
Several studies in obese humans, found that the activity and mRNA 
H[SUHVVLRQ RI ȕ-HSD1 in abdominal subcutaneous adipose tissue was 
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increased compared to non-obese controls. This further emphasises the 
confusion around the specific position of abdominal subcutaneous adipose 
tissue as either visceral or peripheral (Rask et al., 2001; Rask et al., 2002; 
Lindsay et al., 2003; Wake et al., 2003).  
A study on leptin resistant Zucker rats showed that obesity is correlated with 
KLJKHU ȕ-+6' DFWLYLW\ LQ RPHQWDO WLVVXH DQG ORZHUȕ-HSD1 activity in 
liver (Livingstone et al., 2000). The ORZHUȕ-HSD1 activity which was found 
in the liver could be a compensation for the higher cortisol levels in the portal 
YHLQZKLFKDUHGXHWRWKHKLJKȕ-HSD1 activity in omental tissue.  
As discussed in the previous section, mLFH RYHUH[SUHVVLQJ ȕ-HSD1 are 
obese and have more visceral fat than control mice (Masuzaki et al., 2001), 
while ȕ-HSD1 knock out mice tend to distribute their adipose tissue more 
WRZDUGVSHULSKHUDO UHJLRQV LQGLFDWLQJDUROH IRUȕ-HSD1 in the regulation 
of fat distribution (Morton et al., 2001). 
1.5.6 EVIDENCE FOR THE DEVELOPMENTAL PROGRAMMING OF GENES INVOLVED IN 
GLUCOCORTICOID SIGNALLING 
Glucocorticoids can have important roles in the programming of later health 
or disease of an individual. This is clearly demonstrated by the fact that 
glucocorticoid treatment during pregnancy alters birth weight in humans, 
sheep and mice (Reinisch et al., 1978; Ikegami et al., 1997; French et al., 
1999; Bloom et al., 2001), increases blood pressure in the fetal, juvenile and 
adult sheep offspring and in the adult rat offspring (Benediktsson et al., 
1993; Dodic et al., 1998; Dodic et al., 1999; Dodic et al., 2002; Jensen et al., 
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2002) and leads to permanent hyperglycaemia in adult rats (Lindsay et al., 
1996; Nyirenda et al., 1998; Sugden et al., 2001). Prenatal glucocorticoid 
administration has been shown to accelerate maturation of particular organs 
in human, of which the lung is the most notable one (Ward, 1994).  
Another clear demonstration of the essential role of glucocorticoids in the 
developmental origins of health and disease is provided by Langley-Evans 
and colleagues, who demonstrated that in the maternal protein restricted rat 
model, the development of hypertension by the age of 7 weeks in the 
offspring can be prevented by administration of glucocorticoid synthesis 
inhibitors to the pregnant dam (Langley-Evans, 1997).  
Several animal models have indicated differences in glucocorticoid sensitivity 
or glucocorticoid signalling enzymes following pre-natal challenges such as 
maternal dietary restriction. Glucocorticoid sensitivity in the liver and visceral 
adipose tissue was significantly increased in rat offspring as a result of 
PDWHUQDO QXWULHQW UHVWULFWLRQ DQG SODFHQWDO ȕ-HSD2 activity is selectively 
downregulated. These effects were present in fetal, neonatal, juvenile and 
adult offspring (Langley-Evans et al., 1996; Nyirenda et al., 1998; Bertram et 
al., 2001; Cleasby et al., 2003a). Hepatic GR levels are increased in the 
neonatal offspring of undernourished ewes and in the adult offspring of rats 
that were treated with dexamethasone during pregnancy (Nyirenda et al., 
1998; Whorwood et al., 2001; Cleasby et al., 2003b).  
Chadio and colleagues showed that ewes that were nutrient restricted during 
early gestation had significantly higher cortisol levels. The offspring of those 
ewes had significantly higher areas under the curve for ACTH and cortisol in 
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response to a CRH challenge, indicating increased HPA axis activation 
(Chadio et al., 2007). 
A challenge of antenatal dexamethasone exposure demonstrates that 
programming of genes involved in glucocorticoid sensitivity also occurs in 
adipose tissue, by showing a significant increase in the expression of GR in 
visceral adipose tissue both in adult rats and in neonatal sheep (Whorwood 
et al., 2001; Cleasby et al., 2003a).  
The programming of glucocorticoids and the HPA axis can occur very early 
in life as was shown by periconceptional undernutrition (PCUN) in a sheep 
model. Exposure of the oocyte and/or embryo to maternal undernutrition 
results in an increase in arterial blood pressure in the foetus and an 
increased and precocious activation of the HPA axis during late gestation 
(Edwards & McMillen, 2002a, b; Edwards et al., 2005). When maternal 
undernutrition extends from the periconceptional period into early pregnancy 
(i.e. from 60 days prior to conception and up to 30 days of pregnancy) a 
reduced foetal growth rate occurs with hyperactivation of the HPA axis and 
an increase in premature deliveries in sheep (Bloomfield et al., 2003; Oliver 
et al., 2005) 
 
It is clear that glucocorticoids play an important role in adipose tissue growth 
in the body. This role can include stimulation of lipolysis, lipogenesis and 
adipogenesis. The action of glucocorticoids on local tissues is dependent on 
WKHDEXQGDQFHRI*5DQGWKHHQ]\PHVȕ-+6'DQGȕ-HSD2. It is also 
clear that the body sensitivity to glucocorticoids can be programmed from 
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very early on in life. In this thesis we aim to elucidate the exact role of 
glucocorticoids in the development of regional differences in adipose tissue 
in early life. 
 
1.6 The effects of Insulin like growth factors on adipose tissue 
 
IGF1 and IGF2 are both monomeric plasma proteins present in bound and 
free form in plasma and in most or all body tissues (Daughaday, 1989; 
Daughaday & Rotwein, 1989; Humbel, 1990). Both IGF1 and IGF2 are 
structurally similar to insulin (Rinderknecht & Humbel, 1978; Humbel, 1990; 
O'Dell & Day, 1998).  IGF1 and IGF2 contribute to approximately 90% of the 
total extractable non-insulin insulin-like material in the serum (Froesch et al., 
1985). This similarity could well be responsible for the interactions that occur 
EHWZHHQ ,*)V DQG LQVXOLQ DW HDFK RWKHU¶V UHFHSWRUV (Froesch et al., 1985). 
The receptor for IGF1, IGF1R, is structurally very similar to IR. IGF1R can 
bind IGF1, IGF2 and insulin (Nielsen, 1992; O'Dell & Day, 1998). The 
receptor for IGF2, IGF2R, binds only IGF2 for internalisation and degradation 
(Nielsen, 1992; O'Dell & Day, 1998). 
1.6.1 RELEVANCE OF IGFS IN GROWTH 
IGFs are considered to be amongst the most important growth factors in the 
body. In humans IGF1 cord serum levels are directly related to body weight, 
length and head circumference (Gluckman et al., 1983; Verhaeghe et al., 
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1993; Geary et al., 2003). IGF1 cord serum levels were found to be 40% 
lower in infants that were small for gestational age and 28% higher in infants 
that were large for gestational age compared to infants that were average for 
gestational age (Verhaeghe et al., 1993). In sheep foetal body weight is 
directly related to circulating IGF1 levels (Owens et al., 1994; Carr et al., 
1995; Kind et al., 1995) and to liver IGF1 mRNA expression levels (Rhoads 
et al., 2000).  An infusion of IGF1 in rats that were hypophysectomised 
resulted in rats with increased body weight and bone width (Schoenle et al., 
1985).  
Another example that illustrates the importance of IGF1 in growth is seen in 
the Pygmies that live in Central Africa; people who are known to have a short 
stature. They were found to have low basal IGF1 levels and no rise in IGF1 
levels was found in response to exogenous growth hormone (GH) 
administration (Zapf et al., 1978).  
IGF1 homozygous knockout mice have been developed. These mice show 
foetal growth failure from day 13.5 of gestation. They also show growth 
retardation postnatally, which results in adult mice with a weight of 30-60% of 
normal adult weight (Baker et al., 1993; Liu et al., 1993). 
In humans, one male has been reported to have a homozygous partial IGF1 
deletion. He has reduced IGF1 concentrations and truncated protein. His 
basal and peak GH levels were elevated. At birth he showed symmetric 
growth retardation with a weight of 1.4 kg (3.9 SD below mean), a length of 
37.8 cm (5.4 SD below mean) and a head circumference of 27 cm (4.9 SD 
below mean). In infancy and childhood he had severe growth failure. 
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Treatment with recombinant IGF resulted in an improvement of his linear 
growth and normalisation of his GH and insulin levels (Woods et al., 1996; 
Woods et al., 1997; Camacho-Hubner et al., 1999). 
Ashton and colleagues measured IGF1 levels in the foetus from 15 to 23 
weeks of gestation. They found that the foetal levels were lower than cord 
blood levels at birth or adult levels. They also found that foetal IGF1 levels 
correlated with placental weight, foetal body weight and foetal body length 
(Ashton et al., 1985). Langford and colleagues demonstrated that at 27 
weeks of gestation IGF1 cord serum levels were lower in small for 
gestational age foetuses with placental insufficiency compared to average for 
gestational age babies or small for gestational age babies without placental 
insufficiency (Langford et al., 1995). 
After birth plasma IGF1 levels remain stable for the first 2 days in sheep. 
This period is followed by a rise in plasma IGF1 during postnatal day 3-7, 
during this period the relationship between plasma IGF1 levels and birth 
weight disappears. Plasma IGF2 levels remain stable from 12 hours after 
birth at a level comparable to the level in adult sheep (Gluckman et al., 1983; 
Daughaday & Rotwein, 1989).  
The relationship between IGF2 and body weight is not as clear as between 
IGF1 and body weight. Gluckman and colleagues reported no correlation 
between IGF2 cord serum levels at birth and size at birth (Gluckman et al., 
1983). While Geary and colleagues reported a correlation between cord 
plasma IGF2 levels and birth weight, length at birth and head circumference 
in a study of 987 singleton newborns (Geary et al., 2003). Ashton measured 
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IGF2 levels in the foetus between 15 and 23 weeks of gestation and found 
no correlation between IGF2 levels and placental weight, foetal body weight 
or length (Ashton et al., 1985). Verhaeghe and colleagues measured cord 
serum IGF2 levels during the 3rd trimester and at birth and found that IGF2 
levels were 8-10% higher in large for gestational age newborns compared to 
average or small for gestational age newborns. He also reported that the 
levels of IGF2 were 6-10 times higher than IGF1 levels during this period 
(Verhaeghe et al., 1993). 
A knockout model for IGF2 has been developed. Mice are heterozygous null 
for IGF2. These mice have 10 times less IGF2 mRNA compared to 
homozygous wild type mice and they are 50% smaller at birth. There were 
however no differences in postnatal growth rate between wild type and 
knockout mice (DeChiara et al., 1990). 
 
1.6.1.1 IGFs in adipose tissue growth 
IGF1 is one of the most important growth factors involved in adipose tissue 
growth. It has been shown to stimulate DNA synthesis and cell replication in 
embryo cultures and several cell lines (Zapf et al., 1978). Most of the 
circulating IGF1 however is of hepatic rather than adipogenic orgin (Butler et 
al., 2002). This together with evidence from different in vitro studies has led 
most researchers to believe that the effects of IGF1 on adipose tissue are 
delivered through autocrine and paracrine rather than endocrine 
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mechanisms (Faust et al., 1978; Lau et al., 1990; Peter et al., 1993; 
Considine et al., 1996; Marques et al., 1998; Butler et al., 2002).  
IGF1 is an important factor in the proliferation and differentiation of 
preadipocytes. In cell culture it has proven, like glucocorticoids, to be an 
essential requirement for the induction of adipocyte differentiation (Gregoire 
et al., 1998; Soret et al., 1999). The role of IGF1 in adipocyte differentiation 
has also been shown to be present in other in vitro and in vivo studies (Smith 
et al., 1988; Ramsay et al., 1989b; Wright & Hausman, 1995; Rajkumar et 
al., 1999; Holzenberger et al., 2001).  
Marques and colleagues performed an experiment in which IGF1 was 
stripped from the culture medium. Preadipocyte proliferation from inguinal 
and epididymal fat from rats was completely prevented in this study 
(Marques et al., 2000). Holzenberger and colleagues showed with their 
experiment that a global IGF1R deficiency in transgenic mice led to growth 
restriction and a reduction in relative fat mass (Holzenberger et al., 2001). 
Furthermore, Clarke and colleagues have demonstrated that IGF1 levels in 
plasma are correlated with lipid content in perirenal fat during the first month 
of postnatal life in sheep (Clarke et al., 1997b).  
 
1.6.1.2 Factors that influence IGF function 
IGF levels are influenced by many factors which include growth hormone, 
insulin, NEFA and leptin levels. Insulin and growth hormone have been 
shown to have stimulatory effects of IGF1 secretion in porcine and human 
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preadipocyte and adipocyte cultures (Chen et al., 1996; Wabitsch et al., 
2000). Work from a colleague in our laboratory has shown that there was no 
relationship between plasma insulin and IGF1 mRNA levels in perirenal 
adipose tissue of the sheep during the first three weeks of life. Furthermore it 
was shown that plasma leptin on postnatal day 1 was related to perirenal 
IGF1 mRNA expression at three weeks of age in both male and female 
lambs (Duffield, 2007). 
The relevance of IGF1 in nutrition driven growth was demonstrated by a 
study by Rhoads and colleagues who showed that lambs that were given a 
balanced diet compared to lambs given a diet that lacked in energy and 
protein grew faster, but also had IGF1 plasma levels twice as high (Rhoads 
et al., 2000). Several other studies showed the effects of nutrition on IGF 
expression and function. Hua and colleagues showed that sheep which were 
fasted for three days had a reduction in plasma IGF1 but not IGF2 levels 
both at the age of 4 months and at the age of 2 years (Hua et al., 1995). 
They also showed a reduction in plasma IGF1, but not IGF2, levels and 
kidney IGF1 mRNA levels after fasting for 5 days in sheep at the age of six 
months (Hua et al., 1993).  Fasting did not, however, affect liver or skeletal 
muscle IGF1 mRNA levels in sheep at six months of age (Hua et al., 1993; 
Rhoads et al., 2000).  
Another important factor for expression levels of IGF1 is gender. Sexual 
dimorphisms of IGF expression and function have been shown in numerous 
studies (Hindmarsh et al., 1999; Fall et al., 2000). At birth human males have 
higher levels of cord GH, IGF1 and IGF-binding protein-3 compared to 
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females (Geary et al., 2003). In sheep, plasma IGF1 levels have been shown 
to be higher in males compared to females both in lambs and in adults (Van 
Vliet et al., 1983; Gatford et al., 1996). IGF1 mRNA levels in perirenal 
adipose tissue of 3 week old sheep were also higher in males compared to 
females and in subcutaneous adipose tissue a trend was shown for higher 
levels in males compared to females (Duffield, 2007). It could be that the 
increase in circulating IGF1 in males compared to females is secondary to 
an increased IGF1 transcription in adipose tissue (Nam & Marcus, 2000).  
 
1.6.2  IGFS IN DIFFERENT ADIPOSE TISSUE DEPOTS 
The expression levels of IGF1, IGF2 and their receptors have been shown to 
be adipose tissue depot-specific. A colleague from our laboratory has shown 
that at three weeks of age in sheep, IGF1 expression was higher in perirenal 
adipose tissue compared to subcutaneous adipose tissue, whilst IGF2, 
IGF1R and IGF2R were lower in the perirenal depot compared to the 
subcutaneous depot (Duffield, 2007). It has been suggested that depot 
specific expression levels of insulin like growth factor receptors could be an 
explanation for the variation in proliferative capacities of preadipocytes in 
different adipose tissue depots and the differences in metabolism between 
fat depots (Wang et al., 1989; Bouchard et al., 1993; Dieudonne et al., 2000; 
Blaak, 2001). However expression levels of IGFs and their receptors in 
different visceral adipose tissue depots has not been investigated to date. 
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1.6.3 EVIDENCE FOR THE DEVELOPMENTAL PROGRAMMING OF GENES INVOLVED IN 
INSULIN LIKE GROWTH FACTOR SIGNALLING 
Most of the developmental challenges that have shown to have a 
programming effect on insulin sensitivity and signalling have also been 
shown to affect insulin like growth factor signalling. IGF1 protein in foetal 
arterial blood has been shown to be related to placental as well as to foetal 
weight. IGF1 protein in foetal blood was also related to IGF1 mRNA levels in 
liver, kidney and skeletal muscle, but not lung or heart. IGF2 protein in foetal 
arterial blood however showed no relationship with placental or foetal weight 
or tissue levels of IGF mRNA (Kind et al., 1995). Small for gestational age 
infants have lower levels of circulating IGF1, which is related to a reduced 
relative adipose tissue mass at birth (Enzi et al., 1981). Intra-uterine growth 
restricted foetuses (IUGR), which were 50% smaller than control foetuses, 
had reduced levels of liver IGF1 mRNA (Rhoads et al., 2000). 
Periconceptional maternal undernutrition has been shown to reduce foetal 
sheep plasma IGF1, but not IGF2 during late gestation (Lee et al., 1997; 
Gallaher et al., 1998). Nutritional challenges during pregnancy, such as 
maternal nutrient restriction or placental restriction have been shown to 
reduce plasma IGF1 and IGF mRNA in liver, kidney and skeletal muscle of 
the fetal sheep (Owens et al., 1994; Kind et al., 1995; Osgerby et al., 2002). 
Placental restriction has also been shown to result in a reduction of IGF1 
mRNA expression in perirenal adipose tissue during foetal life (Gemmell & 
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Alexander, 1978; Klaus, 1997). Other challenges such as hypoxaemia have 
also been shown to affect liver IGF1 mRNA in fetal sheep, but not IGF1 
mRNA in kidney, muscle, lung or thymus. In addition, hypoxaemia had no 
effect on IGF2 mRNA levels (McLellan et al., 1992). 
 
It is clear that IGFs play an important role in adipose tissue development and 
that IGF expression and function can be programmed during early life. 
Whether this programming of IGF expression in early life remains present in 
the long term and whether this could influence the adipose tissue distribution 
in later life, however, remains uncertain.  
 
1.7 Hypotheses 
1.7.1 MAIN HYPOTHESIS 
Adipose tissue distribution and development are regulated by a complex 
interaction between the local actions of insulin, glucocorticoids and insulin 
like growth factors on individual adipose tissue depots. Insulin promotes 
adipose tissue growth by promoting adipogenesis and lipogenesis and 
inhibiting lipolysis. Glucocorticoids decrease adipose tissue growth in the 
short term by promoting lipolysis but chronic exposure to high glucocorticoid 
concentrations stimulate adipose tissue growth through a stimulation of  
adipogenesis and lipogenesis. Insulin like growth factor 1 promotes 
adipogenesis.  
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I propose that changes in adipose tissue distribution and development, as a 
consequence of exposure to different patterns of nutrition in the neonatal 
period, are secondary to changes in the balance between the actions of 
insulin, glucocorticoids and insulin like growth factors on regional adipose 
tissue depots.  
 
1.7.2 SPECIFIC HYPOTHESES 
1.7.2.1 Adipose tissue development and distribution in early postnatal 
life 
Individual adipose tissue depots develop at different stages in the perinatal 
period. The subcutaneous and perirenal adipose tissue depot start to 
develop during prenatal life, while the omental depot develops predominantly 
in postnatal life. During prenatal life the foetus is exposed to insulin, which 
drives growth. Adipose tissue which is exposed to high insulin levels can 
develop a relative resistance to the anti-lipolytic effects of insulin. 
 
I propose that the relatively prolonged exposure of perirenal and 
subcutaneous adipose tissue to the effects of insulin, compared to the 
omental adipose tissue depot, which develops mainly in postnatal life, make 
these tissues relatively more resistant to the local actions of insulin 
compared to the omental depot during the first few weeks of postnatal life. 
Therefore, after birth when enteral food intake commences, the tissue that is 
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most sensitive to the local actions of insulin will be the omental adipose 
tissue depot, which would result in an accelerated growth of this depot in 
immediate postnatal life. 
 
In chapter two we test this hypothesis by analysing growth of the individual 
adipose tissue depots and markers of the tissue sensitivity to the local 
actions of insulin in omental and perirenal adipose tissue during early life. 
 
1.7.2.2 Periconceptional undernutrition and its effects on 
glucocorticoid-insulin balance 
Exposure of the oocyte and/or embryo to maternal undernutrition 
(periconceptional undernutrition; PCUN) results in a premature activation of 
the HPA axis during late gestation. Furthermore it results in an enhanced 
cortisol response after a CRH challenge. This increased pituitary-adrenal 
activation occurs during late gestation, the period during which the 
subcutaneous and perirenal adipose tissue depot undergo rapid growth.  
Offspring exposed to high cortisol levels in utero, such as in maternal nutrient 
restriction, have a greater response to HPA axis activation in later life. It is 
unknown to date whether this response is tissue specific. 
 
I hypothesise that PCUN will result in an enhanced glucocorticoid response 
in subcutaneous and perirenal adipose tissue depots which will persist after 
birth. When this period of periconceptional nutrient restriction occurs in 
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women that are already overweight, these effects are exaggerated, due to 
the increased insulin exposure of the perirenal and subcutaneous adipose 
tissue depot during prenatal life. Therefore these two depots become 
relatively even more insulin resistant and therefore more sensitive to the 
effects of glucocorticoids, which results in an even greater lipolytic activity in 
these depots and a greater nutrient supply for the omental depot. 
 
In chapter three we test this hypothesis by examining the effect on 
periconceptional undernutrition in ewes that were of a normal weight and 
ewes that were obese on adipose tissue growth and distribution in early life. 
We further test the described mechanism by investigating the expression of 
markers of the tissue sensitivity to the actions of insulin and glucocorticoids 
in the individual adipose tissue depots. 
 
1.7.2.3 Periconceptional undernutrition and the effects on insulin like 
growth factors 
Most tissues during development undergo a transition in the role of the 
insulin like growth factors and their receptors. This transition is, at least 
partly, mediated by glucocorticoids which stimulates IGF1R expression.  
 
I hypothesise that PCUN will result in a glucocorticoid mediated transition of 
IGF2R to IGF1R expression which happens mainly in the perirenal and 
subcutaneous adipose tissue depots which are present during foetal life. 
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Therefore the effects of IGF1 will be enhanced in the perirenal and 
subcutaneous adipose tissue depots, resulting in an increase in 
adipogenesis. 
  
In chapter four we test this hypothesis by examining the effects of 
periconceptional undernutrition in ewes that were of a normal weight and 
ewes that were obese on the expression of IGF1, IGF2, IGF1R and IGF2R in 
individual adipose tissue depots. 
 
1.7.2.4 Formula feeding and the effects on adipose tissue growth and 
distribution 
Formula feeding is associated with an increased food intake in early life and 
an increased plasma insulin concentration.  
 
I hypothesise that formula feeding results in a reduced sensitivity of adipose 
tissue to the actions of insulin. This reduction in sensitivity to insulin will 
switch the balance between insulin and glucocorticoids action on adipose 
tissue towards a stronger sensitivity of the adipose tissue to glucocorticoids. 
In the long term this increased glucocorticoid action will result in an increase 
in adipogenic growth in adipose tissue. The reduction in local sensitivity to 
the action of insulin will be greatest in the omental depot, which is developing 
rapidly during this period in life. The effects on increased adipose tissue 
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growth will therefore be greatest in this depot and lead to a redistribution of 
adipose tissue towards the omental depot. 
 
In chapter five we test this hypothesis by examining the effects of formula 
feeding or maternal milk feeding on the development and distribution of 
adipose tissue in lambs of three months of age. We further examine the 
expression of markers of the tissue sensitivity to the actions of insulin and 
glucocorticoids in individual adipose tissue depots. 
 
1.7.2.5 Adipose tissue distribution with adult-onset obesity 
Obesity is related to relative insulin resistance.  
 
I propose that the decreased response to the actions of insulin in adipose 
tissue will result in a reduction of thHLQVXOLQPHGLDWHGLQKLELWLRQRIȕ-HSD1 
expression resulting in enhanced local production of cortisol resulting in an 
increase in adipogenesis and adipose tissue growth.  
In obesity, however, the subcutaneous and perirenal depots are relatively 
less insulin resistant compared to the omental depot. In these depots insulin 
remains the main driver of growth. When the effects of obesity are combined 
with the effects of formula feeding an earlier shift towards glucocorticoid 
driven control of adipose tissue will occur in the omental depot, resulting in 
an exacerbation of the effects of an obesogenic lifestyle in people that were 
formula fed in early life. 
Chapter 1 74 
Literature Review 
 
In chapter six we test this hypothesis by examining the effects of an 
obesogenic lifestyle in animals that were fed maternal milk and animals that 
were formula fed on adipose tissue distribution. We further examine the 
expression and abundance of markers of tissue sensitivity to the actions of 
insulin and glucocorticoids in individual adipose tissue depots. 
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2. Ontogeny of the distribution of adipose tissue and 
differential abundance of proteins in the insulin signalling 
cascade in adipose tissue in early life 
 
 
2.1 Summary 
It is well established that an increase in visceral adipose tissue mass relates 
to an increase in metabolic risks in an individual. In large mammals, like 
sheep, at birth the major visceral adipose tissue depot is the perirenal depot. 
Later in life the omental depot develops but little is known about the 
differential growth patterns of these individual adipose tissue depots. Insulin 
is considered to be a major driving factor regulating adipose tissue growth. 
The actions of insulin are dependent on the efficiency of a complex cascade 
of several factors that involve insulin signalling in the cell. It has not been 
investigated whether the tissue specific abundance of factors involved in the 
insulin signalling cascade is different between adipose tissue depots. We 
hypothesised that omental adipose tissue has a relative accelerated growth 
pattern compared to other visceral adipose tissue depots in early life. We 
further hypothesised that this accelerated growth pattern is secondary to a 
relatively enhanced efficiency of the insulin signalling cascade in this depot in 
early postnatal life. 
Visceral adipose tissue was collected from sheep at different ages in early 
life and the growth of the individual visceral adipose tissue depots was 
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determined. The abundance of key factors in the insulin signalling cascade: 
IR, p85, Glut4 and IGF1R was determined in omental and perirenal adipose 
tissue from 7 and 14 day old lambs using Western Blotting.  
We found that during the first three months of postnatal life omental adipose 
tissue has a relative accelerated growth compared to the other visceral 
adipose tissue depots. IR abundance was significantly higher in perirenal 
compared to omental adipose tissue while p85 abundance was significantly 
lower in perirenal compared to omental adipose tissue. Glut4 and IGF1R 
abundance were not different between adipose tissue depots. All 
investigated proteins had a higher abundance at 7 days of age compared to 
14 days of age.  
This study has clearly shown that visceral adipose tissue development in 
early life is depot specific and that markers of insulin signalling are different 
between depots in early life. A lower abundance of IR in omental compared 
to perirenal adipose tissue, combined with a comparable abundance of Glut4 
between the depots, could potentially mean that the omental depot has a 
relatively more efficient insulin signalling cascade compared to the perirenal 
depot. However, this effect seems to be compensated by an upregulation of 
IR in the perirenal depot, leading to similar levels of Glut4 between tissues. 
Therefore, no conclusive evidence was found that the relative accelerated 
growth of omental adipose tissue in early postnatal life is driven by greater 
abundance of proteins involved in the insulin signalling cascade. 
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2.2 Introduction 
 
Obesity is a very important health problem in our present day society. The 
metabolic risk factors associated with obesity are dependent on the 
distribution of adipose tissue. Increased central as opposed to subcutaneous 
adipose tissue is associated with a higher cardiovascular risk (Fujioka et al., 
1987; Despres et al., 1989; Pouliot et al., 1992; Yusuf et al., 2004).  
Mechanisms that have been supposed to explain the difference in risk 
patterns associated with a more central than peripheral adipose tissue 
distribution include the production of cytokines by visceral adipose tissue and 
the direct release of free fatty acids from the visceral depot into the portal 
vein. The increased release of free fatty acids into the portal vein could be 
secondary to a decreased sensitivity to antilipolytic stimuli, by for example 
insulin (Arner et al., 1990; Hellmer et al., 1992; Marin et al., 1992a; Smith & 
Zachwieja, 1999). An increase in FFA in the portal drained viscera leads to a 
reduced insulin clearance and increased insulin secretion by the liver and 
ultimately insulin resistance. An increase in FFA in the portal vein also 
contributes to dyslipidaemia (Svedberg et al., 1990; Boden et al., 1998; 
Smith & Zachwieja, 1999). 
 
Visceral adipose tissue does not consist of one major adipose tissue depot 
but rather an amalgamation of pericardial (around the heart), perirenal 
(around the kidneys), omental (around the mesentery and intestines) 
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adipose tissue, and, arguably, also the subcutaneous adipose tissue that 
surrounds the abdomen (Himms-Hagen & Ricquier, 1998). In contrast to all 
the research that has been focusing on the differences between central and 
peripheral adipose tissue there has hardly been any research focusing on 
the differences between the depots that are all considered central.  
Previous studies have shown that in large mammals, like sheep, at birth the 
most important visceral adipose tissue depot is the perirenal adipose tissue 
depot (Clarke et al., 1997a; Symonds & Stephenson, 1999). After birth, 
however, the omental adipose tissue depot starts to develop. Little is known 
about the growth rate of those different depots and the factors that influence 
the distribution of adipose tissue between visceral fat depots.  
 
Adipose tissue deposition is influenced by several factors amongst which 
insulin is one of the most important ones. Insulin inhibits lipolysis and 
therefore promotes adipose tissue growth. The local tissue-specific effects of 
insulin are dependent on the level of circulating insulin, the density of 
membrane bound insulin receptors and the intracellular efficiency of insulin-
stimulated second messenger signalling. 
 
It has been shown that the anti-lipoloytic effect of insulin is lower in obese 
compared to lean individuals and that this is related to insulin resistance 
(Landin et al., 1990). This suggests that increased exposure of adipose 
tissue to insulin results in a reduced sensitivity of adipose tissue to the 
effects of insulin. 
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We propose that the relatively prolonged exposure of perirenal and 
subcutaneous adipose tissue to the effects of insulin, compared to the 
omental adipose tissue depot, which develops mainly in postnatal life, make 
these tissues relatively more insulin resistant compared to the omental depot 
during the first few weeks of postnatal life. Therefore, after birth when enteral 
food intake commences, the tissue that is most insulin sensitive will be the 
omental adipose tissue depot, which would result in an accelerated growth of 
this depot in immediate postnatal life. 
 
In this chapter we test this hypothesis by analysing growth of the individual 
adipose tissue depots and markers of the tissue sensitivity to the local 
actions of insulin in omental and perirenal adipose tissue during early life. 
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2.3 Methods 
  
2.3.1 ONTOGENY OF THE DISTRIBUTION OF ADIPOSE TISSUE IN THE SHEEP 
In this study, cross sectional data from multiple groups of nutritional control, 
twin sheep were used to delineate the postnatal ontogeny of regional 
adipose tissue depots in sheep. Data are: day 140 foetal samples (n=16, 
female [10] and male [6]); term, n=15 lambs (female [9] male [6]); day 7, n=7 
lambs (female [1], male [6]); day 14, n=6 lambs (female [1] male [5]); one 
month of age, n=9 lambs (female [3] male [6]); three months of age, n=6 
lambs (female [0] male [6]); six months of age, n=7 lambs (female [5] male 
[2]); 12 months of age, n=12 lambs (female [5] male [7]) and 36 months of 
age, n=8 lambs (female [0] male [8]). Details of the different animal cohorts 
can be found in Table 2.1. Animals were humanely killed using a 
pentobarbitone overdose and omental, perirenal and pericardial adipose 
tissue was collected, weighed and snap frozen in liquid nitrogen and stored 
at -80ºC for further laboratory analysis. 
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Table 2.1; Overview of animal cohorts studied 
Different animal cohorts studied at specific ages. Information regarding breed and animal 
numbers in each cohort. 
 
2.3.2 SAMPLE PREPARATION FOR REGIONAL ADIPOSE INSULIN SENSITIVITY 
ANALYSIS DURING THE FIRST TWO WEEKS OF POSTNATAL LIFE 
Protein was extracted from perirenal and omental adipose tissues of the 7 
and 14 day old lambs. Lambs of 7 and 14 days of age were chosen because 
it appeared that the difference in growth rate between perirenal and omental 
adipose tissue was greatest at these ages. Unfortunately no subcutaneous 
adipose tissue was available from these animals for further analyses. 
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2.3.2.1 Protein extraction 
To extract protein a lysis buffer was made by combining 75 ml RIPA, 750 ȝO
PMSF, 2250 ȝODSURWLQLQDQG ȝOsodium orthovanadate. 2.5 g of adipose 
tissue was homogenised in 7.5 ml of the lysis buffer. 50 ȝO306)ZDVDGGHG
and the mixture was incubated for 30 minutes on ice. The mixture was then 
centrifuged at 10000 rpm for 10 minutes at 4ºC. The supernatant was 
collected and recentrifuged for another 10 minutes at 10000 rpm at 4ºC. The 
supernatant was again collected, aliquoted into 2 tubes and stored at -20ºC.  
 
2.3.2.2 Measurement of protein concentration 
The protein content was measured using a bicinchoninic acid kit. Reagent A 
was prepared using 0.5 g 1% bicinchoninic acid (BCA), 1 g 2% sodium 
carbonate, 0.08 g 0.16% sodium tartrate and 0.2 g 0.4% sodium hydroxide in 
water to a total volume of 50 ml. 10% sodium bicarbonate was used to 
achieve a pH of 11.25. Reagent B was prepared with 2 g of 4% copper 
sulphate in water to a total volume of 50 ml. Reagent C was prepared by 
combining reagent A and B in a ratio of 100:2. A serial dilution of a 1 mg/ml 
stock solution of BSA in 0.9% saline was used as a standard.  
Samples were diluted 1:20 with distilled water. 50 ȝORIVWDQGDUGVROXWLRQRU
sample was added to 1 ml of reagent C and incubated while shaking at 37ºC 
for 30 minutes. 200 ȝO IURP HDFK WXEH ZDV DQDO\VHG LQ WULSOLFDWH ZLWK D
photospectrometer at 570 nm. All protein samples were diluted to the 
concentration of 1 mg/ml. SDS loading buffer (5 ml 1M Tris-HCL pH6.8, 1.54 
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grams dithiotreitol, 2 g SDS, 10 ml glycerol and bromophenol blue, mixed 
and diluted 1 in 5) was used to dilute the samples.  
 
2.3.2.3 Protein separation using electrophoresis 
A resolving buffer was prepared from 30 ml 40% acrylamide, 7.8 ml 2% 
ELVDFU\ODPLGHPOGLVWLOOHGZDWHUPO07ULV+&O S+ȝO
ZY6'6ȝO7(0('DQGȝOZY$367KHUHVROYLQJ
buffer was loaded in a prepared gelholder (2 glassplates rinsed with 70% 
ethanol and distilled water, fixed with sticky tape and clips), layered with a 
butanol-water mixture and left to set for 35 minutes. The butanol-water 
mixture was removed, a comb was placed and a stacking gel was added (7.5 
ml 40% acrylamid, 3.9 ml 2% bisacrylamide, 39.9 ml distilled water, 7.5 ml 
07ULV+&OS+ȝOZY6'6ȝO7(0('ȝOZY
APS). The stacking gel was left to set for 15-20 minutes. The tape was 
removed and the gelholder was placed in a geltank. Running buffer (10x 
running buffer = 60 g Tris base, 288 g glycine, 100 ml 20% SDS, 2 L distilled 
water) was added and the comb was removed. Protein samples were heated 
WR & IRU  PLQXWHV  ȝO RI HDFK VDPSOH ZDV ORDGHG RQ WKH JHO $
negative control was used which contained 100% SDS. One sample of 
omental and one sample of perirenal tissue were loaded twice, once with 10 
ȝODQGRQFHZLWK ȝOLQRUGHUWRDVVHVVWKHDGHTXDWHH[SRVXUHWRPHDVXUH
protein amounts. A marker was loaded to assess protein size. The gel tank 
was closed and an electrical power of 25V was applied overnight.  
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2.3.2.4 Protein transfer onto Western Blotting membrane 
The following day protein was transferred onto a membrane. A transfer 
buffer was prepared as follows: 50x transfer buffer = 9.3 g SDS, 145.25 g 
Trisbase, 73 g Glycine, 500 ml distilled water. Filter paper and membranes 
were soaked for 1 minute in methanol and for 1 minute in distilled water prior 
to be soaked in 1x transfer buffer. A horizontal transfer chamber was used 
for sample transfer. 8 layers of filter paper were placed underneath the 
membrane; the gel was placed on top and covered with another 8 layers of 
filter paper. All layers were soaked in transfer buffer. The protein samples 
were transferred at 400mA, 10 W to a maximum of 21 V for 1 hour and 35 
minutes. The membrane was then removed and placed in blocking buffer (20 
ml 10x TBS, 0.5 ml Tween 20, 2g Marvel powdered skimmed milk in a total 
of 200 ml distilled water) overnight at 4ºC while continuously shaking.  
 
2.3.2.5 Blotting the membranes with primary and secondary antibodies 
The following morning the blocking buffer was drained and a dilution of 
primary antibody was added. Ovine antibodies used were to insulin receptor 
ȕ-subunit (IR, 1:200) (Santa Cruz, Autogen Bioclear, UK), glucose 
transporter 4 (Glut4, 1:5000$EFDP&DPEULGJHVKLUH8.SĮ-subunit of 
phophatidylinositol 3-kinase (p85, 1:1000) (Upstate Biotech) and insulin like 
JURZWK IDFWRU  UHFHSWRU ȕ-subunit (IGF1R, 1:200) (Santa Cruz, Autogen 
Bioclear, UK). The dilutions were made using PBS buffer (10 tablets PBS, 20 
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g Marvel powdered skimmed milk, 2 ml Tween 20, distilled water up to a total 
of 2 L). The membranes were incubated with the primary antibodies for 1 
hour at room temperature. The membranes were then washed in TBSE 
buffer (100 ml 10x TBS, 5ml 20% SDS, 10ml 0.5M EDTA, 10ml Triton X 100, 
10g deoxycholic acid, distilled water up to a total of 1L) for 35 minutes. The 
membranes were then washed twice for 5 minutes each in fresh PBS buffer. 
The secondary antibodies anti-rabbit (Amersham, UK) were diluted 1:5000 in 
PBS.  The membranes were incubated 1 hour at room temperature with 
secondary antibody, before being washed for 35 minutes with TBSE and 
twice for 5 minutes with PBS buffer.  
 
2.3.2.6 Chemiluminence and densitometric analysis of protein 
concentration 
Chemiluminence was performed by mixing reagent A and B from Millipore 
chemiluminence substrate (Millipore, USA). The membranes were incubated 
for 1 minute in substrate and then wrapped in clingfilm. The membranes 
were placed in a hypercasette and exposed in a dark room at different 
exposure times. Protein concentrations were analysed using densitometry. 
The exposure which produced a ratio of 1:2 of protein concentration for the 
sample that was loaded twice with a double amount was used for further 
analyses of the other samples. An example of a Western Blot image is 
shown in Figure 2.1. 
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Figure 2.1; Example of Western Blot gel image 
Gel image of P85 western blot. Marker: protein markers, Samples: unknown samples loaded 
with 10 ȝg protein, 100%: sample loaded with 10 ȝg protein, 200%: same sample as 100% 
loaded with 20 ȝg protein, negative control: loaded with SDS buffer. 
 
 
2.3.3 STATISTICAL ANALYSIS 
Differences in gene expression between depots and groups of lambs of 
different ages were determined using a multifactorial ANOVA with repeated 
measures using STATA 10.0 (StataCorp, College Station, Texas, USA) in 
which the outcomes for the different depots were considered to be repeated 
within each animal. Extensive consideration has been given to the choice of 
using analyses for repeated or independent measures. Data have been 
analysed using both methods obtaining similar results. It was felt that data 
from different depots could not be considered as indepent and therefore 
analyses using repeated measures were chosen to be presented here. Given 
the unequal gender distribution in our cohorts, the effect of gender could not 
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be analysed in this chapter. Results are presented as means ± standard 
error of the mean.   
 
2.4 Results 
 
2.4.1 GENERAL ONTOGENY OF VISCERAL ADIPOSE TISSUE DISTRIBUTION IN LEAN  
SHEEP 
Figure 2.2 illustrates the development of regional adiposity in female sheep. 
At birth approximately 90% visceral adipose tissue in the term lamb is 
located around the kidneys. Within 6 months, the relative distribution 
changes considerably with a rapid expansion of the omental depot and 
relative loss of the perirenal depot. After this time, the relative mass of each 
depot remains relatively stable (Figure 2.2). The absolute weight of each 
adipose tissue depot at different ages can be found in Table 2.2. 
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Figure 2.2; Relative contribution of specific visceral adipose tissue depots to total 
visceral adipose tissue in control sheep over time 
Contribution of total omental, perirenal and pericardial adipose tissue to total visceral adipose 
tissue during prenatal (140 days gestation) and postnatal (up to 36 months) development in 
control sheep. Data are: 140 days gestation: n=16, term: n=15, 7 days postnatal: n=7, 14 
days postnatal: n=6, 1 month: n=9, 3 months: n=6, 6 months: n=7, 12 months: n=12, 36 
months: n=8. 
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Age Omental weight 
(g) 
Perirenal weight 
(g) 
Pericardial weight 
(g) 
140 days gestation - 20.1 ± 0.9 3.7 ± 0.3 
Term - 19.8 ± 1.1 4.5 ± 0.4 
7 days 11.7 ± 2.7 43.3 ± 6.8 4.5 ± 0.3 
14 days 46.7 ± 6.8 87.5 ± 14.9 8.2 ± 2.2 
1 month 99.4 ± 1.4 119.2 ± 12.6 29.6 ± 7.2 
3 months 340.0 ± 77.1 372.5 ± 98.1 49.2 ± 6.3 
6 months 523.6 ± 82.6 269.7 ± 39.7 36.2 ± 3.8 
12 months 714.7 ± 92.3 472.0 ± 80.9 92.7 ± 11.3 
36 months 712.9 ± 128.3 474.5 ± 112.0 63.5 ± 10.7 
Table 2.2; Absolute adipose tissue weight per depot at different ages 
Absolute weight in grams (mean ± SEM) of the different adipose tissue depots at different 
ages. Data are: 140 days gestation: n=16, term: n=15, 7 days postnatal: n=7, 14 days 
postnatal: n=6, 1 month: n=9, 3 months: n=6, 6 months: n=7, 12 months: n=12, 36 months: 
n=8. 
 
 
2.4.2 VISCERAL ADIPOSE TISSUE DISTRIBUTION AT 7 AND 14 DAYS 
The rapid expansion of the omental depot during the first six months of life 
starts within the first two weeks. The relative contribution of omental adipose 
tissue to total visceral fat increases from 19.6 ± 3.3% to 33.2 ± 2.3% during 
the period from 7 to 14 days (P = 0.008, Figure 2.3). During the same period 
in life there is a tendency towards a lower relative contribution of perirenal 
adipose tissue to visceral fat from 72.6 ± 4.0% to 61.4 ± 2.6% (P = 0.08, 
Figure 2.3). 
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Figure 2.3; Relative contribution of omental and perirenal adipose tissue to total 
visceral fat in control sheep at 7 and 14 days 
Omental and perirenal adipose tissue mass as a percentage of total visceral adipose tissue 
mass at 7 and 14 days of age. * indicate differences between 7 and 14 days. Data are: 
7days: n=7, 14 days: n=6. 
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2.4.3 INSULIN RECEPTOR ABUNDANCE IN 7 AND 14 DAY OLD LAMBS 
The abundance of insulin receptor was higher in 7 day old lambs compared 
to 14 day old lambs. This effect was significant in the perirenal as well as in 
the omental adipose tissue depot (P<0.001). At both 7 and 14 days of age IR 
abundance was higher in perirenal compared to omental adipose tissue 
(P=0.005, Figure 2.4). No interaction was found between age and adipose 
tissue depot. 
 
Figure 2.4; IR abundance in omental and perirenal adipose tissue in control sheep at 7 
and 14 days of age 
* indicate differences between 7 and 14 days, different letters indicate differences between 
depots. Data are: 7days: n=7, 14 days: n=6. 
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2.4.4 P85 ABUNDANCE IN 7 AND 14 DAY OLD LAMBS 
The abundance of p85 was higher in 7 day old lambs compared to 14 day 
old lambs in perirenal and omental adipose tissue (P=0.007). p85 
abundance was higher in the omental compared to the perirenal depot 
(P=0.011). No interaction was found between age and adipose tissue depot 
(Figure 2.5). 
 
 
Figure 2.5; p85 abundance in omental and perirenal adipose tissue in control sheep at 
7 and 14 days of age 
* indicate differences between 7 and 14 days, different letters indicate differences between 
depots. Data are: 7days: n=7, 14 days: n=6. 
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2.4.5 GLUT4 ABUNDANCE IN 7 AND 14 DAY OLD LAMBS 
Glut4 abundance tended to be higher at 7 days than at 14 days (p=0.06). 
The abundance was not significantly different between the perirenal and the 
omental adipose tissue depot (Figure 2.6). 
 
Figure 2.6; Glut4 abundance in omental and perirenal adipose tissue in control sheep 
at 7 and 14 days of age 
Data are: 7days: n=7, 14 days: n=6. 
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2.4.6 IGF1R ABUNDANCE IN 7 AND 14 DAY OLD LAMBS 
Protein abundance of IGF1R was higher in 7 day old lambs when compared 
to 14 day old lambs (P=0.034). There was no difference in the abundance of 
IGF1R between the two investigated depots, neither was there an interaction 
between the effect of age and depot (Figure 2.7).  
 
Figure 2.7; IGF1R abundance in omental and perirenal adipose tissue in control sheep 
at 7 and 14 days of age 
* indicate differences between 7 and 14 days. Data are: 7days: n=7, 14 days: n=6. 
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The protein abundance of IR, P85, Glut4 and IGF1R in all animals is 
summarised in Table 2.3. 
 
 
Table 2.3; Protein abundance of IR, p85, Glut4 and IGF1R in arbitrary units in perirenal 
and omental fat of 7 and 14 day old lambs 
Data are: 7days: n=7, 14 days: n=6. 
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2.5 Discussion 
 
This study, using cross-sectional data, is the first to show relatively 
accelerated growth of the omental adipose tissue depot compared to the 
perirenal and pericardial depots during early neonatal life.   
 
It has been shown in non-human primates, that the postnatal increase in 
adipose tissue mass is predominantly through tissue hypertrophy rather than 
hyperplasia (Lewis et al., 1986, 1989), a finding recently corroborated in 
humans (Spalding et al., 2008). Furthermore it is clear that the structure and 
function of adipose tissue is not homogenous throughout the body; and that 
increased visceral adipose i.e. omental and mesenteric, is implicated as key 
to the deleterious consequences of obesity (Despres & Lemieux, 2006; 
Hayashi et al., 2008). Indeed, increased visceral adiposity (marked by an 
increased waist circumference) even in normal weight people, has been 
found to be a strong independent risk factor for death (Pischon et al., 2008). 
Therefore, factors that influence the development, growth and metabolism of 
visceral adipose, specifically, are of particular interest. 
 
Other experimental studies using animal models have described the 
neonatal period as important with respect to adipose tissue development, 
structure and function (McCance, 1962; Dietz, 1994). Here we show quite 
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clearly that the regional distribution of visceral adipose tissue in the sheep 
occurs during the first six months of life and changes little thereafter.  
 
We hypothesised that the increased growth of the omental relative to the 
other visceral adipose tissue depots was secondary to a relative increased 
sensitivity to the actions of insulin in this depot.  
 
This study has clearly shown that adipose tissue per se is metabolically 
different between regional depots; abundance of IR was much lower in the 
omental compared to the perirenal depot at both 7 and 14 days of age. This 
implies significant differences in insulin signalling and possibly local 
sensitivity to the actions of insulin between perirenal and omental adipose 
tissue. The depot specific differences between insulin receptor abundance 
are however not reflected by depot specific differences of other markers of 
the insulin signalling cascade. P85 abundance was higher in omental 
compared to perirenal adipose tissue while Glut4 abundance was not 
different between the two depots. This shows that individual markers of the 
insulin signalling cascade have fundamentally different abundance patterns 
between perirenal and omental adipose tissue. This could potentially mean a 
difference in the efficiency of the insulin signalling cascade in the two depots 
and therefore a potentially different sensitivity to the local actions of insulin. 
Several mechanisms could be responsible for these protein specific 
differences in the insulin signalling cascade. Sympathetic nervous system 
activation or cytokine stimulation, for example, in the perirenal adipose tissue 
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could result in serine phosphorylation of insulin receptor substrate (IRS), 
which causes the signal in the insulin signalling cascade to be blunted (Klein 
et al., 1999; Le Marchand-Brustel et al., 2003; Tanti et al., 2004; Gual et al., 
2005).  
 
We could speculate that the relatively prolonged exposure to insulin in the 
perirenal adipose tissue depot has resulted in a decreased efficiency of the 
insulin signalling cascade in this depot and that IR abundance has increased 
in an attempt to compensate for the decreased insulin signalling efficiency. 
Kasuga and colleagues showed that adipocytes of streptozotocin treated 
diabetic rats had increased expression of insulin receptor and increased 
insulin binding capacity, indicating that the mechanism of insulin resistance is 
at post-receptor level and receptor expression can be upregulated in a 
compensatory response (Kasuga et al., 1978) 
 
Unfortunately we were unable to investigate the expression of markers of 
local tissue sensitivity to the effects of glucocorticoids at this age due to 
degradation of the RNA samples that were collected from these cohorts. 
Therefore we do not know whether the differences in abundance of proteins 
of the insulin signalling cascade in the perirenal compared to the omental 
depot are associated with differences in the expression of markers of the 
local sensitivity to the actions of glucocorticoids. Future studies will have to 
investigate the local tissue sensitivity to the actions of glucocorticoids in both 
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depots to further elucidate the exact role of glucocorticoids in growth patterns 
of different adipose tissue depots during this critical period in early life. 
 
Insulin like growth factor 1 receptor abundance was not significantly different 
between depots. However, at 7 days of age there was a strong trend towards 
a higher expression in the omental adipose tissue depot. This implies a 
possible difference in insulin like growth factor sensitivity between the two 
adipose tissue depots during this important period in early life. IGF1 
sensitivity could have a role in the accelerated growth of the omental depot 
at this stage in life. However at 14 days of age this trend is not present 
anymore while omental adipose tissue remains to grow at accelerated levels, 
indicating that IGF1 sensitivity is, at least, not the only factor contributing to 
this increased growth rate. 
 
All proteins that were investigated in this study showed higher abundance 
levels at 7 compared to 14 days of age independent of adipose tissue depot. 
Numerous studies have indicated increased levels of protein abundance or 
gene expression of several genes and proteins around birth (Liggins, 1976; 
Smith et al., 2009). The increased levels of the investigated proteins at 7 
days of age could be secondary to this rise in protein abundance around 
birth. 
 
In conclusion, the increased growth of the omental depot confirms the 
hypothesis that this depot undergoes accelerated growth in early life. 
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However, Glut4 abundance was similar in the omental compared to ther 
perirenal adipose tissue depot at 7 and 14 days of age. Other proteins 
involved in the insulin signalling cascade had differential abundance patterns 
between the two depots, indicating that there are fundamental metabolic 
differences in the insulin signalling cascade between the two depots. No 
definite conclusion can be made on the effects of those differential 
abundance patterns on the specific tissue sensitivity to the local actions of 
insulin.  
 
Given the differential growth rate of omental and perirenal adipose tissue 
during the first six months of life, the differences in local tissue sensitivity to 
the actions of insulin and glucocorticoids are likely to be most prominent at 
the age of three months. In chapter 3 and 5 we therefore examined local 
tissue sensitivity to the actions of insulin and glucocorticoids in perirenal and 
omental adipose tissue of lambs at the age of 3-4 months. We also 
investigated whether the differential growth of adipose tissue and the 
expression of key genes in the insulin signalling cascade could be influenced 
by nutritional challenges in the periconceptional period (Chapter 3) or the 
early postnatal period (Chapter 5). 
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3. Periconceptional nutrition influences adipose tissue 
development in sheep. 
 
 
3.1 SUMMARY 
 
With the increase in the incidence of obesity, the number of women that are 
entering pregnancy obese rises dramatically as well. Women that are obese 
when they enter pregnancy are relatively more insulin resistant than normal 
weight women during pregnancy. Associated with this increase in insulin 
resistance is an increase in the number of heavy babies born to mothers that 
were overweight or obese when they entered pregnancy. Heavier babies are 
more likely to become obese in adulthood. These obese adults then enter 
pregnancy themselves -an intergenerational cycle of obesity is established. It 
is to date not known whether this cycle relies on the weight of the women in 
the periconceptional period or later on in pregnancy. It is also not known 
whether the offspring of overnourished mothers have increased amounts of 
specific adipose tissue depots in their body. 
This study investigated the effects of periconceptional overnutrition, followed 
or not followed by a period of dietary restriction on the development of 
adipose tissue in the offspring. The study used embryo transfer and donor 
mothers in a sheep model to isolate the period of periconceptional nutrition 
from changes in maternal nutrition later in pregnancy. 
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Female offspring from ewes that were overnourished during the 
periconceptional period had higher total fat mass compared to offspring of 
control-fed ewes. This increase in fat mass was attenuated if the period of 
overnutrition was followed by a period of nutrient restriction. This indicates 
that the periconceptional period is an important programming period for the 
development of adipose tissue in the female offspring.  
The effect of periconceptional nutrition on adipose tissue development did 
not seem to be driven by changes in RNA expression of factors involved in 
the local sensitivity to the actions of insulin or glucocorticoids, since transcript 
expression of markers of each hormone were similar between treatment 
groups. However in offspring at the age of 4 months, independent of 
treatment group, the expression of markers of local sensitivity to the actions 
of insulin and glucocorticoids was highly depot specific. Furthermore the 
expression of markers of glucocorticoid sensitivity was negatively associated 
with weight of the donor ewe in the periconceptional period, but only in the 
omental adipose tissue depot of females. This study therefore shows that the 
omental and perirenal adipose tissue depot are significantly metabolically 
different at the age of 4 months and can be programmed by periconceptional 
nutritional status. 
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3.2 Introduction 
 
It is clear that alterations in nutrient supply during pregnancy have significant 
programmed effects on the health of the offspring in adulthood. These 
effects include increased risks for diseases like type 2 diabetes mellitus, and 
cardiovascular disease. 
It appears that these detrimental effects can find their origin as early in life as 
during the periconceptional period. Exposure of the oocyte and/or embryo to 
maternal undernutrition (periconceptional undernutrition; PCUN) resulted in a 
decrease in foetal weight and an increase in relative perirenal adipose tissue 
in twin pregnancies (Edwards et al., 2005). Furthermore, a relationship was 
seen in twin pregnancies between weight loss of the ewe and placenta and 
offspring size, such that an increase in weight loss resulted in relatively 
heavier placentae and larger foetuses at 55 days of gestation (MacLaughlin 
et al., 2005). Furthermore, it has been shown that PCUN results in an 
increase in arterial blood pressure in the foetus and a greater and precocious 
activation of the HPA axis during late gestation (Edwards & McMillen, 2002a, 
b; Edwards et al., 2005). 
When maternal undernutrition extends from the periconceptional period into 
early pregnancy (i.e. from 60 days prior to conception and up to 30 days of 
pregnancy) a reduced foetal growth rate occurs with hyperactivation of the 
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HPA axis and an increase in premature deliveries (Bloomfield et al., 2003; 
Oliver et al., 2005). 
It has also been shown that antenatal exposure to glucocorticoids results in 
programming of the expression of genes involved in the local sensitivity to 
the actions of glucocorticoids in adipose tissue. Cleasby and colleagues 
demonstrated that antenatal exposure to dexamethasone resulted in a 
significant increase in the expression of GR in visceral adipose tissue in rats 
(Cleasby et al., 2003a). Whorwood and colleagues showed a similar 
response to antenatal dexamethasone in sheep visceral adipose tissue 
(Whorwood et al., 2001).  
Since periconceptional undernutrition increases the exposure of the offspring 
prenatally to glucocorticoids, it is likely that PCUN will have programmed 
effects on the local sensitivity to glucocorticoids in adipose tissue that will last 
into later life. 
 
In our present day society obesity is an ever growing problem. With the 
increase in the obesity prevalence over the last few decades there has also 
been an increase in the number of women that are entering pregnancy 
obese (Bergmann et al., 2003; LaCoursiere et al., 2005). LaCoursiere and 
colleagues reported that in 1991 25.1% of women entered pregnancy 
overweight or obese. In 2001 this number had increased by 40.2 % to 35.2% 
(LaCoursiere et al., 2005). However, periconceptional overnutrition i.e. 
increased nutrient supply at this time, has been little explored in experimental 
studies but is becoming more prevalent in modern society.  
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Women who are overweight or obese at this time are more likely to have a 
reduced insulin sensitivity compared to lean women. During normal 
pregnancies the insulin sensitivity of the mother decreases in order to 
provide sufficient glucose supply to the foetus. Obese women, however, are 
more likely to have an insulin sensitivity that is already decreased even 
before pregnancy. The insulin sensitivity of obese women remains lower 
compared to that of lean women throughout pregnancy (Catalano & 
Ehrenberg, 2006). 
An excessive reduction in insulin sensitivity during pregnancy can lead to an 
excessive nutrient supply to the foetus, as is the case in gestational 
diabetes. Obese women are more likely to develop gestational diabetes or 
reduced insulin sensitivity (Sebire et al., 2001; LaCoursiere et al., 2005). The 
increased nutrient supply, associated with the reduction in insulin sensitivity, 
can result in increased growth of the foetus and macrosomia (Sebire et al., 
2001; Yajnik et al., 2002; Bergmann et al., 2003; Catalano et al., 2003; 
Gillman et al., 2003; Jensen et al., 2003; Ehrenberg et al., 2004). Catalano 
and colleagues showed that the strongest predictor of foetal fat accretion 
was pregravid maternal insulin sensitivity. They hypothesised that obese 
women, having lower insulin sensitivities, are therefore more at risk of having 
a large baby (Catalano et al., 1995). The Hyperglycaemia and Adverse 
Pregnancy Outcome Study Cooperative Research Group found that even in 
normal maternal glucose ranges there is an association between maternal 
glucose levels and birth weight of the offspring (Metzger et al., 2008), while 
Jensen and colleagues showed that even in women with a normal glucose 
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tolerance, obesity or being overweight was still associated with an increased 
risk of macrosomia (Jensen et al., 2003). 
 
A combination of periconceptional undernutrition, which affects the HPA axis, 
and maternal obesity in the periconceptional period, which affects the insulin 
supply to the foetus, is likely to have complicated effects on adipose tissue 
growth and development in the offspring.  
 
In this chapter we investigate these effects by using a model which combines 
periconceptional overnutrition, which functions as a model for maternal 
obesity, followed by periconceptional undernutrition, which functions as a 
model for dietary restriction. Embryo transfer and donor ewes were used 
after the periconceptional period to be able to look at the programmed 
effects of nutrition during the periconceptional period alone on adipose tissue 
development in the offspring. This enables us to distinguish the potentially 
beneficial effects of dietary restriction in the periconceptional period from 
dietary restriction during pregnancy.  
 
I hypothesise that the premature activation of the HPA axis during late 
gestation in PCUN will result in increased expression of genes involved in the 
local sensitivity of the tissue to the actions of glucocorticoids in the 
subcutaneous and perirenal adipose tissue, which are undergoing rapid 
growth during this period of life. I further hypothesise that this increased 
expression in of genes involved in the local sensitivity of tissue to the actions 
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of glucocorticoids in these depots will persist after birth. The omental depot, 
however, develops after birth and I therefore hypothesise that after PCUN 
this depot is not exposed to the increased actions of local glucocorticoids. 
Thus the growth of this depot is primarily mediated by insulin in the postnatal 
period.  
When this period of periconceptional nutrient restriction occurs in women 
that are already overweight, these effects are exaggerated, due to the 
increased insulin exposure of the perirenal and subcutaneous adipose tissue 
depot during prenatal life. Therefore these two depots become relatively 
more resistant to the local effects of insulin and therefore more sensitive to 
the local effects of glucocorticoids, which results in an even greater lipolytic 
activity in these depots and a greater nutrient supply for the omental depot. 
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3.3 Methods 
3.3.1 ANIMALS AND EXPERIMENTAL DESIGN 
All procedures were approved by The University of Adelaide Animal Ethics 
Committee and by the Institute of Medical and Veterinary Science Animal 
Ethics Committee. 
23 Non-pregnant Merino ewes were included in this study. All ewes were 
weighed and body condition score was assessed by an experienced 
assessor using a scale of 1-5 with intervals of 0.5 (Russel et al., 1969; 
Greenwood et al., 2000). A body condition score of 1 represents an 
extremely emaciated animal and a body condition score of 5 represents an 
extremely obese animal.  
During an acclimatisation period of 2 weeks the ewes were fed 100% 
metabolisable energy requirements (ME) as defined by the Agricultural and 
Food Research Council in 1993 (AFRC, 1993). The food consisted of pellets 
containing cereal hay, lucerne hay, barley, oats, almond shells, lupins, oat 
bran, lime and molasses (Johnsons & Sons Pty Ltd, Kapunda, South 
Australia, Australia).  
After the acclimatisation period, the ewes were randomly allocated to one of 
four treatment groups. The control-control group (CC, n=6) received a diet of 
100% metabolisable energy requirements (ME) for 4 months prior to 
conception. The control-restricted group (CR, n=6) received a diet of 100% 
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ME for 3 months followed by 70% ME for 1 month. The high-high group (HH, 
n=6) was fed ad libitum (170-190% ME) for 4 months. The high-restricted 
group (HR, n=5) was fed ad libitum (170-190% ME) for 3 months followed by 
a diet of 70% ME for 1 month prior to conception.  
 
The reproductive cycle of all ewes was synchronised by the administration of 
a progesterone pessary (45 mg flugestone acetate, Intervet, Paris France) 
for two weeks. Superovulation was induced by the administration of FSH 
(Folltropin, equivalent to 180 mg NIH-HSH-P1 standard), administered by 6 
intramuscular injections given over 3 days, twice daily, starting 48 hours 
before pessary removal and the final injection given 12 hours after pessary 
removal. Pessaries were removed on day 14 in the afternoon for donor ewes 
and 12 hours later in recipient ewes. Fresh semen was collected from a ram 
of proven fertility using the protocol specified by Kakar and colleagues 
(Kakar et al., 2005).  
Donor ewes were inseminated by laparoscopy with approximately 20 * 106 
spermatazoa being placed directly into the lumen of each uterine horn 
approximately 36 hours after pessary withdrawal.  
Prior to the commencement of surgery a blood sample was collected by 
venipuncture from the jugular vein. 6 days after ovulation, the donor ewes 
were anaesthetised and embryos were collected by mid-ventral laparotomy. 
Each uterine horn was flushed with 20 ml PBS containing 5% HISS (v:v).  
At embryonic day 6-7, donor embryos oI JRRG TXDOLW\   FHOOV DQG
acceptable morphology) were transferred to adult recipient ewes by 
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laparotomy. Recipients ewes (n=41) were maintained on a control diet for the 
maintenance of singleton bearing pregnant ewes (100% ME) at all times. 
Pregnancies were monitored by ultrasonography at day 45 of gestation and 
then once a month until term. The pregnant ewes were allowed to give birth 
naturally (term = 147±3 days).  
 
Lambs (n=41) remained with their mothers until weaning at three months of 
age. Ewes and lambs were housed in individual pens in an indoor housing 
facility. The ambient temperature in the housing facility was kept constant 
between 20 and 22°C. Animals were exposed to a 12 hour light, 12 hour 
dark cycle. 
Ewes were weighed and their body condition was assessed and scored 
approximately every two weeks after commencing the feeding regime until 
delivery. Body condition score of the recipient ewes ranged from 3.0 ± 0.02 
at the beginning of pregnancy to 3.2 ± 0.04 at the end of pregnancy, with no 
differences between treatment groups. Lambs were weighed at birth and 
approximately every two weeks until post mortem. Figure 3.1 shows a flow 
diagram of the experimental design used in this study (Figure 3.1). 
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Figure 3.1; Overview of the experimental design to investigate the effects of 
periconceptional nutrition on adipose tissue development in sheep 
ME: metabolisable energy requirements, F: female, M: male 
 
 
Lambs (n=41) were humanely killed at 4 months of age with an overdose 
sodium pentobarbitone (Virbac Pty Ltd, Peakhurst, New South Wales, 
Australia); all adipose tissue (perirenal, pericardial, subcutaneous, omental, 
axillary and gonadal) was collected and weighed at post mortem, samples 
were rapidly snap frozen in liquid nitrogen and stored at -80°C for further 
analysis.  
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3.3.2 PLASMA METABOLITES 
Blood samples were collected from the jugular vein by venipuncture from all 
lambs at post mortem. Blood samples were collected into chilled heparinised 
tubes. All samples were centrifuged at 1500 x g for 10 minutes and plasma 
was isolated and stored into aliquots at -20°C for the measurement of non-
esterified free fatty acids (FFA), glucose, insulin and cortisol. 
3.3.2.1 Glucose 
Plasma glucose concentrations were measured by enzymatic analysis using 
hexokinase and glucose-6-phosphate dehydrogenase to measure the 
formation of NADH photometrically at 340 nm (COBAS MIRA automated 
analysis system, Roche Diagnostica, Basel, Switzerland). The sensitivity of 
the assay was 0.5 mmol/l and the intra- and inter assay coefficients of 
variation were both < 5%. 
3.3.2.2 Insulin 
Plasma insulin concentrations were measured using a radioimmunoassay 
(Rat insulin kit, Linco Research, Inc., Missouri, USA), which was validated 
for use with sheep plasma. This assay has previously been shown to have a 
cross-reactivity of 100% with sheep insulin and no detectable cross-
reactivity with related proteins (C-peptide, glucagon, somatostatin, 
pancreatic polypeptide or IGF-1) (Linco Research, Inc., Missouri, USA). The 
recovery of insulin from lamb plasma was 96.5 ± 3.7 %. When insulin was 
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measured in increasing volumes of lamb plasma, the displacement curve 
was parallel to the assay standard curve. Samples (10 µl) were assayed in 
duplicate and added to borosilicate glass tubes with 100 µl of hydrated 125I-
Insulin and guinea-pig anti-rat insulin antibody and incubated overnight at 
4qC. Precipitating reagent (1ml) was added and tubes were centrifuged for 
25 min at 2000g, the contents were then aspirated and total counts 
measured by gamma counter. The sensitivity of the assay was 0.01 ng/ml 
and the intra and inter assay coefficients of variance were both <10%. 
3.3.2.3 Non-esterified fatty acids 
Plasma FFAs were measured by an in vitro enzymatic colorimetric method 
(Wako Pure Chemicals Industries Ltd, Osaka, Japan). The method relies 
upon the acylation of coenzyme A (CoA) by the fatty acids in the presence 
of added acyl-CoA synthetase (ACS). The acyl-CoA thus produced is 
oxidised by added acyl-CoA oxidase (ACOD) with generation of hydrogen 
peroxide. Hydrogen peroxide, in the presence of peroxidase (POD) permits 
the oxidative condensation of 3-methyl-N-ethyl-N-(E-hydroxyethyl)-aniline 
(MEHA) with 4-aminoantipyrine to form a purple coloured adduct which can 
be measured colorimetrically at 550nm (COBAS MIRA automated analysis 
system, Roche Diagnostica, Basel, Switzerland). The sensitivity of the 
assay was 0.25 ng/ml and the intra- and inter assay coefficients of variation 
were both < 10 %. 
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3.3.2.4 Cortisol RIA 
Cortisol was extracted from foetal plasma samples in duplicate using 
dichloromethane (Bocking et al., 1986) and measured with a 
radioimmunoassay (PerkinElmer Pty Ltd, Waltham, Massachusetts, USA) 
previously validated for use in foetal sheep plasma (MacLaughlin et al., 
2007). The efficiency of recovery of 125I-cortisol from foetal plasma using this 
extraction procedure was always greater than 90%. Samples were then 
reconstituted in assay buffer (Tris hydrochloride, BSA, and sodium azide). 
Rabbit anti-cortisol (1:450 dilution, MP Biomedicals, Seven Hills, NSW, 
Australia) was added followed by 125I-labeled cortisol (Amersham Pharmacia 
Biotech, Little Chalfont, UK). Tubes were vortexed and incubated at 37°C for 
1 h before the addition of goat anti-rabbit serum (1:30 dilution, Chemicon, 
Billerica, MA, USA) and 20% polyethylene glycol (BDH Laboratory Supplies, 
Poole, UK). After centrifugation at 3700 × g and 4°C for 30 min, the 
supernatant was aspirated and the precipitate counted on a Gamma-counter 
(Packard, Downers Grove, IL, USA). The sensitivity of the assay was 0.2 
nmol/L, and the intraassay and interassay coefficients of variation were <5% 
and 6.3%, respectively. 
3.3.3 RNA EXTRACTION AND CDNA SYNTHESIS 
RNA was isolated from frozen omental, perirenal and subcutaneous adipose 
tissue samples using Trizol reagent (Invitrogen, Groningen, The 
Netherlands) and purified using the RNeasy Mini Kit (Qiagen, Basel, 
Switzerland). In detail; 120-130 mg of adipose tissue was homogenised in 1 
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ml of Trizol reagent. Samples were left to stand at room temperature for 5 
PLQXWHV  ȝO FKORURIRUP ZDV DGGHG WR HDFK VDPSOH Samples were 
shaken vigorously for 15 seconds and allowed to stand at room temperature 
for 2-12 minutes prior to be centrifuged at 12000 g for 15 minutes at 4ºC. 
After centrifugation the upper aqueous, RNA containing, layer was 
transferred into a new eppendorf tube. Equal volume of cold 70% ethanol 
were added to the aqueous phase and the samples were mixed by inverting 
a few times. The solution was then transferred into a Qiagen column (in two 
steps). The liquid was eluted by centrifugation at 10000 rpm for 15 seconds 
at room temperature. Any flow through was discarded and these steps were 
UHSHDWHGZLWK WKH UHPDLQGHURI WKHVDPSOHȝORIEXIIHU5: IURP WKH
RNeasy Mini Kit was added to each column and column were centrifuged for 
15 seconds at 10000 rpm. )ORZ WKURXJKZDVGLVFDUGHGDQGȝORI53(
buffer (RNeasy Mini Kit) with added ethanol (as per manufacturers¶
instructions) was added. Columns were centrifuged at 10000 rpm for 2 
minutes and the flow through was discarded. Columns were then placed in a 
fresh collection tube and centrifuged at maximum speed for 1 minute to 
remove any left over buffer on the column membrane. Columns were again 
SODFHGLQDIUHVKFROOHFWLRQWXEHȝORIPROHFXODUJUDGHZDWHUZDVDGGHG
directly onto the membrane and columns were centrifuged for 1 minute at 
10000 rpm to elute the RNA in water.  
RNA was quantified by spectrophotometric measurements at 260 and 280 
nm. cDNA was synthesised from 2 µg RNA using Superscript III (Invitrogen, 
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Groningen, The Netherlands) by reverse transcription. Controls containing no 
RNA transcript or no superscript were used to test for DNA contamination. 
 
3.3.4 QUANTITATIVE REAL-TIME RT-PCR 
1RUPDOLVHG P51$ H[SUHVVLRQ IRU JOXFRFRUWLFRLG UHFHSWRU *5 ȕ- 
K\GUR[\VWHURLG GHK\GURJHQDVH W\SH  ȕ-+6' LQVXOLQ UHFHSWRU ȕ ,5
and glucose transporter 4 (Glut4) was determined in omental, perirenal and 
subcutaneous adipose tissue by reverse transcription real time PCR using 
the SYBR Green system in an ABI Prism 7000 Sequence Detection System 
(Applied Biosystems, Foster City, California). Each qRT-PCR well contained 
5 µl SYBR Green Master Mix (Applied Biosystems), 1 µl each of forward and 
reverse primer (GeneWorks, Adelaide, South Australia, Australia) for the 
appropriate gene (Table 3.1), 2 µl water and 50 ng/µl cDNA (1µl) to give a 
total volume of 10 µl. Controls for each primer set containing no cDNA were 
included on each plate. Three replicates of cDNA for each adipose tissue 
sample were performed to determine intra-plate variation. Two quality control 
samples were run on each plate to determine inter-plate variation. 
Amplification efficiencies were determined from the slope of a plot of Ct 
(defined as the threshold cycle with the lowest significant increase in 
fluorescence) against the log of the cDNA template concentration (ranging 
from 1-100 ng/µl). The abundance of each transcript relative to the 
abundance of the reference gene ribosomal protein P0 (RpP0) was 
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calculated using Q-Gene analysis software (Muller et al., 2002). RpP0 
expression was not influenced by treatment, gender or adipose tissue depot. 
The expressLRQ RI ȕ-K\GUR[\VWHURLG GHK\GURJHQDVH W\SH  ȕ-HSD2) 
was examined as described above. The expression was however too low to 
be able to obtain reproducible results.  
 
 
Primer Sequence Accession 
number 
GR F: ¶-ACT GCC CCA AGT GAA AAC AGA-¶ 
R: ¶-ATG AAC AGA AAT GGC AGA CAT TTT ATT-¶ 
NM_001114186 
 
ȕ-HSD1 F: ¶-GCG CCA GAT CCC TGT CTG AT-¶ 
R: ¶-AGC GGG ATA CCA CCT TCT TT-¶ 
NM_001009395 
 
ȕ-HSD2 F: ¶-AGC AGG AGA CAT GCC GTT TC-¶ 
R: ¶-GCA ATG CCA AGG CTG CTT-¶ 
NM_001009460 
 
,5ȕ F: ¶-CAT CCC CAG AAA ATC ATC TTC AG-¶ 
R: ¶-CAA GGG CTC TGC GTT TCC T-¶ 
Y16092 
 
Glut4 F: ¶-GTG GCC ATC TTT GGC TTC GTG-¶ 
R: ¶-CGG CTG AGA TCT GGT CAA AC-¶ 
AY949177 
 
RpP0 F: ¶-CAA CCC TGA AGT GCT TGA CAT-¶ 
R: ¶-AGG CAG ATG GAT CAG CCA -¶ 
NG_009485 
 
Table 3.13ULPHUVHTXHQFHVIRU3&5DQDO\VLVRI*5ȕ-HSD1ȕ-+6',5ȕ*OXW
and RpP0 
F: forward primer sequence, R: reverse primer sequence 
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3.3.5 STATISTICAL ANALYSIS 
Data are presented as the mean ± SEM. The effects of periconceptional 
overnutrition and dietary intervention on depot specific adipose tissue 
H[SUHVVLRQ RI *5 ȕ-HSD1, IR and Glut4 were determined using a 
multifactorial ANOVA using SPSS for Windows version 16.0 (SPSS Inc, 
Chicago, Illinois). Differences in gene expression between depots were 
determined using a multifactorial ANOVA with repeated measures using 
STATA 10.0 (StataCorp, College Station, Texas, USA) in which the 
outcomes for the different depots were considered to be repeated within 
each animal. Extensive consideration has been given to the choice of using 
analyses for repeated or independent measures. Data have been analysed 
using both methods obtaining similar results. It was felt that data from 
different depots could not be considered as indepent and therefore analyses 
using repeated measures were chosen to be presented here. Bonferroni post 
hoc tests were used where more than two groups were present. Relations 
between variables were assessed by linear regression using SigmaPlot 9.0 
(SPSS). A probability level of 5% (P<0.05) was considered to be significant. 
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3.4 Results 
 
3.4.1 WEIGHT OF DONOR EWE 
Body weight of the donor ewes in the HH and HR group was significantly 
higher compared to the CC and CR group at the time of embryo transfer. 
Dietary restriction did not result in a significant decrease in weight of the CR 
and HR group (Table 3.2). However the change in weight of the non-
pregnant donor ewes between 25 weeks before conception and the day of 
embryo transfer (day 6-7 pregnancy) was significantly different in each of the 
groups (P<0.001, Figure 3.2). 
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Weight of the ewe 
Treatment group 
CC CR HH HR 
25 weeks prior to 
conception (kg) 54.8 ± 1.2 54.5 ± 0.7 54.9 ± 1.1 55.9 ± 0.3 
1 month prior  
to conception (kg) 59.9 ± 1.2 58.1 ± 1.2 72.8 ± 3.6* 70.9 ± 1.4* 
Conception (kg) 55.7 ± 0.8 53.6 ± 1.5 69.4 ± 2.9* 65.1 ± 1.0* 
Embryo transfer (kg) 62.6 ± 1.4 58.6 ± 1.2 73.6 ± 3.1* 68.7 ± 0.8* 
Table 3.2; Weight of the donor ewes 25 weeks prior to conception, 1 month prior to 
conception, at conception and at the time of embryo transfer (day 6-7 pregnancy) 
Data are mean ± SEM. Asterisk (*) indicates a significant difference between the HH and HR 
group compared to the CC and CR group (P < 0.01). Data are: CC: n=7, CR: n=10, HR: 
n=12, HH: n=12 
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Figure 3.2; Changes in the weight of the non-pregnant donor ewes between 25 weeks 
before conception to the day of embryo transfer 
Different letters indicate significant differences between treatment groups. Data are: CC: n=7, 
CR: n=10, HR: n=12, HH: n=12 
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3.4.2 LAMB BODY WEIGHT AND FAT MASS 
There was no difference in lamb birth weight or weight at post mortem 
between the four treatment groups. Male lambs (n=21) were heavier than 
females (n=20) at birth and at four months of age (P<0.001 both time points, 
Figure 3.3). At post mortem female lambs had higher total fat mass 
compared to males despite a lower body weight (P=0.001, Figure 3.4). 
Female lambs in the high-high group had higher total fat mass compared to 
females in the control and the control-restricted group. This effect was 
attenuated when overnutrition was followed by a period of nutrient restriction 
(Figure 3.4). No differences were found between the weights of the individual 
adipose tissue depots and between the relative distribution of adipose tissue 
in the body between the different treatment groups. Table 3.3 gives an 
overview of the individual adipose tissue mass of the separate depots in 
males and females of the different treatment groups (Table 3.3). 
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Figure 3.3; Weight of the lambs at birth (A) and at 4 months of age (B) 
Males were significantly heavier than females at both timepoints. Males: n=21, Females: 
n=20. By group: CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.4; Total adipose tissue mass at 4 months of age in male (A) and female (B) 
lambs.  
Males have significantly less total adipose tissue mass (P = 0.001). Different letters indicate 
differences between different treatment groups. Males: n=21, Females: n=20. By group: CC: 
n=7, CR: n=10, HR: n=12, HH: n=12 
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Table 3.3; Absolute adipose tissue mass of the individual depots in male and female 
lambs at post mortem 
M: male, F: female. Female lambs had higher total fat mass compared to males. * 
signifanctly different from total fat mass in females in the CC and CR groups. 
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3.4.3 PLASMA METABOLITES 
Periconceptional overnutrition and a period of dietary restriction did not lead 
to significant alterations in plasma glucose, insulin, free fatty acid and cortisol 
concentrations in the offspring at four months of age. There was no effect of 
gender on these plasma metabolite levels (Table 3.4). 
 
  
 
Table 3.4; Plasma glucose, insulin, free fatty acid and cortisol concentrations in the 
lambs at 4 months 
No significant differences were found. 
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3.4.4 PERIRENAL GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
RQ WKHH[SUHVVLRQRI*5ȕ-HSD1, IR and Glut4 in the perirenal adipose 
tissue depot. Neither was the expression of these genes influenced by 
gender in perirenal adipose tissue (Figure 3.5 and Figure 3.6). 
 
3.4.5 OMENTAL GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
RQ WKHH[SUHVVLRQRI*5ȕ-HSD1, IR and Glut4 in the omental adipose 
tissue depot. Neither was the expression of these genes influenced by 
gender in omental adipose tissue (Figure 3.7 and Figure 3.8). 
 
3.4.6 SUBCUTANEOUS GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
on the expression RI*5ȕ-HSD1, IR and Glut4 in subcutaneous adipose 
tissue. Neither was the expression of these genes influenced by gender in 
subcutaneous adipose tissue (Figure 3.9 and Figure 3.10). 
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Figure 3.5([SUHVVLRQRI*5$DQGȕ-HSD1 (B) in perirenal adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.6; Expression of IR (A) and Glut4 (B) in perirenal adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.7; Expression of GR (A) and ȕ-HSD1 (B) in omental adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.8; Expression of IR (A) and Glut4 (B) in omental adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.9; Expression of GR (A) and ȕ-HSD1 (B) in subcutaneous adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 3.10; Expression of IR (A) and Glut4 (B) in subcutaneous adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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3.4.7 INTERACTIONS BETWEEN WEIGHT OF THE DONOR EWE, PLASMA 
METABOLITES AND GENE EXPRESSION 
Weight of the donor ewe at 14 days before conception only, was negatively 
associated wLWK RPHQWDO *5 DQG ȕ-HSD1 mRNA expression in female 
offspring at 4 months of age (GR: P = 0.035, R2 = 0.223, n=20ȕ-HSD1: P 
= 0.043, R2 = 0.208, n=20, Figure 3.11). FFA plasma levels at post mortem 
were associated with omentaO DQG VXEFXWDQHRXV ȕ-HSD1 mRNA 
H[SUHVVLRQEXWQRWZLWKSHULUHQDOȕ-HSD1 mRNA expression (omental: P 
= 0.003, R2 = 0.209, n=39, subcutaneous: P = 0.030, R2 = 0.121, n=39, 
Figure 3.12).  
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Figure 3.11; Correlations between weight of the donor ewe 14 days before conception 
DQGRPHQWDO*5$DQGȕ-HSD1 (B) expression in female lambs at 4 months of age 
N=20 in both graphs
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Figure 3.12; Correlations between plasma FFA levels at post mortem and expression 
RIȕ-HSD1 in perirenal (A), omental (B) and subcutaneous (C) adipose tissue 
N=39 for each depot 
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3.4.8 DEPOT SPECIFIC GENE EXPRESSION 
Since there were no significant differences between groups or gender in the 
expression of the investigated genes, data were pooled to allow a 
comparison of gene expression between different adipose tissue depots. The 
expression of all investigated genes was highly depot specific, with the 
expression being lowest in the subcutaneous depot compared to both 
YLVFHUDO DGLSRVH WLVVXH GHSRWV ȕ-HSD1: omental vs. subcutaneous: P = 
0.040, perirenal vs. subcutaneous: not significant, all other genes: omental 
vs. subcutaneous P < 0.001, perirenal vs. subcutaneous P < 0.001). 
Expression of GR and IR was higher in perirenal adipose tissue than omental 
adipose tissue (GR: P = 0.024, IR: P = 0.0011). No differences between 
RPHQWDODQGSHULUHQDOH[SUHVVLRQOHYHOVZHUHIRXQGIRUȕ-HSD1 and Glut4 
(Figure 3.13 and Figure 3.14). 
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Figure 3.13; Expression of GR (A) and ȕ-HSD1 (B) across adipose tissue depots 
Lambs of 4 months of age. Different letters indicate significant differences between adipose 
tissue depots. Both graphs: n=41 
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Figure 3.14; Expression of IR (A) and Glut4 (B) across adipose tissue depots 
Lambs of 4 months of age. Different letters indicate significant differences between adipose 
tissue depots. Both graphs: n=41 
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3.5 Discussion 
 
Periconceptional undernutrition did not result in a redistribution of growth 
towards the omental depot, as hypothesised. Neither did PCUN result in 
increased markers of local sensitivity to the actions of glucocorticoids in the 
perirenal or subcutaneous depot. However a reduction of weight of the ewe 
around conception did correlate with an increase in markers of sensitivity of 
the tissue to the actions of glucocorticoids, which could be a predictive 
adaptive response to the reduction in nutrient supply in the periconceptional 
period. The predictive adaptive response hypothesis suggests that the early 
life environment prepares an individual for a similar environment in later life 
and protects it from adverse effects of this type of environment (Gluckman & 
Hanson, 2004a, b). We could speculate that a low nutrient supply leads to 
mechanisms which protect the infant from decreased adipose tissue growth 
later in life, such as an up regulation of genes involved in glucocorticoid 
signalling. This response was only present in the omental depot, which is 
surprising since this depot is the last one to develop. However, given the 
anatomic location of the omental adipose tissue depot, it is widely 
recognised as the more metabolically active than other adipose depots and 
therefore more susceptible to the effects of changes in nutrition (Alvarez et 
al., 2002; Wilding, 2007; Hayashi et al., 2008; Lafontan & Girard, 2008). The 
relevance of the anatomic location of the omental adipose tissue depot 
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during this embryonic period of life is however uncertain, given that a 
significant amount of the nutrient supply from the umbilical cord bypasses 
the portal circulation and drains into the inferior vena cava.  
 
Periconceptional overnutrition did not result in the hypothesised reduction in 
markers of tissue sensitivity to the action of insulin in any of the investigated 
depots. Periconceptional overnutrition did result in an increase in total 
adipose tissue mass in females, which could indicate a response to the 
increased substrate supply in this offspring. However, no changes were 
IRXQGEHWZHHQWKHH[SUHVVLRQRI*5DQGȕ-HSD1 between dietary groups. 
It is therefore unlikely that the increased growth of adipose tissue mass in 
the female offspring of periconceptionally overnourished ewes is secondary 
to changes in the expression of markers of the local tissue sensitivity to the 
actions of glucocorticoids. Furthermore, no changes were found in the 
expression of IR and Glut4 between treatment groups. It is therefore unlikely 
that changes in the expression of key molecules in the insulin signalling 
cascade are underlying this difference in growth. However, we did not 
investigate other molecules involved in the insulin signalling cascade, such 
as IRS and PI3-kinase. Furthermore due to time limitations, we were unable 
to investigate protein abundance of proteins involved in the insulin signalling 
cascade in these samples. Future studies to investigate the expression and 
abundance of those and other relevant factors in the insulin signalling 
cascade could further elucidate whether increased tissue sensitivity to the 
actions of insulin in the female offspring of periconceptionally overnourished 
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ewes could underly the increased adipose tissue mass that is found in this 
group. 
 
An interesting finding in this study was that a restriction of energy intake 
during the periconceptional period in previously overnourished ewes leads to 
a normalisation of adipose tissue mass in the offspring. This is an important 
finding since it highlights a potential beneficial effect of a period of dietary 
restriction in obese individuals before and around conception. Other studies 
have shown that especially in people with fertility problems a period of 
dietary restriction has shown to have positive effects on conception rate 
(Mitchell & Rogers, 1953; Kiddy et al., 1992; Guzick et al., 1994). This study 
indicates that the effects could be much longer lasting than the immediate 
period of conception. However, it is not possible to make definite conclusions 
regarding the effect of periconceptional undernutrition in overnourished 
individuals based on our study. Key differences between a real life human 
situation and our study include the use of an animal model and the use of 
embryo transfer and recipient ewes. The use of embryo transfer and 
recipient ewes does allow us to solely look at the periconceptional period and 
investigate the effects of dietary restriction in isolation from the further 
pregnancy environment on later pregnancy outcome.  
 
We found that with an increase oI WKH H[SUHVVLRQ RI ȕ-HSD1 in the 
omental or subcutaneous adipose tissue depot the plasma FFA 
concentration rises. This could support our theory that glucocorticoids have a 
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stronger lipolytic than lipogenic effect on adipose tissue in the short term. 
Similar relations have been found between the effects of hypercortisolaemia 
and fatty acid turnover (Divertie et al., 1991; Dinneen et al., 1995). The 
DEVHQFH RI WKLV FRUUHODWLRQ EHWZHHQ SHULUHQDO ȕ-HSD1 and plasma FFA 
could be explained by the fact that at the age of 4 months, the perirenal 
depot is relatively smaller compared to the other depots and would therefore 
contribute less to total plasma FFA levels.  
 
The expression of markers of tissue sensitivity to the actions of insulin is 
lower in the subcutaneous adipose tissue compared to both visceral adipose 
tissue depots. This would support our hypothesis that this tissue which 
develops prenatally has a reduced tissue specific sensitivity to the actions of 
insulin in early postnatal life. However the perirenal adipose tissue also 
develops prenatally and does not show this reduction in the markers of 
tissue sensitivity to the actions of insulin. In order to make definite conclusion 
regarding tissue sensitivity to insulin more markers of the insulin signalling 
cascade need to be investigated. Furthermore we hypothesised that the 
actions of insulin are balanced against the actions of glucocorticoids and 
depot specific changes in this balance are responsible for differential growth 
of adipose tissue. In our study we also found a decrease in markers of 
sensitivity of the tissue to the actions of glucocorticoids in subcutaneous 
adipose tissue. This does not support our hypothesis that depot-specific 
differential growth patterns are secondary to changes in the balance of local 
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expression of markers of sensitivity to the local actions of insulin and 
glucocorticoid.  
 
The programming of adipose tissue mass in females during the 
periconceptional period could not be explained by changes in markers of 
insulin or glucocorticoid signalling. Therefore we can not conclude that this 
increased growth of adipose tissue mass in females is driven by changes in 
local sensitivity to the actions of insulin or glucocorticoids. In the next chapter 
we examine the effect of periconceptional overnutrition on insulin like growth 
factors and their receptors in order to further investigate other mechanisms 
that could explain the increased adipose tissue mass that was found in 
female offspring of ewes that were overnourished in the periconceptional 
period. 
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4. Periconceptional nutrition and the expression of insulin 
like growth factor 1, 2 and their receptors in individual 
adipose tissue depots in sheep.  
 
4.1 SUMMARY 
 
Most tissues during development undergo a transition in the role of the 
insulin like growth factors and their receptors. This transition is, at least 
partly, mediated by glucocorticoids which stimulate IGF1R expression. We 
hypothesised that PCUN will result in a glucocorticoid mediated transition of 
IGF2R to IGF1R expression which happens mainly in the perirenal and 
subcutaneous adipose tissue depots as these are present during foetal life. 
Therefore the effects of IGF1 will be enhanced in the perirenal and 
subcutaneous adipose tissue depots, resulting in an increase in 
adipogenesis. Omental adipose tissue on the other hand, will undergo 
transition from IGF2R to IGF1R at a later stage in life. Therefore IGF2R 
remains abundant in early life, resulting in an enhanced clearance of IGFs 
and no enhanced effects of IGFs on adipogenesis in this tissue. We 
hypothesised that the growth of this depot therefore remains, during early 
postnatal life, insulin driven. 
This study found no effects of PCUN on the expression of IGF1, IGF2, 
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IGF1R and IGF2R in omental, perirenal and subcutaneous adipose tissue of 
4 month old offspring. However, the lack of an effect of PCUN on markers of 
tissue sensitivity to glucocorticoids could provide a potential explanation for 
the absence of an effect. The increased adipose tissue mass in female 
offspring of PCON ewes, which was found in Chapter 3, could not be 
explained by changes in expression of the IGFs and their receptors.  
This study did find evidence for positive relations between GR and IGF1R 
and also between IR and IGF1R, indicating possible synergistic effects of 
glucocorticoids and IGFs and of insulin and IGFs. Interestingly a negative 
relationship was found between perirenal IGF1 expression and perirenal and 
subcutaneous adipose tissue mass, suggesting a regulatory role for the 
perirenal adipose tissue in the development of both adipose tissue depots.  
Finally an increased expression of IGF2 and IGF2R in the omental depot, 
relative to the other depots was found, supporting our hypothesis that 
delayed development of this depot is associated with a delayed transition 
from IGF1 to IGF2 dominance. 
Chapter 4 147 
Periconceptional nutrition and insulin like growth factors 
 
4.2 Introduction 
 
In the previous chapter we demonstrated that adipose tissue mass in 
females can be programmed as early as the periconceptional period. A high 
nutrient intake in the ewe resulted in an increase in total fat mass in the 
female offspring at four months of age. We investigated the effect of factors 
influencing sensitivity to glucocorticoids and insulin on depot specific adipose 
tissue growth. The increase in total omental adipose tissue mass in female 
offspring of ewes that were overnourished during the periconceptional period 
could not be explained by differences in the expression of the investigated 
genes. 
 
In this chapter we will investigate other growth promoting factors that could 
be responsible for differential growth patterns of adipose tissue depots, 
namely the insulin like growth factors. Insulin like growth factor 1 (IGF1) and 
insulin like growth factor 2 (IGF2) are well known to promote DNA synthesis 
and cell replication in human serum (Zapf et al., 1978). Actions of IGF1 
include stimulations of proliferation and differentiation of preadipocytes both 
in vivo and in cell culture in a number of species (Smith et al., 1988; Gregoire 
et al., 1998; Rajkumar et al., 1999; Soret et al., 1999; Holzenberger et al., 
2001). Furthermore, human umbilical cord serum levels of IGF1 positively 
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correlate with body weight and length (Gluckman et al., 1983; Verhaeghe et 
al., 1993; Geary et al., 2003). 
 
The role of IGF2, although less clear than the role of IGF1, involves mainly 
the stimulation of antenatal growth as suggested by knockout mice studies 
and the relationship between size for gestational age and serum IGF2 
concentrations that was found in human newborns (DeChiara et al., 1990; 
Verhaeghe et al., 1993). IGF2 is expressed in a range of tissues at high 
levels during early gestation in rats and sheep (van Dijk et al., 1988; Han et 
al., 1992), making it potentially vulnerable to dietary interventions in early 
gestation or the periconceptional period. Periconceptional maternal 
undernutrition has been shown to reduce foetal sheep plasma IGF1, but not 
IGF2 during late gestation (Lee et al., 1997; Gallaher et al., 1998). A study 
investigating the effects of periconceptional undernutrition on expression of 
IGF1, IGF2, IGF1R and IGF2R in sheep adrenal glands showed no effect of 
undernutrition on IGF gene expression (MacLaughlin et al., 2007). However, 
a study that investigated the effect of a low protein diet during the 
preimplantation period in rats did show a significant reduction in IGF2 
expression in the liver of male offspring only. The effect was only present if 
the diet was restricted to the preimplantation period and was abolished when 
the low protein diet continued throughout pregnancy (Kwong et al., 2006). 
 
Verhaeghe and colleagues reported that human serum levels of IGF2 were 
6-10 times higher than IGF1 levels during late gestation (Verhaeghe et al., 
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1993). Several studies have indicated that during development a transition 
occurs from predominantly IGF2R expression to IGF1R expression in a 
variety of species such as sheep, pigs and rats, and in a variety of tissues 
such as liver, adrenal glands, bones, kidneys and pancreas (Sara & Hall, 
1990; Delhanty & Han, 1993; Li et al., 1993; Peng et al., 1998; Hyatt et al., 
2004). This transition is, at least partly, mediated by glucocorticoids which 
stimulate IGF1R expression (Bennett et al., 1984; Li et al., 1993; Lu et al., 
1994). 
 
We hypothesise that the premature activation of the HPA axis in PCUN will 
result in a glucocorticoid mediated transition of IGF2R to IGF1R mRNA 
expression which happens mainly in the perirenal and subcutaneous adipose 
tissue depots because these are present during foetal life. Therefore the 
effects of IGF1 will be enhanced in the perirenal and subcutaneous adipose 
tissue depots, resulting in an increase in adipogenesis. Omental adipose 
tissue on the other hand, will undergo transition from IGF2R to IGF1R at a 
later stage in life. Therefore IGF2R remains abundant in early life, resulting 
in an enhanced clearance of IGFs and no enhanced effects of IGFs on 
adipogenesis in this tissue. The growth of this depot therefore remains, 
during early postnatal life, insulin driven.  
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4.3 Methods 
 
4.3.1 ANIMALS AND EXPERIMENTAL DESIGN 
The animal protocol and experimental design used in this study is identical to 
that described in detail in the previous chapter.  
In brief: 23 Non-pregnant Merino ewes were included in this study. During an 
acclimatisation period of 2 weeks the ewes were fed 100% metabolisable 
energy requirements (ME) as defined by the Agricultural and Food Research 
Council in 1993 (AFRC, 1993).  
After the acclimatisation period, the ewes were randomly allocated to one of 
four treatment groups. The control-control group (CC, n=6) received a diet of 
100% metabolisable energy requirements (ME) for 4 months prior to 
conception. The control-restricted group (CR, n=6) received a diet of 100% 
ME for 3 months followed by 70% ME for 1 month. The high-high group (HH, 
n=6) was fed ad libitum (170-190% ME) for 4 months. The high-restricted 
group (HR, n=5) was fed ad libitum (170-190% ME) for 3 months followed by 
a diet of 70% ME for 1 month prior to conception.  
The reproductive cycle of all ewes was synchronised and superovulation was 
induced. Fresh semen was collected from a ram of proven fertility and donor 
ewes were inseminated by laparoscopy with approximately 20 * 106 
spermatazoa being placed directly into the lumen of each uterine horn.  
Chapter 4 151 
Periconceptional nutrition and insulin like growth factors 
6 days after ovulation, the donor ewes were anaesthetised and embryos 
were collected by mid-ventral laparotomy. At embryonic day 6-7, donor 
HPEU\RV RI JRRG TXDOLW\   FHOOV DQG DFFHSWDEOH PRUSKRORJ\ ZHUH
transferred to adult recipient ewes by laparotomy. Recipients ewes were 
maintained on a control diet for the maintenance of singleton bearing 
pregnant ewes (100% ME) at all times. The pregnant ewes were allowed to 
give birth naturally (term = 147±3 days).  
Lambs remained with their mothers until weaning at three months of age. 
Lambs (n=41) were humanely killed at 4 months of age with an overdose 
sodium pentobarbitone (Virbac Pty Ltd, Peakhurst, New South Wales, 
Australia); all adipose tissue was collected and weighed at post mortem, 
samples were rapidly snap frozen in liquid nitrogen and stored at -80°C for 
further analysis.  
 
4.3.2 LABORATORY ANALYSIS 
RNA was extracted and cDNA was synthesised from frozen omental, 
perirenal and subcutaneous adipose tissue as described in Chapter 3. 
Normalised mRNA expression for insulin-like growth factor 1 and 2 (IGF1 
and IGF2) and their receptors (IGF1R and IGF2R) was determined by 
reverse transcription real time PCR as described in Chapter 3. The 
sequences of the individual primers can be found in Table 4.1. 
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Primer Sequence Accession 
number 
IGF1 F: ¶-TTG GTG GAT GCT CTC CAG TTC-¶ 
R: ¶-AGC AGC ACT CAT CCA CGA TTC-¶ 
NM_001009774 
 
IGF2 F: ¶- GCT TCT TGC CTT CTT GGC CTT-¶ 
R: ¶- TCG GTT TAT GCG GCT GGA T-¶ 
M89789 
IGF1R F: ¶-AAG AAC CAT GCC TGC AGA AGG-¶ 
R: ¶-GGA TTC TCA GGT TCT GGC CAT T-¶ 
AY162434 
 
IGF2R F: ¶- GAT GAA GGA GGC TGC AAG GAT-¶ 
R: ¶- CCT GAT GCC TGT AGT CCA GCT T-¶ 
AF327649 
RpP0 F: ¶-CAA CCC TGA AGT GCT TGA CAT-¶ 
R: ¶-AGG CAG ATG GAT CAG CCA -¶ 
NG_009485 
  
Table 4.1; Primer sequences for PCR analysis of IGF1, IGF2, IGF1R, IGF2R and RpP0 
F: forward primer sequence, R: reverse primer sequence 
 
4.3.3 STATISTICAL ANALYSIS 
Data are presented as the mean ± SEM. The effects of periconceptional 
overnutrition and dietary intervention on depot specific adipose tissue 
expression of IGF1, IGF2, IGF1R and IGF2R were determined with an 
ANOVA using SPSS for Windows version 16.0 (SPSS Inc, Chicago, Illinois). 
Differences in gene expression between depots were determined using a 
multifactorial ANOVA with repeated measures using STATA 10.0 
(StataCorp, College Station, Texas, USA) in which the outcomes for the 
different depots were considered to be repeated within each animal. 
Extensive consideration has been given to the choice of using analyses for 
repeated or independent measures. Data have been analysed using both 
methods obtaining similar results. It was felt that data from different depots 
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could not be considered as indepent and therefore analyses using repeated 
measures were chosen to be presented here. Bonferroni posthoc tests were 
performed when more than two groups were present. Relationships between 
variables were assessed by linear regression using SigmaPlot 9.0 (SPSS). A 
probability level of 5% (p<0.05) was considered to be significant. 
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4.4 Results 
 
4.4.1 PERIRENAL GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
on the expression of IGF1, IGF2, IGF1R and IGF2R in the perirenal adipose 
tissue depot. Neither was the expression of these genes influenced by 
gender in perirenal adipose tissue (Figure 4.1 and Figure 4.2). 
 
4.4.2 OMENTAL GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
on the expression of IGF1, IGF2, IGF1R and IGF2R in the omental adipose 
tissue depot. Neither was the expression of these genes influenced by 
gender in omental adipose tissue (Figure 4.3 and Figure 4.4). 
 
4.4.3 SUBCUTANEOUS GENE EXPRESSION 
There was no effect of periconceptional overnutrition and dietary restriction 
on the expression of IGF1, IGF2, IGF1R and IGF2R in subcutaneous 
adipose tissue. Neither was the expression of these genes influenced by 
gender in subcutaneous adipose tissue (Figure 4.5 and Figure 4.6). 
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Figure 4.1; Expression of IGF1 (A) and IGF1R (B) in perirenal adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 4.2; Expression of IGF2 (A) and IGF2R (B) in perirenal adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 4.3; Expression of IGF1 (A) and IGF1R (B) in omental adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 4.4; Expression of IGF2 (A) and IGF2R (B) in omental adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 4.5; Expression of  IGF1 (A) and IGF1R (B) in subcutaneous adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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Figure 4.6; Expression of  IGF2 (A) and IGF2R (B) in subcutaneous adipose tissue 
Male and female lambs at 4 months of age. No significant differences were found. Data are: 
CC: n=7, CR: n=10, HR: n=12, HH: n=12 
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4.4.4 INTERACTIONS BETWEEN GENES, PLASMA METABOLITES AND DEPOTS 
No interactions were found between the expression of IGF1, IGF1R, IGF2 or 
IGF2R expression and plasma metabolites. 
In male lambs perirenal expression of IGF1 was strongly negatively 
associated with relative perirenal and subcutaneous adipose tissue mass 
(perirenal adipose tissue: P = 0.002, R2 = 0.4191, n=21, subcutaneous 
adipose tissue: P = 0.005, R2 = 0.3466, n=21, Figure 4.7). There was also a 
significant association between perirenal IGF1 and total fat mass, but this 
correlation was no longer significant when controlled for subcutaneous 
adipose tissue mass. 
In both males and females the expression of GR was positively correlated 
with the expression of IGF1R. This correlation was significant in omental and 
perirenal adipose tissue although the slope of the regression line was 
significantly lower in omental compared to perirenal adipose tissue (omental: 
P = 0.003, R2= 0.40, slope: 12.79, n=41, perirenal: P=0.019, R2 = 0.27, 
slope: 17.26, n=41, Figure 4.8). The expression of IR was also positively 
correlated with the expression of IGF1R. This correlation was significant in all 
investigated depots and the slope was significantly higher in perirenal 
compared to omental adipose tissue (omental: P <0.0001, R2 = 0.50, slope: 
2.51, n=41, perirenal: P = 0.002, R2 = 0.23, slope: 3.17, n=41, 
subcutaneous: P = 0.0254, R2 = 0.12, slope: 0.81, n=41, Figure 4.9). A 
correlation between expression levels of GR and IR was no longer significant 
when controlled for IGF1R expression levels. 
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Figure 4.7; Correlation between perirenal expression levels of IGF1 and relative 
perirenal (A) and subcutaneous (B) adipose tissue mass in males 
Male lambs at four months of age, n=21 
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Figure 4.8; Correlations between GR and IGF1R in perirenal (A), omental (B) and 
subcutaneous (C) adipose tissue 
Lambs at 4 months of age. A; perirenal (GR = 17.26 IGF1R + 0.1394, P = 0.019, R2 = 0.27, 
n=41). B; omental (GR = 12.79 IGF1R + 0.1232, P = 0.003, R2 = 0.40, n=41).  C; 
subcutaneous (no significant correlation). 
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Figure 4.9; Correlations between IR and IGF1R in perirenal (A), omental (B) and 
subcutaneous (C) adipose tissue 
Lambs at 4 months of age. A; perirenal (IR = 3.1684 IGF1R + 0.0116, P = 0.002, R2 = 0.22, 
n=41). B; omental (IR = 2.5143 IGF1R + 0.0059, P < 0.001, R2 = 0.50, n=41). C; 
subcutaneous (IR = 0.8146 IGF1R + 0.009, P = 0.025, R2 = 0.12, n=41) 
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4.4.5 DEPOT SPECIFIC GENE EXPRESSION 
Since there were no significant differences between groups or gender in the 
expression of the investigated genes, data were pooled to allow a 
comparison in gene expression between different adipose tissue depots. The 
expression of all investigated genes was highly depot specific. Expression of 
IGF1 and IGF1R were significantly lower in subcutaneous compared to 
omental and perirenal adipose tissue (P < 0.001, all cases, Figure 4.10).  
Expression of IGF2 was significantly higher in omental compared to perirenal 
adipose tissue (P < 0.001). The expression of IGF2 in subcutaneous adipose 
tissue was lower compared to both visceral adipose tissue depots (P < 
0.001, both cases). Expression of IGF2R was also significantly higher in 
omental compared to both other depots (P < 0.001, omental vs. perirenal 
and P = 0.006, omental vs. subcutaneous). The subcutaneous expression of 
IGF2R was lower than the omental IGF2R expression but higher than the 
perirenal IGF2R expression (P < 0.001, Figure 4.11). 
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Figure 4.10; Expression of IGF1 (A) and IGF1R (B) across adipose tissue depots 
Lambs of 4 months of age. Different letters indicate significant differences between adipose 
tissue depots. Both graphs: n=41. 
Chapter 4 167 
Periconceptional nutrition and insulin like growth factors 
  
 
Figure 4.11; Expression of IGF2 (A) and IGF2R (B) across adipose tissue depots 
Lambs of 4 months of age. Different letters indicate significant differences between adipose 
tissue depots. Both graphs: n=41. 
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4.5 Discussion 
 
Periconceptional undernutrition did not result in the expected increased 
expression of IGF1 or IGF1R in any of the investigated depots. Furthermore, 
no effects of periconceptional overnutrition or nutrient restriction on the 
expression of IGF1, IGF2, IGF1R or IGF2R in perirenal, omental or 
subcutaneous adipose tissue were found. The increased amount of total 
adipose tissue which was found in periconceptionally overnourished (female) 
sheep cannot, therefore, be explained by differences in the expression of 
insulin like growth factors and their receptors. 
However we did find an association between GR and IGF1R which supports 
our hypothesis that glucocorticoids stimulate IGF1R expression and 
therefore work synergistically with IGF1. Bennett and colleagues found 
similar relations in their study (Bennett et al., 1984), while Conover and 
colleagues and Tronche and colleagues found that glucocorticoids 
stimulated IGF1 action in vivo (Conover et al., 1985; Tronche et al., 2004) 
 
Since our hypothesis was initially based on an increase in markers of tissue 
sensitivity to the actions of glucocorticoids in perirenal and subcutaneous 
adipose tissue resulting in an increase in IGF1R, the absence of an effect of 
PCUN on IGF1 and IGF1R expression in those depots could be secondary to 
the absence in the effect of markers of the tissue sensitivity to 
glucocorticoids in PCUN. Given the relationship between markers of tissue 
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sensitivity to the actions of glucocorticoids and IGF1R it is therefore possible 
that the effects of PCUN on IGF1 expression are absent because PCUN 
does not alter tissue sensitivity to the actions of glucocorticoids as seen in 
the previous chapter. 
Unfortunately, due to time limitations, we were not able to measure protein 
abundance of insulin like growth factors and their receptors in different 
adipose tissue depots in this study. Future data will further elucidate the 
effects of periconceptional nutrition on insulin like growth factors protein 
abundance. 
 
The relationship between IGF1R and IR suggests that not only do 
glucocorticoids work synergistically with IGF1 but that insulin has the same 
effect. It has been shown in the past that insulin can directly stimulate 
plasma IGF1 concentrations (Gluckman et al., 1987; Fowden, 1989). 
Furthermore, IGF1 and IGF2 plasma concentrations were related to foetal 
glucose concentrations, a relationship that was considered to be secondary 
to the effects of insulin (Gluckman, 1986; Oliver et al., 1993). Our data 
suggest that the relationship between insulin and IGF1 not only exists at a 
plasma metabolite level, but also on a local tissue sensitivity level. 
The relationship between IR and GR was no longer present when controlled 
for IGF1R which suggests that there is no direct synergistic effect between 
the actions of insulin and glucocorticoids. The lack of evidence for a 
synergistic effect between insulin and glucocorticoids could provide support 
for our hypothesis of a counter-acting balance between the two. 
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An interesting negative relationship was found between perirenal IGF1 
expression and perirenal and subcutaneous adipose tissue mass. We 
expected IGF1 to have autocrine and paracrine adipogenic effects, so it was 
surprising to see a negative relationship. Even more surprising is the 
relationship between perirenal IGF1 expression and subcutaneous adipose 
tissue mass. This suggests some cross-talk between perirenal and 
subcutaneous adipose tissue, although the precise nature has yet to be 
defined. Since most of the plasma IGF1 is hepatic in origin, it is unlikely that 
this cross-talk is mediated by IGF1 itself. It could be that perirenal adipose 
tissue growth results in the production of a signalling factor, such as leptin or 
adiponectin, which subsequently results in endocrine effects on the growth of 
the subcutaneous depot and at the same time down-regulates IGF1 in the 
perirenal depot in an attempt to prevent it from further growth. Such a 
mechanism of cross-talk has been proposed before by Duffield and 
colleagues. They reported similar relationships between perirenal fat and the 
development of subcutaneous adipose tissue. They also found relationships 
between both perirenal adipose tissue mass and perirenal adipocyte size 
with the expression of leptin mRNA in subcutaneous adipose tissue (Duffield, 
2007). 
 
Finally we found increased levels of IGF2 and IGF2R in the omental depot 
compared to the other depots which supports our hypothesis that the 
delayed effects of omental growth coincide with a delayed switch from IGF2 
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to IGF1 dominance. Previous studies have indicated that this transition was 
driven, at least partly, by glucocorticoids in the liver and adrenal gland (Li et 
al., 1993; Lu et al., 1994). The omental depot which develops post-natally is 
not exposed to the cortisol surge which occurs before parturition (Liggins, 
1976; Smith et al., 2009) which could potentially explain a delayed switch 
from IGF2 to IGF1 dominance. A recent study in near-term baboons also 
found a higher abundance of IGF2R in omental compared to subcutaneous 
adipose tissue in the abdominal or femoral regions (Tchoukalova et al., 
2009). They suggested that a relative increase in the abundance of the 
clearance receptor IGF2R results in a lower bioavailability and activity of 
IGF2, which could result in a restraint differentiation of the omental adipose 
tissue.  They did however not examine the abundance of IGF2. Our study 
has shown that both IGF2 and IGF2R are, at the age of 4 months, elevated 
in omental adipose tissue in sheep. The exact effects on the bioavailability 
remain to be investigated. 
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5. The effects of formula feeding on differential expression 
of key genes involved in adipose tissue growth. 
 
5.1 SUMMARY 
 
Formula feeding is associated with an increased food intake in early life and 
increased plasma insulin concentrations. We hypothesise that formula 
feeding results in a reduced sensitivity of adipose tissue to the actions of 
insulin. This reduction in sensitivity to insulin will switch the balance between 
insulin and glucocorticoid action in adipose tissue towards a stronger 
sensitivity of the adipose tissue to glucocorticoids, resulting in an increase in 
long term adipogenic growth. We hypothesise that the reduction in local 
sensitivity to the action of insulin will be greatest in the omental depot, which 
is developing rapidly during this period in life. The effects on increased 
adipose tissue growth will therefore lead to a redistribution of adipose tissue 
towards the omental depot. 
 
We tested this hypothesis by examining the effects of formula feeding or 
maternal milk feeding on the development and distribution of adipose tissue 
in lambs at three months of age. We further examined the transcript 
expression of key markers of the tissue sensitivity to the actions of insulin 
and glucocorticoids in individual adipose tissue depots. 
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Formula feeding in this study did not lead to a redistribution of adipose tissue 
at the age of 3 months. Formula feeding did lead to a significant reduction in 
Glut4 expression in all depots. A reduction in Glut4 expression combined 
with an absence of an effect on insulin receptor expression could potentially 
mean that the tissue is more resistant to the actions of insulin as a result of 
formula feeding, suggesting that the reduction in insulin sensitivity could be 
secondary to a decrease in the efficiency of the insulin signalling cascade 
which occurs as early as at the age of 3 months. 
)XUWKHUPRUH IRUPXOD IHHGLQJ UHVXOWHG LQ DQ LQFUHDVH LQ ȕ-HSD1 
H[SUHVVLRQ LQ DOO DGLSRVH WLVVXH GHSRWV 7KH LQFUHDVHG H[SUHVVLRQ RI ȕ-
HSD1 could in the long term have an adipogenic effect and be a mechanism 
that explains the increased growth of adipose tissue in formula fed infants. 
GR expression was higher in perirenal and subcutaneous adipose tissue 
which would support our hypothesis that these depots are relatively more 
sensitive to the actions of glucocorticoids compared to the omental depot 
during this period of life.  
Furthermore an increase in IGF1 in the perirenal adipose tissue compared to 
omental and subcutaneous adipose tissue supports our hypothesis that there 
is a relationship between the actions of glucocorticoids and IGF1 in the 
tissue.  
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5.2 Introduction 
 
It has long been known that breastfeeding as opposed to formula feeding 
has beneficial effects on short term health outcomes such as infections and  
long term health outcomes such as the development of asthma and allergies 
in later life (Saarinen et al., 1979; Lucas et al., 1990; Saarinen & Kajosaari, 
1995). The effects of breastfeeding on the incidence of obesity and 
cardiovascular risk factors in adulthood, however, have been a subject of 
debate in many studies over the last decades. The general conclusion that 
was obtained from several large meta-analyses was that breastfeeding has a 
small but significant protective effect on the incidence of obesity later in life 
and this effect could have a dose-response element (Dietz, 2001; Dewey, 
2003; Arenz et al., 2004; Harder et al., 2005; Owen et al., 2005). The 
protective effect of breast feeding appears more prominent in adolescence 
compared to childhood, which suggests a possible programmed effect 
(Dewey, 2003). Given the present obesity epidemic, any possible prevention 
method of obesity is worth investigating; even very small effects can still 
have major impacts on society as a whole.  
 
Several mechanisms have been proposed to explain the relationship 
between formula feeding and obesity. Formula fed infants have a higher 
food, energy and protein intake compared to breast fed infants, which leads 
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to an increased weight gain and fat mass (Heinig et al., 1993; Dewey, 1998). 
Insulin like growth factor 1 (IGF1), an important growth factor in postnatal life, 
has been shown to be dependent on amino acid availability (Wheelhouse et 
al., 1999). An increased protein intake in formula fed infants could therefore 
lead to increased levels of amino acids and increased IGF1 levels 
subsequently promoting increased growth and BMI in later life. 
 
Another important driver of adipose tissue growth is insulin. Insulin acts 
through a series of second messenger molecules ultimately resulting in 
translocation of the glucose transporter 4 (Glut4) from storage vesicles in the 
cytosol to the cell membrane, leading to an increase in glucose uptake by 
the adipocyte and fat cell growth (Wallberg-Henriksson & Zierath, 2001). 
Children who were formula fed as opposed to being breast fed showed 
increased plasma insulin levels and prolonged insulin responses at the age 
of 6 years (Lucas et al., 1980; Lucas et al., 1981). Several studies have also 
shown a relationship between formula feeding and a decreased glucose 
tolerance (Pettitt et al., 1997; Ravelli et al., 2000; Singhal et al., 2003). It is to 
date not known whether these effects of postnatal diet on later life obesity 
and glucose tolerance are mediated by programmed changes in adipose 
tissue insulin signalling proteins such as IR and Glut4. 
 
Equally important for adipose tissue growth are the effects of glucocorticoids. 
Immediate effects of glucocorticoids include a counteracting of the effects of 
insulin and an increase in lipolysis (Dallman et al., 2004). Long term effects 
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of glucocorticoids, however, involve adipose tissue growth. This effect seems 
WREHDGLSRVHWLVVXHGHSRWVSHFLILFDVLVDSSDUHQWLQSDWLHQWVZLWK&XVKLQJ¶V
syndrome who have increased central adiposity (Pasquali & Vicennati, 2000; 
Despres & Lemieux, 2006). It is not know to date whether formula feeding 
has an effect on systemic or tissue specific glucocorticoid action. 
 
We hypothesise that formula feeding results in a reduced local sensitivity of 
adipose tissue to the actions of insulin. This reduction in sensitivity to insulin 
will switch the balance between insulin and glucocorticoid action on adipose 
tissue towards a stronger sensitivity of adipose tissue to glucocorticoids. We 
hypothesise that in the long term this increased glucocorticoid action will 
result in an increase in adipogenic growth potential. We expect that the 
reduction in local sensitivity to the action of insulin will be greatest in the 
omental depot, which is developing rapidly during this early postnatal period 
of life. We hypothesise therefore that the effects on increased adipose tissue 
growth will be greatest in the omental adipose tissue depot and lead to a 
redistribution of adipose tissue towards the omental depot. 
 
In this chapter we test this hypothesis by examining the effects of formula 
feeding or maternal milk feeding on the development and distribution of 
adipose tissue in lambs at three months of age. We further examine the 
expression of markers of the tissue sensitivity to the actions of insulin and 
glucocorticoids in individual adipose tissue depots. 
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5.3 Materials and methods 
 
5.3.1 ANIMALS AND EXPERIMENTAL DESIGN 
All procedures were performed in accordance with the UK animals (Scientific 
Procedures) Act, 1986. 7 twin (all males) bearing Mule ewes were included 
in this study. They were fed a fixed amount of hay and concentrate pellets 
sufficient to fully meet their metabolisable energy requirements throughout 
gestation according to AFRC guidelines (AFRC, 1993). The diet contained 
adequate vitamins and minerals. Offspring were delivered spontaneously 
(term 147 ± 3 days). 
After birth one of the lambs remained with the ewe and was maternally 
reared. They were group housed indoors with ad libitum access to hay and a 
fixed amount of concentrate pellets sufficient to fully meet the maternal 
nutrient requirements plus that needed to maintain lactation according to 
AFRC guidelines (AFRC, 1993).  
Remaining lambs in the formula fed group were group housed indoors and 
had free access to formula milk which was fed according to the 
PDQXIDFWXUHUV¶ specifications (Volac International Ltd., Volac House, Orell, 
Royston, UK). Details of the macronutrient composition and availability of the 
formula milk are given in Table 5.1.  
Unfortunately, due to practical issues, it was not possible to measure milk 
intake in either group. 
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 Ewe milk* Formula milk  
Protein (%) ~5 4.8 
Fat (%) ~6 4.8 
Carbohydrates (lactose) (%) ~48 41.5 
Energetic value (MJ/kg) 3-4 4.1 
Table 5.1; Macronutrient content of ewe and formula milk. 
*, values as quoted in standard text (Freer & Dove, 2002). DVTXRWHGE\FRPSDQ\DQDO\VLV
(Volac Ltd). The formula milk is comprised of whey protein powder (as protein source), 
vegetable oil (as fat source), wheat gluten and lactose (as carbohydrate source) with added 
vitamin and minerals (Vitamin A, 50,000 iu/kg; Vitamin D3, 6,000 iu/kg; and Vitamin E, 100 
iu/kg), DL-methionine and calcium carbonate. Formula milk was fed 4x daily for the first 7 
days (maximum intake 1L/day/lamb) and then 2x daily thereafter in a cold ad libitum feeding 
system (calculated at a maximum intake 1L/day/lamb) with concentrate feed available. 
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The weight of each lamb was recorded at weekly intervals. After 
approximately eleven weeks, just before weaning, all lambs were humanely 
killed by electrocortical stunning and exsanguination. All major organs were 
rapidly excised, weighed, and a representative sample snap-frozen in liquid 
nitrogen before being stored at -80°C until further molecular analysis was 
performed. 
 
5.3.2 RNA EXTRACTION AND CDNA SYNTHESIS 
RNA was isolated from frozen omental, perirenal and subcutaneous adipose 
tissue samples using Trizol reagent (Invitrogen, Groningen, The 
Netherlands) and purified using the RNeasy Mini Kit (Qiagen, Basel, 
Switzerland) as described in detail in chapter 3. RNA was quantified by 
spectrophotometric measurements at 260 and 280 nm. cDNA was 
synthesised from 2 µg RNA using Superscript III (Invitrogen, Groningen, The 
Netherlands) by reverse transcription. Controls containing no RNA transcript 
or no superscript were used to test for DNA contamination. 
 
5.3.3 QUANTITATIVE REAL-TIME RT-PCR 
1RUPDOLVHG P51$ H[SUHVVLRQ IRU JOXFRFRUWLFRLG UHFHSWRU *5 ȕ- 
K\GUR[\VWHURLGGHK\GURJHQDVHW\SHȕ-HSD1), insulin like growth factor 
1 (IGF1), insulin like growth factor 1 receptor (IGF1R), insulin receptor (IR), 
and glucose transporter 4 (Glut4) was determined in omental, perirenal and 
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subcutaneous adipose tissue by reverse transcription real time PCT using 
the SYBR Green system in an ABI Prism 7000 Sequence Detection System 
(Applied Biosystems, Foster City, California). Each qRT-PCR well contained 
5 µl SYBR Green Master Mix (Applied Biosystems), 1 µl each of forward and 
reverser primer (GeneWorks, Adelaide, South Australia, Australia) for the 
appropriate gene (Table 5.2), 2 µl water and 50 ng/µl cDNA (1µl) to give a 
total volume of 10 µl. Controls for each primer set containing no cDNA were 
included on each plate. Three replicates of cDNA for each adipose tissue 
sample were performed to determine intra-plate variation. Two quality control 
samples were run on each plate to determine inter-plate variation. 
Amplification efficiencies were determined from the slope of a plot of Ct 
(defined as the threshold cycle with the lowest significant increase in 
fluorescence) against the log of the cDNA template concentration (ranging 
from 1-100 ng/µl). The abundance of each transcript relative to the 
abundance of the reference gene ribosomal protein P0 (RpP0) was 
calculated using Q-Gene analysis software (Muller et al., 2002). 
The expreVVLRQ RI ȕ-K\GUR[\VWHURLG GHK\GURJHQDVH W\SH  ȕ-HSD2) 
was examined as described above. The expression was however too low to 
be able to obtain reproducible results.  
Due to time limitations the expression of IGF2 and IGF2R was not measured 
in these samples. 
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Primer Sequence Accession number 
GR F: ¶-ACT GCC CCA AGT GAA AAC AGA-¶ 
R: ¶-ATG AAC AGA AAT GGC AGA CAT TTT ATT-¶ 
NM_001114186 
 
ȕ-HSD1 F: ¶-GCG CCA GAT CCC TGT CTG AT-¶ 
R: ¶-AGC GGG ATA CCA CCT TCT TT-¶ 
NM_001009395 
 
ȕ-HSD2 F: ¶-AGC AGG AGA CAT GCC GTT TC-¶ 
R; ¶-GCA ATG CCA AGG CTG CTT-¶ 
NM_001009460 
 
IR F: ¶-CAT CCC CAG AAA ATC ATC TTC AG-¶ 
R: ¶-CAA GGG CTC TGC GTT TCC T-¶ 
Y16092 
 
Glut4 F: ¶-GTG GCC ATC TTT GGC TTC GTG-¶ 
R: ¶-CGG CTG AGA TCT GGT CAA AC-¶ 
AY949177 
 
IGF1 F: ¶-TTG GTG GAT GCT CTC CAG TTC-¶ 
R: ¶-AGC AGC ACT CAT CCA CGA TTC-¶ 
NM_001009774 
 
IGF1R F: ¶-AAG AAC CAT GCC TGC AGA AGG-¶ 
R: ¶-GGA TTC TCA GGT TCT GGC CAT T-¶ 
AY162434 
 
RpP0 F: ¶-CAA CCC TGA AGT GCT TGA CAT-¶ 
R: ¶-AGG CAG ATG GAT CAG CCA -¶ 
NG_009485 
  
Table 5.2; Primer sequences for PCR anaO\VLVRI*5ȕ-+6'ȕ-HSD2, IR, Glut4, 
IGF1, IGF1R and RpP0. 
F: forward primer sequence, R: reverse primer sequence. 
 
5.3.4 STATISTICAL ANALYSIS 
Data are presented as Mean ± SEM. The effects of formula feeding on gene 
expression within each tissue were determined using a paired T-test using 
SPSS for Windows (SPSS Inc, Chicago, Illinois). The differences between 
adipose tissue depots were determined using a multi-factorial ANOVA with 
repeated measures using STATA 10.0 (StataCorp, College Station, Texas, 
USA). In order to take into account that siblings across treatment groups had 
similar genetic backgrounds, each pair was treated as a repeated outcome 
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measure within the mother. Similarly in vivo data of lamb growth were 
analysed using a multi factorial ANOVA with repeated measures for lamb 
siblings within the maternal ewe and different time-points of growth within 
each lamb. Extensive consideration has been given to the choice of using 
analyses for repeated or independent measures. Data have been analysed 
using both methods obtaining similar results. It was felt that data from 
different depots within each lamb and data from siblings could not be 
considered as indepent and therefore analyses using repeated measures 
were chosen to be presented here. Different adipose tissue depots were 
treated as repeated outcomes within each lamb. Data from siblings were 
treated as repeated outcomes within each ewe. A probability level of 5% 
(p<0.05) was considered to be significant. 
No significant correlations were found between adipose tissue mass and 
gene expression. 
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5.4 Results 
 
5.4.1 LAMB BIRTH WEIGHT, GROWTH AND DISSECTION DATA 
There was no difference in birth weight of the lambs in either nutritional 
group (Table 5.3). Lambs in the formula fed group were overall smaller 
compared to ewe reared lambs (P< 0.001) but there was no interaction 
between dietary treatment and time (Figure 5.1).  
At post mortem there was no difference in lamb body weight, total visceral fat 
mass, omental, perirenal and pericardial adipose tissue mass between 
treatment groups (Table 5.3). The distribution of visceral adipose tissue was 
not significantly different between formula fed and ewe reared lambs (Figure 
5.2). Absolute pancreas weight was lower in the formula fed animals 
compared to the ewe fed animals (P=0.05). Relative heart weight was higher 
in the formula fed compared to the ewe fed animals (P=0.01). No other 
differences in organ weight were found between the two treatment groups 
(Table 5.3). 
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 Ewe-fed 
Lambs (n=7) 
Formula-fed 
lambs (n=7) 
P value 
Birth weight (kg) 5.1 ± 0.3  4.8 ± 0.2  NS 
Weight at post mortem (kg) 39.2 ± 2.5 36.4 ± 1.8 NS 
Adipose tissue (g)    
Omental 340 ± 77 347 ± 47 NS 
Perirenal 373 ± 98 363 ± 51 NS 
Pericardial 49 ± 6 54 ± 5 NS 
Total visceral  762 ± 174 764 ± 97 NS 
Relative adiposity (g.kg-1) 18.5 ± 3.6 20.6 ± 2.0 NS 
Organ weights (g)    
Liver 659 ± 63 612 ± 42 NS 
Lung 529 ± 62 517 ± 39 NS 
Heart 183 ± 12 191 ± 9 NS 
Kidney 141 ± 14 126 ± 5 NS 
Spleen 78 ± 7 72 ± 6 NS 
Pancreas 47 ±5 34 ± 4 0.05 
Adrenal 2.6 ± 0.3  2.4 ± 0.2 NS 
Relative organ weights (g.kg-1)    
Liver 16.7 ± 0.8 16.8 ± 0.5 NS 
Lung 13.3 ± 0.9 14.5 ± 1.6 NS 
Heart 4.7 ± 0.1 5.3 ± 0.2 0.01 
Kidney 3.6 ± 0.2 3.5 ± 0.1 NS 
Spleen 2.0 ± 0.1 2.0 ± 0.1 NS 
Pancreas 1.2 ± 0.1 0.9 ± 0.1 NS 
Adrenal 0.07 ± 0.0 0.07 ± 0.0 NS 
Table 5.3; Weight of lambs at birth and post mortem and organ weight at post mortem.  
Data are presented as means ± standard errors of the mean. NS: no significant difference 
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Figure 5.1; Growth from birth to post mortem in ewe reared and formula fed lambs. 
Lambs in the formula fed group were smaller compared to ewe reared lambs (P=0.001), 
there was no interaction between dietary treatment and time. Ewe means ewe reared lambs 
(black circles) n=7, FF means formula fed lambs (light circles) n=7. 
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Figure 5.2; Visceral adipose tissue distribution in formula fed and ewe reared lambs. 
Omental, perirenal and pericardial adipose tissue mass expressed as a percentage of total 
visceral adipose tissue mass. Ewe means ewe reared lambs (black bars) n=7, FF means 
formula fed lambs (light bars) n=7. 
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5.4.2 ADIPOSE TISSUE EXPRESSION PROFILE 
5.4.2.1 Insulin like growth factor 1 and its receptor 
IGF1 expression was not altered by postnatal diet but was significantly 
higher in perirenal compared to omental and subcutaneous adipose tissue 
(perirenal vs. omental: P=0.004, perirenal vs. subcutaneous P=0.004) 
(Figure 5.3). IGF1R expression was down-regulated in the omental depot 
with formula feeding (P=0.016) (Figure 5.3). 
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Figure 5.3; Expression of insulin like growth factor 1 (A) and its receptor (B) relative to 
housekeeper ribosomal protein P0. 
Ewe means ewe reared lambs (black bars), FF means formula fed lambs (light bars). * 
indicates differences between ewe and formula fed lambs, different letters indicate 
differences between adipose tissue depots, P<0.05, n=7 in both groups. 
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5.4.2.2 Expression of genes involved in insulin signalling 
Insulin receptor expression levels were not influenced by either diet or 
adipose tissue depot (Figure 5.4). Overall expression levels of Glut4 were 
decreased in the formula fed lambs (P=0.005) while being similar across 
adipose tissue depots (Figure 5.4).  
 
5.4.2.3 Expression of genes involved in glucocorticoid sensitivity 
There was no effect of formula-feeding on the expression of GR, but GR 
expression was significantly lower in omental vs. perirenal and/or 
subcutaneous adipose tissue (P<0.001 for effect of depot) (Figure 5.5ȕ-
HSD1 expression was markedly upregulated by formula feeding relative to 
ewe reared animals in all investigated depots (P<0.001) with no effect of 
adipose region on this expression (Figure 5.5 ȕ-HSD2 expression was 
too low to be adequately measured in all depots and diet groups. 
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Figure 5.4; Expression of insulin receptor (A) and glucose transporter 4 (B) relative to 
housekeeper ribosomal protein P0. 
Ewe means ewe reared lambs (black bars), FF means formula fed lambs (light bars). * 
indicates differences between ewe and formula fed lambs, different letters indicate 
differences between adipose tissue depots, P<0.05, n=7 in both groups. 
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Figure 5.5; Expression of glucocorticoid receptor (A) and ȕ- hydroxysteroid 
dehydrogenase type 1 (B) relative to housekeeper ribosomal protein P0. 
([SUHVVLRQRIȕ-HSD2 was too low to be adequately measured. Ewe means ewe reared 
lambs (black bars), FF means formula fed lambs (light bars). * indicates differences between 
ewe and formula fed lambs, different letters indicate differences between adipose tissue 
depots, P<0.05. FF (light bars): formula fed lambs, n=7 in both groups 
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5.5 Discussion 
 
Formula feeding in this study did not lead to a redistribution of adipose tissue 
at the age of 3 months. Furthermore no increased growth, as seen in formula 
fed infants (Dewey et al., 1993; Dewey et al., 1995; Ong et al., 2002; Stettler 
et al., 2005), was found in the formula fed lambs. The mechanism that is 
often suggested as underlying the accelerated growth in formula fed infants, 
involves a higher protein and fat content of human formula as opposed to 
human breast milk, which leads to a 60-70% higher protein intake in formula 
fed infants (Heinig et al., 1993). In sheep however, maternal milk has slightly 
higher protein and fat contents when compared to human breast milk (Freer 
& Dove, 2002), making it therefore more comparable to formula milk and 
possibly thereby abolishing these effects on growth rate in sheep. 
Other theories regarding mechanisms that explain the effects of formula 
feeding however do not involve macro-nutrient content of the milk, but are 
dependent on hormonal factors and growth factors present in maternal milk. 
Despite ewe milk being more similar to formula milk in macro-nutrient 
content, micro-nutrients and factors such as hormones like leptin, growth 
factors and cytokines will still be different between ewe and formula milk. 
Differences in those factors could possibly explain some of the effects seen 
in this study. 
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Formula feeding did lead to a significant reduction in Glut4 expression in all 
depots. We could speculate that a reduction in Glut4 expression combined 
with an absence of an effect on insulin receptor expression could indicate a 
reduced efficiency of the insulin signalling cascade. This would mean that 
the tissue is more resistant to the local actions of insulin as a result of 
formula feeding. These observations would support our hypothesis that 
formula feeding results in reduced tissue sensitivity to the actions of insulin in 
adipose tissue. A reduced expression of Glut4 combined with similar 
expressions of IR could potentially indicate a malfunctioning insulin signalling 
cascade in formula fed animals, ultimately leading to a decreased 
translocation of Glut4 to the cell membrane when stimulated with similar 
levels of insulin. A decreased translocation of Glut4 leads to a decreased 
glucose uptake by the cell and increased plasma glucose levels, ultimately 
leading to an increased insulin secretion by the pancreas (Smith, 2002). The 
observations of increased insulin resistance and an increased prevalence of 
type 2 diabetes mellitus in formula fed individuals (Pettitt et al., 1997; Ravelli 
et al., 2000; Singhal et al., 2003) could potentially be explained by a 
malfunctioning insulin signalling pathway, but in order to make any definite 
conclusions on this point more research into the individual intracellular 
effectors of the insulin signalling cascade in both dietary groups is 
necessary. 
 
Unfortunately no plasma was available from these animals in order to relate 
any of our findings with regards to markers of local sensitivity to the actions 
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of insulin with plasma metabolite levels. Furthermore, due to time 
restrictions, we have not been able to investigate protein abundance of key 
markers in the insulin signalling cascade and have therefore not been able to 
confirm that altered RNA levels result in altered protein abundance in these 
animals. Furthermore our study was limited to male animals only and we 
have therefore not been able to examine whether the effect of formula 
feeding on adipose tissue is gender specific. Future studies will hopefully 
provide more elucidation on the exact insulin sensitivity of the adipose tissue 
in formula fed and maternally fed animals. 
 
Furthermore formula feeding resulted in a marked LQFUHDVH LQ ȕ-HSD1 
expression in all adipose tissue depots, indicating that formula feeding does 
indeed result, at the local level, in an increased sensitivity of adipose tissue 
to the actions of glucocorticoids 7KH LQFUHDVHG H[SUHVVLRQ RI ȕ-HSD1 
could potentially in the long term have an adipogenic effect and be a 
mechanism that explains the increased growth of adipose tissue in formula 
fed infants. Positive correlations between 11ȕ-HSD1 expression and adipose 
tissue mass were found by Gnanalingham and colleagues (Gnanalingham et 
al., 2005) indicating that 11ȕ-HSD1 could well be an important factor in 
adipose tissue deposition. However this effect appears to be present across 
all depots and cannot be responsible for a redistribution of adipose tissue 
growth. Some studies have indicated an inhibitory effect of insulin on the 
H[SUHVVLRQRIȕ-HSD1 (Hammami & Siiteri, 1991; Jamieson et al., 1995; 
Liu et al., 1996). It is poVVLEOHWKDWWKHLQFUHDVHLQȕ-HSD1 in our formula 
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fed animals is secondary to a reduction of the inhibitory effects of insulin in 
adipose tissue in these animals which would further support our main 
hypothesis that adipose tissue growth is regulated by a balance between the 
counteracting effects of insulin and glucocorticoids, however this remains a 
mere speculation at this stage and future studies will need to further 
investigate this possible interaction. 
 
GR expression was higher in perirenal and subcutaneous adipose tissue 
which would be in line with our hypothesis that these depots are relatively 
more sensitive to the actions of glucocorticoids compared to the omental 
depot during this period of life. In this study however the relative increased 
expression of GR in perirenal and subcutaneous adipose tissue did not result 
in a redistribution of adipose tissue growth and therefore this does not 
provide any evidence to support our hypothesis that the redistribution is 
secondary to changes in sensitivity of the tissue to the actions of 
glucocorticoids. 
It was interesting to find that the depot specific expression of GR in this study 
was different compared to the depot specific expression of GR found in 
Chapter 3. In chapter 3 GR expression was higher in perirenal and omental 
adipose tissue compared to subcutaneous adipose tissue, while in this 
chapter the expression was higher in perirenal and subcutaneous adipose 
tissue compared to omental adipose tissue. We can only speculate regarding 
mechanisms that might be responsible for these altered expression patterns. 
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Possible factors that could be involved in those mechanisms include animal 
breed, housing and ambient temperature.  
 
Insulin like growth factor 1 is often suggested as a potential candidate for the 
driver of increased growth in formula fed infants. The proposed mechanism 
of higher IGF1 activity is however, dependent on amino acid availability 
(Wheelhouse et al., 1999).  Given the fact that the formula used in this study 
had comparable protein contents to sheep maternal milk, it is unlikely that 
the amino acid availability was different between ewe reared and formula fed 
animals and it is therefore not surprising that IGF1 expression levels in 
adipose tissue were not different between dietary treatment groups. IGF1 
expression was however, different between adipose tissue depots. An 
increase in IGF1 in the perirenal adipose tissue compared to omental and 
subcutaneous adipose tissue further supports our hypothesis that there is a 
relationship between the actions of glucocorticoids and IGF1 in these 
tissues.  
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6. The effect of postnatal nutrition and juvenile-onset 
obesity on regional adiposity in sheep: depot-specific 
adipose tissue sensitivity to glucocorticoid and insulin 
signalling. 
 
6.1 SUMMARY 
 
Obesity is related to relative insulin resistance. We hypothesised that the 
decreased response to the actions of insulin in adipose tissue will result in a 
reduction in the insulin mediated LQKLELWLRQRIȕ-HSD1 expression resulting 
in enhanced local production of cortisol and an increase in adipogenesis and 
adipose tissue growth. We further hypothesised that the subcutaneous and 
perirenal depots are relatively less insulin resistant compared to the omental 
depot. In these depots insulin remains the main driver of growth. Finally we 
hypothesised that if the effects of obesity are combined with the effects of 
formula feeding an earlier shift towards glucocorticoid driven control of 
adipose tissue will occur in the omental depot. This results in an 
exacerbation of the effects of an obesogenic lifestyle in people that were 
formula fed in early life. 
In this chapter we tested this hypothesis by examining the effects of an 
obesogenic lifestyle in animals that, as infants, were fed either by their 
mothers or were formula fed throughout the lactation period on their adipose 
Chapter 6  198 
Adipose tissue distribution in obesity in adulthood 
tissue distribution and glucocorticoid and insulin sensitivity later in life. The 
latter were assessed through transcript expression profiles in regional 
adipose tissue for key regulatory elements of glucocorticoid and insulin 
signalling.  
 
Juvenile-onset obesity per se did not result in a redistribution of visceral 
adipose tissue in this study. Interestingly, a combination of obesity and 
formula feeding produced adipose redistribution in favour of the perirenal 
depot. However, no differences in the expression of markers of tissue 
sensitivity to the actions of glucocorticoids or insulin were found that could 
potentially underlieunderlie this redistribution in adipose tissue.  
Markers of the tissue sensitivity to glucocorticoids and to insulin were 
significantly reduced in response to obesity in both adipose tissue depots. 
No differences were found in markers of tissue sensitivity to glucocorticoids 
and to insulin between obese ewe fed and obese formula fed animals. This 
opposes our initial hypothesis that differences in the regional distribution of 
adipose tissue are secondary to regional differences in the balance between 
tissue sensitivity to the actions of insulin and glucocorticoids. It further 
opposes our hypothesis that high sensitivity to the actions of glucocorticoids 
or insulin in the long term results in adipogenesis.  
A reduction in markers of tissue sensitivity to the actions of insulin was found 
in obese animals. This could reflect an increased resistance of the tissues to 
the actions of insulin, but the mechanism behind this tissue specific 
resistance to insulin action appears different in omental and perirenal 
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adipose tissue, given differential abundance patterns of Glut4 and IR in 
those depots. 
Finally, we tested the obese RIIVSULQJ¶V HPA axis response to a combined 
CRH and AVP bolus but found the response was unaffected by juvenile-
onset obesity, although, as expected the ACTH response was greater in 
females.  
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6.2 Introduction 
 
Obesity is currently one of the biggest health challenges in the developed 
world (Kelly et al., 2008). The World Health Organisation estimated that 
approximately 400 million adults were obese in 2005 (WHO, 2006). The 
simple cause of obesity is an imbalance between energy intake and energy 
expenditure favouring an excessive intake relative to expenditure, leading to 
increased energy deposition as lipid in adipose tissue.  The metabolic risk 
factors associated with obesity are dependent on the distribution of adipose 
tissue. Increased central as opposed to peripheral adipose tissue is 
associated with higher cardiovascular risks (Krotkiewski et al., 1983; Fujioka 
et al., 1987; Despres et al., 1989; Pouliot et al., 1992; Wajchenberg, 2000; 
Busetto, 2001; Miyazaki et al., 2002; Misra et al., 2004; Despres & Lemieux, 
2006). 
Visceral adipose tissue in comparison to subcutaneous adipose tissue is 
more sensitive to lipolytic stimulation by, for example, the sympathetic 
nervous system. On the other hand, it is less sensitive to antilipolytic stimuli 
by, for example insulin (Rebuffe-Scrive et al., 1989; Arner et al., 1990; Marin 
et al., 1992a; Vikman et al., 1996). Since obesity is associated with a general 
reduction in insulin sensitivity, it is likely that these effects are most 
pronounced in omental adipose tissue. 
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Among the many influences that affect the occurrence of obesity, being 
formula fed as an infant, as opposed to being breast fed, has been shown to 
increase an LQGLYLGXDO¶V susceptibility to greater weight gain and obesity 
(Dewey et al., 1993; Harder et al., 2005) although more recent reports have 
questioned the strength of the effect (Michels et al., 2007; Stettler, 2007). A 
number of studies have attempted to explain the increased risk of adult 
obesity after formula feeding. For example, the total energy and protein 
intake of formula fed infants is generally higher when compared to breast fed 
infants (Heinig et al., 1993; Whitehead, 1995) potentially explaining the 
higher plasma insulin concentrations in formula fed infants (Lucas et al., 
1980).  
In chapter five we hypothesised that formula feeding results in a decreased 
efficiency of the insulin signalling cascade and therefore a reduction in the 
tissue sensitivity to the actions of insulin. We further hypothesised that this 
reduced local insulin action is accompanied by an increase in local 
glucocorticoid action in adipose tissue which ultimately leads to an increase 
in adipose tissue growth. Our results from chapter five supported this 
hypothesis although an increase in adipose tissue growth was not present at 
the age of 3 months. We further hypothesised that the changes in tissue 
sensitivity to the actions of insulin and glucocorticoids would be greatest in 
the omental depot which develops entirely during the period of formula 
feeding (i.e. during lactation). However our data did not show an increase in 
omental adipose tissue at the age of three months. In this chapter we 
investigate the effects of exclusive formula feeding on adipose tissue in the 
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longer term (i.e. in 1 year old young adults) in juvenile-onset obesity.  
 
We hypothesised that with obesity the decreased response of omental 
adipose tissue to insulin action will result in a reduction of insulin-mediated 
LQKLELWLRQ RI ȕ-HSD1 expression (Hammami & Siiteri, 1991; Jamieson et 
al., 1995; Liu et al., 1996) resulting in enhanced local production of cortisol; 
ultimately increasing adipogenesis and adipose tissue growth. We 
hypothesised that, in obesity, the subcutaneous and perirenal depots are 
relatively less insulin resistant compared to the omental depot. In these 
depots insulin remains the main driver of growth. We further hypothesised 
that when the effects of juvenile-onset obesity are combined with the effects 
of formula feeding an earlier shift towards glucocorticoid driven control of 
adipose tissue will occur in the omental depot. This results in an 
exacerbation of the effects of an obesogenic lifestyle in people that were 
formula fed in early life. 
 
In this chapter we test this hypothesis by examining the effects of an 
obesogenic lifestyle in animals that were fed maternal milk and animals that 
were formula fed on regional adipose tissue distribution. We further 
examined the expression and abundance of markers of tissue sensitivity to 
the actions of insulin and glucocorticoids in individual adipose tissue depots. 
Finally we examined the plasma metabolite response to a combined bolus of 
corticotrophin and arginine vasopressin to further elucidate the effect of 
formula feeding on the HPA axis. 
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6.3 Materials and methods 
 
6.3.1 EXPERIMENTAL PROTOCOLS 
6.3.1.1 Effects of Formula Feeding vs. Ewe Rearing on Adipose Tissue 
Development  
All procedures were performed in accordance with the UK animals (Scientific 
Procedures) Act, 1986. 22 pregnant Cross bred Mule sheep were included in 
this study. Throughout gestation all sheep were fed to requirement (i.e. 
100% metabolizable energy requirements (7-13 MJ/day) according to AFRC 
guidelines (AFRC, 1993) allowing for increased metabolic demand with 
gestation and foetal number. All offspring were delivered spontaneously as 
twins and were either reared by their mothers (n = 14) or formula fed (n = 8) 
until weaning (at ~10 weeks). One twin lamb from each ewe was euthanased 
at 7 days post-partum for a separate study. Remaining lambs in the formula 
fed group had free access to formula milk which was fed according to the 
PDQXIDFWXUHUV¶ VSHFLILFDWLRQV 9RODF ,QWHUQDWLRQDO /WG 9RODF +RXVH 2UHOO
Royston, UK). Details of the composition and availability of the formula milk 
are given in Table 6.1.  
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 Ewe milk* Formula milk  
Protein (%) ~5 4.8 
Fat (%) ~6 4.8 
Carbohydrates (lactose) (%) ~48 41.5 
Energetic value (MJ/kg) 3-4 4.1 
Table 6.1; Macronutrient content of ewe and formula milk. 
Values as quoted in standard text (Freer & Dove, 2002). DVTXRWHGE\FRPSDQ\DQDO\VLV
(Volac Ltd). The formula milk is comprised of whey protein powder (as protein source), 
vegetable oil (as fat source), wheat gluten and lactose (as carbohydrate source) with added 
vitamin and minerals (Vitamin A, 50,000 iu/kg; Vitamin D3, 6,000 iu/kg; and Vitamin E, 100 
iu/kg), DL-methionine and calcium carbonate. Formula milk was fed 4x daily for the first 7 
days (maximum intake 1L/day/lamb) and then 2x daily thereafter in a cold ad libitum feeding 
system (calculated at a maximum intake 1L/day/lamb) with concentrate feed available. 
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6.3.1.2 Interaction between Formula Feeding and an Obesogenic 
Postnatal Environment 
After birth, all mothers were fed a diet of hay ad libitum together with a fixed 
amount of concentrate pellets sufficient to fully meet their own metabolizable 
requirements, plus that needed to maintain lactation. All diets contained 
adequate minerals and vitamins. From weaning to 12 months of age, 
offspring were either group-housed in a barn (restricted activity), at a 
stocking rate of 17 animals per 50m2 with ad libitum access to hay and 
concentrate pellets to promote increased fat deposition (obese formula fed; 
OFF [n=8; 4 male, 4 female] and obese ewe-reared sheep; O [n=7; 5 male, 2 
female]) or pasture grazed at a stocking rate of 17 animals per 3000m2 
(unrestricted activity lean sheep ; L, n=7; 0 male, 7 female) with ad libitum 
access to grass and concentrate pellets. An overview of the animal methods 
used in this study can be found in Figure 6.1. 
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Figure 6.1; Overview of animal methods used to investigate the effect of obesity and 
the combination of obesity and formula feeding on adipose tissue distribution in 
adulthood 
M: male, F: female. CRH: corticotrophin, AVP: arginine vasopressin 
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6.3.2 ASSESSMENT OF THE WHOLE BODY ADIPOSE SENSITIVITY TO EXCESS 
GLUCOCORTICOID 
At 1 year of age (young, sexually mature adults) all sheep were instrumented 
with a venous (jugular) catheter and, after withdrawal of all food, but not 
water, for one day, were subjected to an I.V. combined bolus of 
corticotrophin (CRH, 0.5 µg.kg-1) and arginine vasopressin (AVP; 0.1 µg/kg). 
Baseline samples were taken at -30 and -15 min prior the bolus at time zero. 
Thereafter regular blood samples were withdrawn at +5, 15, 30, 45, 60, 90, 
120, 150 & 180 minutes. All blood samples were collected into chilled 
heparinised tubes, centrifuged (800g) for 5 min at 4 ºC and, after decanting 
of the supernatant plasma, were stored at -20 ºC for further analysis of 
plasma ACTH, cortisol, non-esterified fatty acids (NEFA), triglyceride (TG) 
and glucose concentrations.  Plasma metabolites were analysed by auto-
analyser (RX-Imola, Randox, Co Antrim, NI). Thereafter the sheep were 
humanely killed by electrocortical stunning and exsanguination and all major 
organs and adipose depots weighed and a representative sample snap-
frozen in liquid nitrogen before being stored at -80°C until further molecular 
analysis was performed. 
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6.3.3 ESTIMATION OF TOTAL PLASMA ACTH AND CORTISOL 
Radioimmunoassay kits were used for both ACTH (Diasorin, Slough, UK) 
and cortisol (Coat-a-Count, DPC, USA), validated for ovine plasma. The 
assays were conducted as per the PDQXIDFWXUHU¶V instructions and as 
previously described (Gardner et al., 2006). Plasma concentrations for both 
cortisol and ACTH were calculated from interpolation of a semi-log standard 
curve with B/B0 (%) on the y-axis and either ACTH or cortisol on the x-axis. 
Inter and intra-assay coefficients of variation in our hands are between 5.0-
8.0% and 10.0-12.0%, respectively for cortisol and ACTH (Gardner et al., 
2006). 
6.3.4 SAMPLE PREPARATION FOR REGIONAL ADIPOSE INSULIN SENSITIVITY 
ANALYSIS 
Protein was extracted from perirenal and omental adipose tissues using lysis 
buffer and protein content measured using a bicinchoninic acid kit as 
previously described (Gardner et al., 2005). Western blot analysis was 
performed as previously described with the following modifications for sheep: 
Protein lysates from each animal were standardized to a final concentration 
RIPJPOLQ/DHPPOL¶VVDPSOHEXIIHU(TXDODPRXQWVRISURWHLQIRUHDFK
animal (10µg) were loaded onto 10% SDS polyacrylamide gels for separation 
by electrophoresis (Gardner et al., 2005). The ovine antibodies used in this 
VWXG\ZHUHWRLQVXOLQUHFHSWRUȕ-subunit (IR) (Santa Cruz, Autogen Bioclear, 
8. JOXFRVH WUDQVSRUWHU  *OXW $EFDP &DPEULGJHVKLUH 8. S Į-
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subunit of phophatidylinositol 3-kinase (p85) (Upstate Biotech) and insulin 
OLNH JURZWK IDFWRU  UHFHSWRU ȕ-subunit (IGF1R) (Santa Cruz, Autogen 
Bioclear, UK). Secondary antibodies and an antibody-binding (enhanced 
chemiluminescence) kit were both obtained from Amersham, UK.  
 
6.3.5 SAMPLE PREPARATION FOR REGIONAL ADIPOSE GR, 11Ǻ-HSD1, 11Ǻ-
HSD2 MRNA EXPRESSION 
4XDQWLWDWLYH 3&5 ZDV XVHG WR H[DPLQH WKH H[SUHVVLRQ RI *5 ȕ-HSD1, 
ȕ-HSD2 and 18S in omental and perirenal adipose tissue (Table 6.2). 
PCR reactions were carried out in 20 ml volumes consisting of 1-SYBRs 
PCR mastermix (with ROX passive reference dye) (Qiagen Ltd, Crawley, 
UK), 500 nM forward primer, 500 nM reverse primer, and 7 ml nuclease-free 
water. Real time PCR was performed in a Techne QuanticaTM 14 real-time 
thermocycler (Techne, Barloworld Scientific Ltd) on all samples at 95°C (15 
min) followed by 45 cycles of 95°C (15 s), annealing temperature (25 s), 
72°C (25 s). Two negative control reactions were carried out with each set of 
samples analyzed: (1) no RNA template but RT and polymerase provided 
and (2) RNA and polymerase provided but no RT. 
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Primer Sequence Annealing 
temp (°C) 
Accession 
number 
GR F: ¶ - ACT GCC CCA AGT GAA AAC AGA ± ¶ 
R: ¶- ATG AAC AGA AAT GGC AGA CAT T ± ¶ 
59 NM_001114186 
ȕ-HSD1 F: ¶± GCG CCA GAT CCC TGT CTG AT ± ¶ 
R: ¶± AGC GGG ATA CCA CCT TCT TT ± ¶ 
58.5 NM_001009395 
ȕ-HSD2 F: ¶± AGC AGG AGA CAT GCC GTT TC ± ¶ 
R: ¶± GCA ATG CCA AGG CTG CTT ± ¶ 
60 NM_001009460 
18s F: ¶± GAT GCG GCG GCG TTA TTC C ± ¶ 
R: ¶± CTC CTG GTG CTG CCC TCC± ¶ 
60 NR_002170.3 
Table 6.2; Primer sequences for PCR analysis of GR, 11ȕ-HSD1, 11ȕ-HSD2 and 18s 
F: forward primer sequence, R: reverse primer sequence 
 
6.3.6 STANDARD CURVE GENERATION FOR QPCR TRANSCRIPT ANALYSIS 
Standards fRU *5 ȕ-+6' DQG ȕ-HSD2, and for the housekeeping 
gene 18s ribosomal RNA were made from cDNA obtained from a randomly 
selected sample of an L animal using semi-quantitative polymerase chain 
reaction (PCR). The method used oligonucleotide primers to GRȕ-HSD1, 
ȕ-HSD2 and 18s genes generating specific intron-spanning products. The 
PCR program comprised an initial denaturation stage (95°C, 15 min), 
amplification (stage I, 94°C (30 s); stage II, annealing temperature (30 s); 
stage III, 72°C (1 min), aQG ILQDO H[WHQVLRQ &  PLQ & µKROG¶ 7KH
PCR mixture (final volume 20 ml) contained 7 ml nuclease-free water 
(Ambion), 10 ml thermo-start PCR master mix (50 ml contains 1.25U 
Thermo-Start DNA polymerase, 1U thermo-start reaction buffer, 1.5mM 
MgCl2 and 0.2mM each of denatured adenotriphosphate, denatured 20-
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deoxycytidine 50-triphosphate, denatured 20- deoxyguanosine 50-
triphosphate, and denatured 20-deoxythymidine 50-triphosphate (ABgene, 
Epsom, UK)), 1 ml forward primer, 1 ml reverse primer, and 1 ml RT (cDNA) 
product. The annealing temperature and cycle number of all primers were 
optimized and used in their linear range.  Agarose gel electrophoresis (2.0±
2.5%) and ethidium bromide staining confirmed the presence of both the 
product and 18s at the expected sizes. All procedures were performed with 
appropriate negative and positive controls as well as a range of molecular 
weight markers (MBI Fermentas, York, UK). The resultant PCR product was 
extracted (QIAquick gel extraction kit, Qiagens, cat no. 28704), sequenced, 
and results cross-referenced against the Genbank website to determine 
specificity of the target gene. After confirmation that the product was specific 
to the target gene, extracted PCR products were resuspended in nuclease-
free water and a 10-fold serial dilution performed. Standards were stored at -
20°C until use in quantitative PCR. 
 
6.3.7 STATISTICAL ANALYSIS 
The specific contrasts selected a priori for analysis in this study were; 1) an 
effect of region (e.g. omental or perirenal) on adipose tissue biology within 
female individuals (i.e. L group alone), 2) an effect of juvenile-onset obesity 
on similar adipose measurements and HPA axis function (i.e. L vs. O) and 3) 
an effect of being naturally reared or formula-fed on the previously described 
endpoints (i.e. O vs. OFF). Where data were nested within individuals (e.g. 
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different adipose regions within the same individual) the data were 
considered to be repeated measurements within each individual and were 
therefore analyzed by multifactorial ANOVA with the repeated measures of 
dietary group and adipose depot as the fixed effects and each individual as a 
random effect using STATA 10.0 (StataCorp, College Station, Texas, USA). 
Extensive consideration has been given to the choice of using analyses for 
repeated or independent measures. Data have been analysed using both 
methods obtaining similar results. It was felt that data from different depots 
could not be considered as indepent and therefore analyses using repeated 
measures were chosen to be presented here. Different adipose tissue 
depots were treated as repeated outcomes within each lamb. In vivo 
hormone challenge data were similarly analyzed by multivariate repeated 
measures ANOVA with calculated areas-under-the-curve on baseline 
corrected data using Graphpad Prism 5. Where fixed effects (e.g. adipose 
region, postnatal obesity, formula-feeding) were significant appropriate post 
hoc tests (Bonferroni) with correction for multiple comparisons were 
conducted. Gender could only be considered as a fixed effect in the analyses 
when considering the effect of formula-feeding on postnatal endpoints. 
Results are presented as estimated marginal means ± standard error of the 
mean. 
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6.4 Results 
 
6.4.1 DISTRIBUTION OF ADIPOSE TISSUE IN LEAN AND OBESE EWE REARED SHEEP 
AND OBESE FORMULA-FED SHEEP. 
The postnatal obesogenic environment, as expected, led to significantly 
heavier sheep at 1 year of age (L, 57.7±3.2; O, 89.2±2.2; OFF, 98.0±3.6 kg; 
P<0.001 L vs. O) (Figure 6.2). Obesity per se had no effect on the 
distribution of visceral adipose tissue distribution (Figure 6.3), but in 
conjunction with neonatal formula feeding a significant shift in visceral 
adipose tissue distribution was observed. In the OFF group, the perirenal 
depot, expressed as a percentage of total visceral adipose tissue, was 
relatively increased where that of the omental depot was decreased 
(P=0.013 for perirenal and P=0.030 for omental) (Figure 6.3). There was no 
difference in the proportion of pericardial fat mass between groups and 
therefore no further analyses were performed in this depot. 
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Figure 6.2; Sheep weight at post mortem at the age of 1 year 
Different letters indicate significant differences between groups. L, Lean (n=7); O, obese 
(n=7); OFF, Obese formula-fed (n=8) 
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Figure 6.3; Omental and perirenal adipose tissue weight relative to total visceral 
adipose tissue in lean sheep, obese ewe reared sheep and obese formula fed sheep. 
Statistics are; bars with differing superscripts are significantly different at P<0.05 (abc for 
omental and xyz for perirenal adipose tissue). L, Lean (n=7); O, obese (n=7); OFF, Obese 
formula-fed (n=8). 
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6.4.2 ACTH AND CORTISOL RESPONSES TO THE COMBINED CRH AND AVP 
CHALLENGE 
6.4.2.1 ACTH 
Baseline ACTH was not different between groups at 12 months of age (L, 
52.6±7.8; O, 59.7±8.6; OFF, 64.9±7.9 pg.ml-1). Upon bolus administration of 
corticotrophin and arginine vasopressin there were significant (P<0.001) 
similar increments in ACTH in all groups (Figure 6.4). Whilst the response 
was not modified by dietary group, gender did have a significant effect on the 
response (P=0.043) with no interactions between dietary group and gender 
(Figure 6.4). Consequently, the ACTH area-under-the-curve was significantly 
(P=0.039) influenced by gender (female, 77.86±8.98; male, 46.96±11.90; 
pg.ml-1.min-1). The areas under the curve for ACTH in response to a 
combined bolus of CRH and AVP can be found in Table 6.3. 
 
6.4.2.2 Cortisol 
Baseline cortisol was not different between groups at 12 months of age (L, 
63.9±14.1; O, 81.2±14.1; OFF, 56.8±13.2 nmol.L-1). Upon bolus 
administration of CRH and AVP there were significant (P<0.001) increments 
in cortisol in all groups, with no main effects of dietary group, gender or any 
interaction between the two (Figure 6.5). Similarly, there was no impact of 
dietary group on the cortisol data when expressed as area-under-the-curve 
(L, 73.68±14.37; O, 80.34±15.91; OFF, 87.14.± 14.52 nmol.L-1.min-1). The 
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areas under the curve for cortisol in response to a combined bolus of CRH 
and AVP can be found in Table 6.3. 
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Figure 6.4; Plasma ACTH responses to a combined I.V. bolus of CRH and AVP 
CRH (0.5 µg/kg) and AVP (0.1 µg/kg) were administered I.V. as a combined bolus and 
plasma collected for analysis of ACTH by RIA (see Methods). Statistics are P<0.05 female 
vs. male. L, Lean (n=7); O, obese (n=7); OFF, Obese formula-fed (n=8). 
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Figure 6.5; Plasma cortisol responses to a combined I.V. bolus of CRH and AVP 
Data are given as means ± SEM at each timepoint. CRH (0.5 µg/kg) and AVP (0.1 µg/kg) 
were administered I.V. as a combined bolus and plasma collected for analysis of cortisol by 
RIA (see Methods). No significant differences were found. L, Lean (n=7); O, obese (n=7); 
OFF, Obese formula-fed (n=8). 
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6.4.3 ADIPOSE TISSUE SENSITIVITY TO HIGH CIRCULATING GLUCOCORTICOID 
At 12 months of age there were no significant differences in resting plasma 
glucose, non-esterified fatty acids (NEFA) or triglycerides (TG) between 
dietary groups, but obese animals (O and OFF) tended (P=0.06, all cases) to 
have higher glucose, NEFA and TG concentrations (Glucose: L, 4.81±0.47; 
O, 5.01±0.84; OFF, 5.62±0.60 mmol.L-1; NEFA: L, 0.29±0.09; O, 0.61±0.13; 
OFF, 0.45±0.08 mmol.L-1;  triglycerides L, 0.11±0.01; O, 0.18±0.02; OFF, 
0.17±0.01 mmol.L-1). 
 
In response to the CRH and AVP bolus there was a significant, similar 
increase in plasma glucose concentrations in all groups (P<0.01) with no 
interaction between the effects of time and dietary group (Figure 6.6). For 
plasma NEFA, there was a significant decrease with time (P<0.001) but the 
response with time was different between lean (L) and obese animals (O; 
P<0.001 for interaction). Plasma NEFA in obese animals returned toward 
baseline concentrations earlier than in lean sheep (Figure 6.6). Plasma TG 
significantly increased in all groups following the CRH and AVP bolus and 
this increase tended to be greater in the obese groups (P=0.055) (Figure 
6.6). None of the above changes in metabolites were influenced by gender. 
The areas under the curve for plasma metabolites in response to a combined 
bolus of CRH and AVP can be found in Table 6.3. 
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Figure 6.6; Plasma glucose, non-esterified fatty acid and triglyceride response to a 
combined bolus of CRH and AVP 
Data are given as means ± SEM at each timepoint. CRH and AVP were administered as a 
combined bolus as described in the methods section. Plasma glucose, non-esterified fatty 
acid (NEFA) and triglyceride (TG) were measured on an autoanalyser (RX-Imola, Randox, 
Co Antrim). Statistics are *, P<0.05 L vs. O. For triglyceride the P-value was 0.055. L, Lean 
(n=7); O, obese (n=7); OFF, Obese formula-fed (n=8). 
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Table 6.3; HPA axis and plasma metabolite areas under the curve after a combined 
bolus of CRH and AVP. 
Data are given as means ± SEM at each timepoint. CRH and AVP were administered as a 
combined bolus as described in the methods section. Statistics are ACTH: P<0.05 male vs. 
female, cortisol: ns, NEFA: P<0.05 L vs. O, triglyceride: P=0.055 for L vs. O, glucose: ns. 
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6.4.4 GR, 11Ǻ-HSD1 AND 11Ǻ-HSD2 EXPRESSION IN ADIPOSE TISSUE 
GR mRNA expression was not different between omental and perirenal 
adipose tissue, but was lower in the omental depot in obese animals only 
(P=0.006 L vs. O; Figure 6.7   ȕ-HSD1 expression was lower in the 
perirenal and omental depots in obese animals relative to expression in L 
(P<0.001, both cases; Figure 6.7 ȕ-HSD2 mRNA expression was 
significantly lower in the omental region in obese compared to lean animals 
(P<0.001, Figure 6.7).  
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Figure 6.7; Transcript expression of GR (A), 11ȕ-HSD1 (B) and 11ȕ-HSD2 (C) in 
omental and perirenal adipose tissue of lean and obese animals. 
Statistics are; * indicate significant difference between adipose tissue depots, bars with 
differing superscripts are significantly different (abc for omental and xyz for perirenal adipose 
tissue or Greek letters when no interaction is present and the superscripts relate to both 
depots are). L, Lean (n=7); O, obese (n=7); OFF, Obese formula-fed (n=8). 
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6.4.5 INSULIN SIGNALLING PROTEIN ABUNDANCE IN ADIPOSE TISSUE 
Abundance of IR was consistently lower in perirenal relative to omental 
adipose tissue in all dietary groups (P<0.001). In the omental depot, IR 
abundance was lower in obese relative to lean animals (P<0.001 L vs. O). In 
the perirenal depot there were no differences in IR abundance between 
treatment groups (Figure 6.8). The abundance of Glut4 was markedly higher 
in omental relative to perirenal adipose tissue in all treatment groups 
(P<0.001). In addition, in omental, but not perirenal adipose tissue, GLUT4 
abundance was lower in obese ewe-reared animals (O) relative to L 
(P=0.023; Figure 6.8). There was no effect of diet or obesity on P85 
abundance (data not shown). IGF1R abundance was higher in the omental 
compared to the perirenal depot (P=0.001). IGF1R abundance in omental 
and perirenal depots was also lower in obese vs. lean animals (P=0.037, L 
vs. O, Figure 6.8). 
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Figure 6.8; Protein abundance of IR (A), GLUT4 (B) and IGF1-R (C) in omental and 
perirenal adipose tissue of lean and obese animals. 
* indicated differences between adipose tissue depots; bars with differing superscripts are 
significantly different (abc for omental and xyz for perirenal adipose tissue or Greek letters 
when no interaction is present and the superscripts relate to both depots). L, Lean (n=7); O, 
obese (n=7); OFF, Obese formula-fed (n=8). 
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6.5 Discussion 
 
Obesity per se did not result in a redistribution of visceral adipose tissue in 
this study. Interestingly a combination of obesity and formula feeding 
resulted in a redistribution but in favour of the perirenal depot and not, as 
hypothesised, in favour of the omental depot. Furthermore no differences in 
the expression of markers of tissue sensitivity to glucocorticoids or insulin 
were found between obese maternally reared and obese formula fed 
animals. No conclusion can therefore be made which explains the 
redistribution of adipose tissue towards the perirenal depot in the formula fed 
animals. Other factors, such as leptin or adiponectin, could be responsible 
for the shift in adipose tissue distribution with obesity.  
 
7KH LQFUHDVH LQ ȕ-HSD1 and decrease in Glut4 expression which were 
found in formula fed animals at 3 months of age (Chapter 5) appears to be 
no longer present at the age of one year. However this study examined 
formula fed animals that subsequently became obese and obesity as such 
has dramatic effects on the expression of those genes which could 
overshadow any programmed effects secondary to formula feeding. A future 
study of formula fed animals that remain lean will further elucidate this 
possibility. Furthermore differences in the markers of adipose tissue 
sensitivity to the effects of insulin and glucocorticoids, which could explain 
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the redistribution of adipose tissue towards the perirenal depot, could also be 
overshadowed by the effects of obesity per se. 
 
This study focussed on potential programmed effects of our treatments on 
the HPA axis and glucocorticoid and insulin sensitivity of visceral adipose 
tissue. In terms of overall HPA axis activity we observed no effect of obesity 
or formula feeding per se; simply that the overall response curve for ACTH 
was exaggerated in female animals relative to males ± a common finding in 
adult animals (Roelfsema et al., 1993; Andrew et al., 1998; Canny et al., 
1999; Silva et al., 2002; van Lier et al., 2003).  Unfortunately our study had a 
very unequal distribution of gender across treatment groups, with no males in 
the lean group. Our analyses did always take gender into account, it could 
however still be possible that differences exist between lean and obese 
males that are study has been unable to identify given the lack of lean 
males.  
The excursions of plasma lipid metabolites, in particular NEFA, in response 
to high cortisol levels produced by an AVP and CRH challenge were, 
however, significantly affected by obesity; the return to baseline occurred 
much more rapidly in obese animals independently of whether these animals 
had been ewe reared or formula fed in early life. Such a response suggests 
altered adipose tissue sensitivity to cortisol. We therefore characterised 
transcript expression of key genes mediating adipose tissue sensitivity to 
cortisol in omental and perirenal tissue. In omental tissue of obese animals 
only, we found lower GR expression and, in both visceral depots, markedly 
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reduced 11ȕ-HSD 1/2 expression in obese relative to lean animals. Given 
that the visceral depot (i.e. omental/mesenteric) is widely recognised as 
being more metabolically active than other adipose depots e.g. 
subcutaneous (Alvarez et al., 2002; Wilding, 2007; Hayashi et al., 2008; 
Lafontan & Girard, 2008) then the shortened NEFA excursion during the 
HPA challenge may well reflect the lower level of GR expression in this depot 
in obese animals. Furthermore, the marked redXFWLRQLQDGLSRVHȕ-HSD1 
would further compound this effect.  
 
Markers of the tissue sensitivity to glucocorticoids and to insulin were 
significantly reduced in response to obesity in both adipose tissue depots. 
This opposes our initial hypothesis that differences in the regional adipose 
tissue distibution are secondary to regional differences in the balance 
between tissue sensitivity to the actions of insulin and glucocorticoids. It 
further opposes our hypothesis that high sensitivity to the actions of 
glucocorticoids or insulin in the long term results in adipogenesis. We can 
speculate that the reduction in markers of tissue sensitivity to glucocorticoids 
could however be a normal physiological response to an excess in nutrient 
supply, resulting in marked obesity. Such a response would suggest some 
feedback control over whole body adipose tissue expression of markers for 
glucocorticoid and insulin sensitivity mediated by adipose tissue itself. 
Unfortunately we have not been able to measure plasma insulin in those 
animals and are therefore unable to relate our findings to plasma insulin 
levels. 
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A reduction in markers of tissue sensitivity to the actions of insulin was seen 
in the omental depot of obese animals compared to lean animals. This 
reduction in IR and Glut4 abundance could potentially mean reduced tissue 
sensitivity to insulin. A reduction in the efficiency of the insulin signalling 
cascade could be secondary to serine phosphorylation of IRS instead of 
tyrosine phosphorylation. However serine phosphorylation of IRS would be 
expected to lead to a dissociation of the p85 subunit of PI3-kinase (Le 
Marchand-Brustel et al., 2003; Tanti et al., 2004). No differences in p85 
abundance were found suggesting that the reduction in efficiency of the 
insulin signalling cascade occurs at another level than at PI3-kinase. 
Furthermore, a reduction in the abundance of IR could potentially mean 
reduced sensitivity to the actions of insulin starts at a receptor level, rather 
than downstream in the insulin signalling cascade.  
 
While obese animals had significantly lower omental expression of IR and 
Glut4, they maintained IGF1R suggesting a potential mechanism for regional 
insulin resistance but maintenance of the tissue mass. For all the 
investigated proteins and genes, the effects of postnatally acquired obesity 
were more pronounced in the omental than in the perirenal adipose tissue 
depot, further implicating this depot as key to some of the deleterious 
consequences of central obesity (Despres & Lemieux, 2006; Pischon et al., 
2008). Unfortunately no subcutaneous adipose tissue was available to 
further compare visceral and peripheral depots and this could be a point of 
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investigation in future studies.  
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The risk enhancing effects of an increase in visceral adipose tissue in the 
body have been known for a long time. It has also been known for a long 
time that the development of obesity or visceral obesity in particular, can be 
altered by programming processes in early life. The mechanisms behind the 
processes that program the development of adipose tissue in early life are 
not fully understood at this stage. Furthermore, little is known about the 
differences between individual adipose tissue depots that are considered to 
be visceral adipose tissue. 
 
Adipose tissue distribution and development are regulated by a complex 
interaction between the local actions of insulin and glucocorticoids on 
individual adipose tissue depots. Insulin promotes adipose tissue growth by 
promoting adipogenesis and lipogenesis and inhibiting lipolysis (Belfrage et 
al., 1981; Gregoire et al., 1998; Soret et al., 1999). Glucocorticoids decrease 
adipose tissue growth in the short term by promoting lipolysis but chronic 
exposure to high glucocorticoid concentrations stimulate adipose tissue 
growth through a stimulation of  adipogenesis and lipogenesis (Fain et al., 
1963; Hauner et al., 1987; Ramsay et al., 1989a; Divertie et al., 1991; 
Dinneen et al., 1995). 
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I proposed that changes in adipose tissue distribution and development, as a 
consequence of exposure to different patterns of nutrition from the 
periconceptional up to the neonatal period, are secondary to changes in the 
balance between the actions of insulin and glucocorticoids on regional 
adipose tissue depots.  
 
No strong supportive evidence was found that adipose tissue growth and 
distribution is entirely dependent on the balance between the local sensitivity 
of individual depots to the actions of insulin and glucocorticoids. 
 
Several different cohorts of animals were used in this thesis to investigate 
the effects of diet during the perinatal period on the expression of markers of 
tissue sensitivity to the actions of insulin, glucocorticoids and insulin like 
growth factors. Using different cohorts allowed us to look at a fast number of 
data. However, the use of different cohorts is also associated with limitations 
to the interpretation of data. Different breeds of sheep were used, animal 
experiments were run in different countries with different climates and animal 
facilities and experimental methods were slightly different between individual 
studies. All those factors limit the interpretation of data obtained from the 
different studies. Furthermore, we were faced with differences in the 
availability of tissues and samples between studies, making it impossible to 
perform certain analyses, such as RNA expression in our 7 and 14 day 
animals and analysis of subcutaneous tissue in a number of cohorts. Future 
studies could attempt to fill in those gaps and further elucidate the physiology 
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with regards to adipose tissue specific sensitivity to the actions of 
glucocorticoids, insulin and insulin like growth factors. Another limitation in 
this PhD project was time and this resulted in a lack of protein data from the 
periconceptional nutrition and formula feeding studies. Studies are currently 
being conducted to add those data of protein abundance to the data 
presented in this thesis.  
 
The omental depot did undergo accelerated growth in early postnatal life as 
expected, with a significant lessening of the dominance of perirenal adipose 
toward overall fat mass. These changes occurred almost entirely during the 
first 12 weeks of life in sheep (i.e. through lactation) and were not influenced 
thereafter by a high caloric environment in juvenile-to-adult life, nor altered 
nutrition during lactation. We originally hypothesised that this differential 
growth of regional adipose was secondary to increased sensitivity to insulin 
in the omental depot, and decreased sensitivity in the perirenal depot. We 
therefore measured molecular markers of tissue sensitivity to the actions of 
insulin in both the omental and perirenal adipose tissue depot. The 
abundance of IR was much lower in the omental compared to the perirenal 
depot, but in the absence of changes to Glut4 abundance, we could not 
make any conclusions regarding the definite tissue sensitivity to the actions 
of insulin in either depot. Intracellular insulin signalling is effected through a 
highly complicated insulin signalling cascade (Cheatham & Kahn, 1995; 
Alessi et al., 1997; Rea & James, 1997; Peterson & Schreiber, 1999; 
Whiteman et al., 2002) and changes in IR abundance which are not related 
Summary, conclusions and future directions 235 
Summary, conclusions and future directions 
to changes in Glut4 abundance could potentially indicate an altered 
efficiency of this signalling pathway. However, more measurements of other 
specific markers in the insulin signalling cascade and measures of actual 
tissue sensitivity to insulin are necessary to make any definite conclusions 
with regards to insulin sensitivity in the omental and perirenal adipose tissue 
depot during this period of life.  
Unfortunately due to degradation of RNA of our 7 and 14 day old animals we 
were unable to measure markers of the local tissue sensitivity to 
glucocorticoids in those animals. We have therefore not been able to 
investigate the role of glucocorticoids on the different growth rate of 
individual adipose tissue depots during early postnatal life. Furthermore, 
other mechanisms such as decreased expression of leptin, adiponectin and 
growth hormone could potentially explain the differential growth rates that 
were found. This early postnatal period of life is the period in which brown 
(multilocular) adipose tissue transforms into white (unilocular) adipose tissue. 
It is possible that factors that influence this histological change in adipocytes 
are related to growth rate of the individual adipose tissue depots. Future 
studies will hopefully elucidate the exact mechanism that is responsible for 
this differential growth pattern of individual adipose tissue depots. 
   
Exposure of the oocyte and/or embryo to maternal undernutrition 
(periconceptional undernutrition; PCUN) results in a premature activation of 
the HPA axis during late gestation (Edwards & McMillen, 2002a; Bloomfield 
et al., 2003; Edwards et al., 2005). Furthermore it results in an enhanced 
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cortisol response after a CRH challenge. This increased pituitary-adrenal 
activation occurs during late gestation, the period during which the 
subcutaneous and perirenal adipose tissue depot undergo rapid growth 
(Alexander, 1978). I hypothesised that PCUN will result in an enhanced 
glucocorticoid response in these depots which will persist after birth.  
 
Women that are obese or overweight during pregnancy have a reduced 
insulin sensitivity and higher circulating plasma glucose resulting in a greater 
exposure of the foetus to insulin (Catalano & Ehrenberg, 2006). I 
hypothesised that when a period of periconceptional nutrient restriction 
occurs in sheep that are already overweight; the effects of PCUN would be 
exaggerated, due to the increased insulin exposure of the perirenal and 
subcutaneous adipose tissue depot during prenatal life. Therefore these two 
depots would become relatively more insulin resistant and more sensitive to 
the effects of glucocorticoids, resulting in an even greater lipolytic activity in 
these depots and a greater nutrient flux to the omental depot. 
 
Our data showed that weight of the donor ewe during the periconceptional 
period was indeed associated with programming of markers of the local 
sensitivity to the actions of glucocorticoids, but only in the omental depot. 
The increased expression of markers of tissue sensitivity to the actions of 
glucocorticoids in omental adipose tissue in offspring of ewes that were 
lighter around pregnancy was not associated with a redistribution of adipose 
tissue. The increase in markers of tissue sensitivity to the effects of 
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glucocorticoids appeared to be a programmed response to a decrease in 
nutrient supply during the periconceptional period. However it is not clear 
why this response was only present in the omental depot. Given the 
anatomic location of the omental depot it is likely to be more responsive to 
the effects of nutrition compared to the other adipose tissue depots (Alvarez 
et al., 2002; Wilding, 2007; Hayashi et al., 2008; Lafontan & Girard, 2008), 
which could explain a programmed effect in this depot only. However it is 
unclear up to what extent the anatomical location of adipose tissue is 
relevant in this case where nutrition is umbilical and partly bypasses the 
portal circulation.  
 
Furthermore periconceptional overnutrition did not result in changes in the 
investigated molecular markers of tissue sensitivity to the actions of insulin. 
Periconceptional overnutrition did result in an increased adipose tissue mass 
in females. This is a relevant finding considering the current epidemic of 
obesity and the increase of women that enter pregnancy obese (LaCoursiere 
et al., 2005). It appears that overnutrition or obesity in the periconceptional 
period not only has effects on fertility, diseases in pregnancy such as 
gestational diabetes and hypertension, macrosomia but also in the adipose 
tissue distribution of the offspring in later life, at least in females (Ryan, 
2007). The effect of periconceptional overnutrition on adipose tissue mass 
was not associated with changes in markers of the tissue sensitivity to the 
actions of insulin or glucocorticoids and appeared to be merely an effect 
secondary to increased substrate supply. However, future studies to 
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investigate further key elements of the intracellular insulin signalling cascade, 
such as IRS and Akt, could further elucidate whether an increased tissue 
sensitivity to the actions of insulin in the female offspring of 
periconceptionally overnourished ewes could underly the increased adipose 
tissue mass that was found in this group. Future studies could also 
investigate other factors that could influence the increased adipose tissue 
growth in females such as growth hormone, leptin and adiponectin.  
 
Our study into the effects of PCUN demonstrated a direct relationship 
between thH H[SUHVVLRQ RI ȕ-HSD1 in the omental or subcutaneous 
adipose tissue depot and plasma FFA concentration. This relationship 
supports our theory that glucocorticoids have a stronger lipolytic than 
lipogenic effect on adipose tissue in the short term. Similar relations have 
been found between the effects of hypercortisolaemia and fatty acid turnover 
(Divertie et al., 1991; Dinneen et al., 1995).  
 
Most tissues during development undergo a transition in the role of the 
insulin like growth factors and their receptors (Sara & Hall, 1990; Delhanty & 
Han, 1993; Li et al., 1993; Peng et al., 1998). This transition is, at least 
partly, mediated by glucocorticoids which stimulate IGF1R expression 
(Bennett et al., 1984; Li et al., 1993; Lu et al., 1994). We hypothesised that 
PCUN would result in a glucocorticoid mediated transition of IGF2R to IGF1R 
expression which would happen mainly in the perirenal and subcutaneous 
adipose tissue depots which are present during foetal life. Therefore the 
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effects of IGF1 would be enhanced in the perirenal and subcutaneous 
adipose tissue depots, resulting in an increase in adipogenesis. 
  
Periconceptional undernutrition did not result in the expected increased 
expression of IGF1 or IGF1R in any of the investigated depots. However an 
association was found between GR and IGF1R which supports our 
hypothesis that glucocorticoids stimulate IGF1R expression and therefore 
work synergistically with IGF1. Similar associations have been found before 
by different in vitro and in vivo studies (Bennett et al., 1984; Conover et al., 
1985; Tronche et al., 2004). The absence of an effect of PCUN on markers 
of tissue sensitivity to the action of glucocorticoids could potentially provide 
and explanation for the lack of an effect of PCUN on the expression of 
insulin like growth factors and their receptors; as such an effect would be 
driven by glucocorticoids. The role of growth hormone and the GH-IGF axis 
in adipose tissue remain largely unclear at this stage and further 
investigation of growth hormone and growth hormone receptor expression in 
different adipose tissue depots could potentially bring new insides into depot 
specific adipose tissue development.  
 
In lambs at 4 months of age we found increased levels of IGF2 and IGF2R in 
the omental depot compared to the perirenal and subcutaneous depots 
which was consistent with our hypothesis that the delayed effects of omental 
growth coincide with a delayed switch from IGF2 to IGF1 dominance.  
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Our cohort of periconceptional under and overnutrition used donor ewes, 
embryo transfer and recipient ewes in order to be able to examine the effects 
of nutrition during the periconceptional period alone on long term adipose 
tissue development in the offspring. This study has shown that overnutrition 
during the periconceptional period alone leads to an increase in adipose 
tissue mass in the female offspring. In real life however, an embryo is rarely 
exposed to an environment of overnutrition during the periconceptional 
period alone, followed by an environment of normal nutrition during the rest 
of pregnancy. Future studies could combine the effect of periconceptional 
overnutrition with overnutrition later in pregnancy to see whether the effects 
of the offspring remain the same or might even be exacerbated.  
 
Formula feeding is associated with an increased food intake in early life and 
an increased plasma insulin concentration (Lucas et al., 1980; Lucas et al., 
1981; Heinig et al., 1993; Dewey, 1998). We hypothesised that formula 
feeding would result in a reduced sensitivity of adipose tissue to the actions 
of insulin. This reduction in sensitivity to insulin would switch the balance 
between insulin and glucocorticoid action on adipose tissue towards a 
stronger sensitivity of the adipose tissue to glucocorticoids. In the long term 
this increased glucocorticoid action would result in an increase in adipogenic 
growth in adipose tissue. The reduction in local sensitivity to the action of 
insulin would be greatest in the omental depot, which is developing rapidly 
during this period in life. The effects on increased adipose tissue growth 
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would therefore be greatest in this depot and lead to a redistribution of 
adipose tissue towards the omental depot. 
 
Formula feeding resulted in a decrease of *OXW DQG DQ LQFUHDVH LQ ȕ-
HSD1 expression which could potentially mean a reduction of the tissue 
sensitivity to the effects of insulin and an increase of tissue sensitivity to the 
effects of glucocorticoids. A reduction in tissue sensitivity to the actions of 
insulin could be a mechanism that explains the observations of increased 
insulin resistance and an increased prevalence of type 2 diabetes mellitus in 
formula fed individuals (Pettitt et al., 1997; Ravelli et al., 2000; Singhal et al., 
2003). Unfortunately we were not able to relate our findings to plasma levels 
of glucose, insulin and cortisol and neither have glucose tolerance tests been 
performed in our animals. We can therefore not make any definite 
conclusions regarding the relevance of the findings of decreased Glut4 and 
LQFUHDVHGȕ-HSD1 expression. Furthermore these effects were not depot 
specific and did not result in the expected redistribution of adipose tissue. An 
LQFUHDVHLQȕ-HSD1 could mean an increase in the sensitivity of the tissue 
to the effects of glucocorticoids in formula fed animals. This effect could 
potentially result in long term adipogenic effects of glucocorticoids and an 
increase of adipose tissue mass in formula fed infants. Furthermore the 
LQFUHDVH LQ DGLSRVH WLVVXH ȕ-HSD1 secondary to formula feeding, 
combined with a possible reduction in tissue specific sensitivity to insulin, 
favours our hypothesis of a balance between the effects of glucocorticoids 
and the effects on insulin in the tissue. These effects were however not 
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depot specific and were not significant enough to result in a redistribution of 
adipose tissue depots as we initially hypothesised. 
 
In all the animal cohorts that we examined we found marked differences of 
expression of markers of tissue sensitivity to the actions of insulin, 
glucocorticoids and insulin like growth factors between adipose tissue 
depots. Tissue specific expression patterns however appear not consistent in 
our different cohorts. Insulin receptor abundance for example is higher in 
perirenal compared to omental adipose tissue at 7 and 14 days of age, while 
IR expression at 3 months of age is not significantly different between the 
depots, at 4 months of age is higher in perirenal compared to omental 
adipose tissue and at 1 year of age is higher in omental compared to 
perirenal adipose tissue. This inconsistency in expression patterns makes it 
difficult to interpret our data. Obviously a number of key elements are 
different between our cohorts and could provide potential explanations for 
these differences. These explanations include the use of protein abundance 
vs. RNA expression, different breeds and different environmental 
circumstances. It is therefore difficult to make any definite conclusion 
regarding expression of our markers of local tissue sensitivity to insulin, 
glucocorticoid and insulin like growth factor over time. Our data do however 
highlight, for the first time, that there are significant differences in the 
expression of those key markers between omental and perirenal adipose 
tissue. Our data further highlight that those expression patterns are likely to 
change significantly over time. It is therefore important for future studies to 
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recognise the important in examining depot specific effects rather than 
investigating adipose tissue as one organ with similar responses throughout 
the body or throughout the abdomen.  
 
Obesity is related to relative insulin resistance (Wajchenberg, 2000). I 
hypothesised that the decreased response to the actions of insulin in 
adipose tissue results in a reduction of the insulin mediated LQKLELWLRQRIȕ-
HSD1 expression (Hammami & Siiteri, 1991; Jamieson et al., 1995; Liu et 
al., 1996) resulting in enhanced local production of cortisol resulting in an 
increase in adipogenesis and adipose tissue growth.  
In obesity, however, the subcutaneous and perirenal depots are relatively 
less insulin resistant compared to the omental depot. I hypothesised that in 
these depots insulin would remain the main driver of growth. When the 
effects of obesity are combined with the effects of formula feeding an earlier 
shift towards glucocorticoid driven control of adipose tissue would occur in 
the omental depot. I hypothesised that this would result in an exacerbation of 
the effects of an obesogenic lifestyle in people that were formula fed in early 
life. 
 
Obesity did not result in tissue specific changes in the expression of markers 
of tissue sensitivity to insulin and glucocorticoids, nor did it result in the 
expected redistribution of adipose tissue growth. A combination of formula 
feeding and obesity did result in a redistribution of adipose tissue growth but 
was opposite from what was expected - namely in the direction of the 
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perirenal depot. This redistribution could not be explained by differential 
expression of markers of the tissue sensitivity to the effects of insulin or 
glucocorticoids. Possible other mechanisms that could explain this 
redistribution could be differential expression of leptin and adiponectin. 
7KH LQFUHDVH LQ ȕ-HSD1 and decrease in Glut4 expression which were 
found in formula fed animals at 3 months of age appeared to be no longer 
present at the age of one year. However, the investigated animals at one 
year of age which were formula fed were all significantly obese and obesity 
per se had significant effects on the expression of markers of tissue 
sensitivity to the effects of insulin and glucocorticoids. These effects were of 
a considerable magnitude which could potentially mask any effects of 
formula feeding per se. Future studies will therefore focus on the effects of 
formula feeding in lean animals.  
 
The reduction in markers of tissue sensitivity to glucocorticoids and to insulin 
in response to obesity was present in both adipose tissue depots. This 
opposes our initial hypothesis that differences in the regional adipose tissue 
distibution are secondary to regional differences in the balance between 
tissue sensitivity to the actions of insulin and glucocorticoids. It further 
opposes our hypothesis that high sensitivity to the actions of glucocorticoids 
or insulin in the long term results in adipogenesis.  
 
Given this large body of evidence against our hypothesis, we feel that we 
can conclude that adipose tissue growth and distribution in sheep are not 
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directly explained by changes in the tissue specific expression of markers of 
tissue sensitivity to the actions of insulin, glucocorticoids and insulin like 
growth factors.  
 
The formula feeding study was the only study that supported evidence that 
had opposing effects on adipose tissue sensitivity to the actions of 
glucocorticoids and the actions of insulin. However, this effect was not depot 
specific and did not result in a redistribution of adipose tissue growth. 
 
Our hypothesis was based on glucocorticoids promoting lipolysis in the short 
term, however no single relationship was found between tissue sensitivity to 
the effects of glucocorticoids and a reduced short term adipose tissue 
growth. 
Some relationships did favour the expected long term adipogenic effects of 
glucocorticoids, such as the increaVHG H[SUHVVLRQ RI ȕ-HSD1 in formula 
fed animals. Furthermore relationships were found that supported our 
hypothesis of a synergistic relationship between glucocorticoids and IGF1.  
 
Our studies have clearly shown, for the first time, the differential growth 
patterns of adipose tissue depots during postnatal life. Furthermore our 
studies have clearly shown, in a large number of cohorts and animals,  that 
expression of markers of tissue sensitivity to the actions of insulin, 
glucocorticoids and insulin like growth factors is significantly different 
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between different adipose tissue depots in the body, highlighting the 
importance of examining those depots individually in future studies. 
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